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Abstract 
Total knee arthroplasty (TKA) is an effective procedure for the management of late stage knee 
osteoarthritis (OA), and one which is increasing in demand. There are numerous surgical 
approaches of which the subvastus approach (SVa) and medial parapatellar approaches (MPa) are 
two options. Despite claims that SVa provides superior outcomes to the more common MPa, there 
has been little investigation into the physical and functional outcomes associated with each 
approach or their relative effect on patellar vascularity. Studies that have compared the approaches 
contain methodological flaws affecting confidence in the conclusions drawn. Indications for when a 
patient requires referral to an orthopaedic surgeon for TKA are also unclear. A better understanding 
of how surgical approach affects outcomes, and when a patient should be referred to an orthopaedic 
surgeon for review of their knee OA may optimise outcomes and improve efficiencies in patient 
selection. 
The aims of this thesis were to address deficits in the literature concerning the relative merits of the 
MPa and SVa in TKA, and the clinical indications for TKA. The first aim was to conduct a 
systematic review of the literature to compare the two approaches to determine whether one had 
superior outcomes over the other. The second aim was to conduct a randomised controlled trial 
comparing the physical and functional outcomes associated with MPa and SVa in TKA in the short, 
and medium (18 month) terms. The third aim was to conduct a sub-study to determine whether the 
SVa maintained better patellar vascularity than the MPa, thereby reducing the risk of avascular 
necrosis (AVN) and anterior knee pain. The final aim was to conduct modelling to determine if 
physical measures, patient-assessed scoring instruments and/or clinical rating systems could be used 
as indicators for the timely referral of patients to an orthopaedic surgeon.  
Results of the systematic review revealed insufficient or equivocal evidence supporting the SVa 
over the MPa. The methodological quality of most studies was poor as they either failed to 
randomise appropriately, adequately conceal allocation, report complications, define inclusion and 
exclusion criteria, or define outcomes. The use of heterogeneous outcomes prevented pooling of 
data for meta-analysis which may have resulted in stronger conclusions.  
The randomised controlled trial was designed and conducted to address the limitations that were 
highlighted by the systematic review. The American Knee Society Score (AKSS) was used as the 
primary outcome from pre-operatively to 18 months. Secondary outcomes were knee pain, the 
Oxford Knee Score, three metre Timed Up and Go test, knee flexion, extension, quadriceps lag on 
straight leg raise (SLR), days to SLR, knee girth, length of hospital stay, operation duration, 
tourniquet time and surgeon perceived level of difficulty with the approach. Results of the 
vii 
randomised controlled trial, using linear mixed modelling for the analysis of continuous variables, 
revealed no difference on any outcome at any time-point between the SVa and MPa groups. The 
exceptions were earlier SLR in the SVa group, better AKSS Objective scores on day 1 post-
operatively in the SVa group but overall better AKSS Functional scores at 12 and 18 months for the 
MPa group. While earlier SLR was observed in the SVa group, the surgeons perceived this 
approach as more difficult.  
Patellar vascularity was assessed using two novel methods developed for this trial from nuclear 
medicine imaging techniques. These were the pat:fem ratio, which is a ratio of photon counts in the 
patella compared to a standardised region of interest on the femur; and the five-point Bone 
Vascularity Scale (BVS), which is a new quantitative method for analysing images of vascularity. 
There was no difference in patellar vascularity between groups on either the pat:fem or the BVS 
measures.  
The model developed to assist primary health care providers to decide when to refer a patient with 
knee OA to an orthopaedic surgeon, incorporated the AKSS Functional score and knee flexion 
range of motion (AKSSFun/flexion) and predicted group allocation accurately 95% of the time 
(Odds Ratios: 1.28 to 3.40 for 1º and 5º parameter changes in flexion respectively). 
This research program found, on balance, no substantive evidence supporting the superiority of the 
SVa over the MPa over a range of physical, functional and vascularity measures. The findings 
therefore refute previous supposition and claims of advantages the SVa provides over the MPa.  
Keywords 
arthroplasty, replacement, knee, subvastus, medial parapatellar, patellar vascularity, probability 
Australian and New Zealand Standard Research Classifications 
(ANZSRC) 
110314 Orthopaedics 70%, 110317 Physiotherapy 20%, 110313 Nuclear Medicine 10% 
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1 Introduction 
1.1 Background 
Total knee arthroplasty (TKA) for the management of knee osteoarthritis (OA) has increased by 
54.9% per annum since 2003 (Australian Orthopaedic Association, 2011). More than 44,000 knee-
related prosthetic procedures were performed in Australia in 2009, which is a 7.6% increase on the 
previous year. Of these, 85.4% were primary TKAs (Australian Orthopaedic Association, 2011). 
The demand for TKAs is expected to increase in future years alongside an increase in the 
prevalence of knee OA (National Institute of Health, 2004). TKA has proven to be effective as a 
treatment for end stage knee OA and is a well established intervention with favourable outcomes 
relating to decreased pain and improved function (Callahan et al., 1994, 1995; Dieppe et al., 1999).  
There are many considerations a surgeon must address when planning for and performing a TKA. 
These considerations include but are not limited to: the surgical approach to the joint, the type of 
prosthesis, the use or not of bone cement to fixate the prosthesis, the use of wound drains and 
tourniquets, thromboprophylactic management, the method of anaesthesia, and types of wound 
dressings (Solomon et al., 2010). With limited health resources, a plethora of options, and a paucity 
of empirical evidence for combinations, there is a need to determine which options provide better 
physical and functional outcomes. 
One of the key options requiring investigation is the surgical approach to the joint. There are 
numerous options for the approach, each with its own merits. There is, however, a lack of evidence 
supporting one over another. The medial parapatellar approach (MPa) is the most common 
approach and is well described by  Stern (2002). It affords excellent exposure as it extends 
proximally from the superior pole of the patella into the extensor mechanism by 60 to 80mm. The 
subvastus approach (SVa) is arguably more difficult and accesses the knee under the quadriceps 
muscle (Hofmann et al., 1991). This surgical approach purportedly affords better outcomes with 
research demonstrating better quadriceps function (Faure et al., 1993; Cameron, 2001; Roysam et 
al., 2001; Cila et al., 2002; Weinhardt et al., 2004), and less pain (Cameron, 2001; Roysam et al., 
2001; Weinhardt et al., 2004) when compared to the MPa. There are, however, inconsistent findings 
on other outcomes. For example, Cameron et al. (2001) reported flexion was better in the SVa by, 
which did not concur with Roysam et al. (2001) who found no difference. The trend of 
inconsistencies favouring the SVa is found across other outcomes including blood loss (Faure et al., 
1-1 
1993; Cameron, 2001; Roysam et al., 2001; Weinhardt et al., 2004) and length of surgery (Faure et 
al., 1993; Cameron, 2001; Weinhardt et al., 2004). To address the seeming lack of concordance in 
the literature, a systematic review which focused on the quality of the methodology of the research 
that investigated the outcomes of the SVa when compared to the MPa was required. The review 
found only five studies that compared the relative merits of these two arthrotomies (Faure et al., 
1993; Cameron, 2001; Roysam et al., 2001; Cila et al., 2002; Weinhardt et al., 2004) and due to 
study design limitations including randomisation and blinding concerns, firm conclusions about the 
superiority of either approach was not possible. 
It is biologically plausible that a patient with less pain, better quadriceps function, greater knee 
range of motion and less blood loss will be independently mobile sooner than someone who is not. 
As these factors are critical in determining when discharge from hospital is appropriate, it follows 
that length of stay could be reduced if it were found that the surgical approach to the knee could 
positively influence these outcomes. Therefore, in order to optimise outcomes and direct resources 
towards the most efficacious practices for TKA, there is a need to further investigate and define the 
effect of surgical approach on physical and functional outcomes. As the answer to this question is 
not clear from the existing literature, a randomised controlled trial comparing the MPa and SVa on 
both physical and functional outcomes is required. One of the strongest arguments used to support 
the SVa is the theoretical advantage of improved blood supply achieved by preservation of the 
patella arterial supply (Hofmann et al., 1991) and the avoidance of subsequent avascular necrosis 
(AVN), a complication that the SVa purportedly avoids (Hofmann et al., 1991). The effect of the 
surgical approach on the patency of the geniculate arteries that nourish the patella, and subsequent 
anterior knee pain requires investigation. 
Furthermore, the indications for TKA are not definitively known, with reasons such as pain 
(Mancuso et al., 1996; Naylor et al., 1996; Hadorn et al., 1997), loss of joint space or joint damage 
(Mancuso et al., 1996; Hadorn et al., 1997), high patient motivation (Mancuso et al., 1996), 
functional impairment (Naylor et al., 1996; Hadorn et al., 1997), radiographic severity (Kellgren et 
al., 1950; Ahlback, 1968; Insall et al., 1989), and problems with care giving (Naylor et al., 1996; 
Hadorn et al., 1997) all cited as potential indicators. However, there are currently no definitive 
quantitative criteria to assist primary health care providers, such as physiotherapists, in determining 
when patients warrant referral to an orthopaedic surgeon for consideration for surgical intervention. 
Indecision may result in inappropriate referrals, longer waiting times and higher costs. To address 
these issues, a quantitative method that is based on both functional and objective outcomes is 
required. 
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The implications of knowing which approach produces superior physical, functional and vascularity 
outcomes are numerous. Should the SVa afford better outcomes, there will be an imperative for 
surgeons to use it for appropriate patients. A reduction in pain and earlier return to function will 
reduce the burden of recovery on patients and health care systems. Additionally, the long term 
debilitating effect of anterior knee pain due to AVN may be a complication relegated to surgical 
history books. Finally, being able to quantify which patients require referral to an orthopaedic 
surgeon will ensure appropriate and timely referrals resulting in improved patient satisfaction and 
appropriate use of orthopaedic services. 
1.2 Thesis aims 
The purpose of this thesis was to investigate whether the SVa in TKA affords better physical and/or 
functional outcomes than the more commonly performed MPa and to investigate whether either 
surgical approach influences the incidence of subsequent AVN. In addition, the question of when 
patients should be referred to an orthopaedic surgeon will be addressed.  
Specifically, the aims of this thesis are: 
A1:  to systematically review current literature comparing the MPa and SVa in TKA to determine 
whether one has superior outcomes over the other; 
A2: to conduct a randomised controlled trial to compare the physical and functional outcomes 
associated with MPa and SVa in TKA in the short and medium (18 month) terms; 
A3: to determine whether the SVa maintains vascularity to the patella better than the MPa, 
thereby reducing the risk of AVN and anterior knee pain; and 
A4: to conduct modelling to determine if physical measures, patient-assessed scoring 
instruments and/or clinical rating systems could be used as indicators for the timely referral 
of patients to an orthopaedic surgeon. 
1.3 Hypotheses 
The hypotheses related to the experimental research (A2–A4) were that:  
H1: (i) participants receiving the SVa would experience better early outcomes than those 
receiving the MPa and (ii) that outcomes would converge by 18 months after surgery; 
H2: the SVa would have better outcomes for vascularity and anterior knee pain than the MPa 
due to the extensive dissection of the patellar arterial blood supply in the MPa; and 
H3: a model based on physical and functional measures could be used to quantify when it is 
appropriate to refer a patient to an orthopaedic surgeon.  
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1.4 Thesis overview 
This thesis first presents a concise summary (Chapter 2) of knee OA and TKA. It includes 
information about the epidemiology and pathology of OA with a brief outline of conservative 
management of the osteoarthritic knee. Chapter 2 also outlines indications for TKA and focuses on 
surgical approaches and complications of TKA. Chapter 3 reports a systematic review of the 
literature comparing the MPa and SVa in TKA. Chapter 4 reports the details of a randomised 
controlled trial comparing the SVa and MPa in TKA. Chapter 5 investigates patellar vascularity 
after TKA using nuclear medicine technologies, and introduces a novel vascularity scoring system. 
Chapter 6 investigates a model based on physical and functional outcomes to determine when a 
patient with knee OA should be referred to an orthopaedic surgeon. The discussion (Chapter 7) and 
conclusion (Chapter 8) address the implications and limitations of the research and future directions 
for research in this area. 
References cited in this body of research are presented as a single list at the conclusion of the thesis, 
rather than after each chapter (including the published papers) to avoid repetition in their listing. 
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2 Knee osteoarthritis and arthroplasty 
Total knee arthroplasty (TKA) is an effective procedure for obtaining favourable outcomes in the 
management of late stage knee osteoarthritis (OA) (Callahan et al., 1994). This chapter reviews the 
incidence, pathology and conservative management of knee OA and discusses TKA from an 
historical perspective. Surgical approaches in TKA are outlined including the subvastus approach 
(SVa) and medial parapatellar approach (MPa) upon which a comparison forms the basis of this 
thesis. 
2.1 Epidemiology and incidence of knee osteoarthritis 
OA is the most common indication for knee arthroplasty (DeFrances et al., 2006; Australian 
Orthopaedic Association, 2010). OA varies with ethnicity, with Chinese demonstrating a lower 
incidence than Caucasians, and people of African descent demonstrating up to a 35% higher 
incidence than Caucasians (Braga et al., 2009; Nelson et al., 2010). There is a genetic component to 
the disease which is associated with a 30% higher risk of knee OA progression (Kerkhof et al., 
2010). Two other factors which increase the risk of established OA progressing are the presence of 
low vitamin D (serum 25-hydroxyvitamin D) (McAlindon et al., 1996) and low vitamin C 
(McAlindon et al., 1996). Additionally, low selenium levels are associated with worse knee OA 
(Jordan et al., 2005). OA is known to progress in the anatomically malaligned knee and will 
accelerate in the compartment or area where compressive forces are highest (Sharma et al., 2001; 
Solomon et al., 2010). The risk of progression is up to four times more for medial compartment 
disease than for that of the lateral compartment (Cerejo et al., 2002). Ligamentous laxity is an 
unconfirmed risk factor for knee OA (Zhang et al., 2010), also leg length discrepancy of greater 
than 2cm doubles the likelihood of osteoarthritic knee symptoms and radiographic findings 
(Golightly et al., 2007).  
Demand for TKA is expected to increase in line with an increase in the prevalence of OA (National 
Institute of Health, 2004). In the 10 years from September 1999 to December 2009, 333,764 knee 
related prosthetic procedures were performed in Australia (Australian Orthopaedic Association, 
2011). Figures published by the Australian Orthopaedic Association indicate that in the 2009 
calendar year there were 44,490 knee-related prosthetic procedures carried out in Australia, an 
increase of 7.6% on the previous year. Of these, 80.7% were primary TKA.  
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2.2 Pathology and presentation of osteoarthritis  
Osteoarthritis is a process of progressive degenerative change with attempted repair of hyaline 
cartilage and subchondral bone. It is the most common joint disease in the world (Felson et al., 
1998) and may be primary (i.e. no apparent cause, age related) or secondary in nature (i.e. related to 
other processes, e.g. diabetes, haemochromatosis, post trauma, obesity) (Kumar et al., 2005). 
Hyaline cartilage is present in synovial joints and coats the ends of bones. Its main functions, when 
combined with synovial fluid, are to reduce friction associated with joint movement and to attenuate 
forces associated with joint compression (Kumar et al., 2005). Hyaline cartilage is made up of Type 
II collagen and proteoglycans which are secreted from chondrocytes (Kumar et al., 2005). Although 
OA is largely thought to be a mechanical process of wear and tear, other factors such as 
chondrocyte viability and genetic factors may be causes. Across a broad range of ethnic groups, 
genome-wide association scan technology has identified three loci with alleles associated with OA, 
which affirm the contention that OA has a genetic component (Kerkhof et al., 2010). 
Early in the disease two concurrent processes occur. The cartilage is excessively hydrated and there 
is a reduced density of proteoglycans; Type II collagen synthesis reduces, thereby changing the 
ability of the cartilage to attenuate compressive forces. Fissures form both vertically and 
horizontally eventually exposing subchondral bone (van den Berg, 2011). As the disease process 
progresses, the chondrocytes are unable to keep up with the required rate of regeneration of 
proteoglycans and Type II collagen thus leading to cartilage failure. In response to the load, which 
is now unable to be adequately attenuated by the cartilage, the cancellous bone underlying the 
defect becomes sclerotic and appears eburnated. The space between the articular surface narrows 
and small fractures and/or bony loose bodies are not uncommon. As synovial fluid enters the 
subchondral space through these defects, cysts are formed. Osteophytes coated with fibrocartilage 
present around the margins of the joint (Kumar et al., 2005; Solomon et al., 2010). The key 
radiographic features of an osteoarthritic joint are joint space narrowing, marginal osteophytes, 
subchondral sclerosis and subchondral cysts (Solomon et al., 2010). 
OA was originally graded in the 1950s by Kellgren and Lawrence using x-rays (Kellgren et al., 
1957). They used a five-point scale to grade OA where: 0=None, 1=Doubtful, 2=Minimal, 
3=Moderate and 4=Severe. The more common contemporary method is the Osteoarthritis Research 
Society International (OARSI) OA cartilage histopathology assessment system (Pritzker et al., 
2006). In this seven-point system, Grades 0–4 describe the articular cartilage, while Grades 5–6 
describe bony changes. The grades are: Grade 0=surface intact, cartilage morphology intact; Grade 
1=surface intact (superficial fibrillation); Grade 2=surface discontinuity; Grade 3=vertical fissures 
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(clefts); Grade 4=erosion; Grade 5=denudation (sclerotic bone); and Grade 6=deformation (bone 
remodelling). Figure 2-2 illustrates varying degrees of OA within a joint immediately prior to TKA. 
 
Figure 2-1 Knee joint osteoarthritis prior to total knee arthroplasty 
 
The patient with OA of a primary nature usually presents in their fifties or beyond describing 
stiffness of the joint, a deep, dull ache in the joint (DeFrances et al., 2006), crepitus with movement 
and some loss of range of movement. The disease is progressive and debilitating. Peripheral joints 
most commonly effected are the knees, hips, interphalangeal joints of the fingers and both the first 
carpometacarpal and tarsometatarsal joints (Kumar et al., 2005). The pain associated with knee OA 
fluctuates, and to some degree is activity dependent. Investigation of the effects of activity 
modification during painful periods is difficult because patients’ experience of pain and how they 
will answer pain-related questions is not solely dependent on the painful joint. Answers are also 
based on pain elsewhere in the body, its variability and the functional impact of pain (Gooberman-
Hill et al., 2007). 
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Some areas of the knee are aneural. Types three (A delta) and four (C) nerve fibres are the primary 
nociceptors in the knee joint and are not found in hyaline cartilage or deep avascular portions of the 
meniscus (Wyke, 1981). They are found in most other surrounding structures. Importantly they are 
found in subchondral bone, which explains why pain near to the cartilage may be experienced 
(Wojtys et al., 1990). It is probable that the most pain-sensitive structures in the knee are the pre-
patellar fat pad, entheses and synovium. Increased pressure in the subchondral space is the likely 
cause of bone pain in OA (Samuel, 1949; Kellgren et al., 1950; Dye et al., 1993).  
People with OA of the knee experience lower levels of function than those without. People with 
knee OA are likely to have poor function if they have proprioceptive dysfunction, knee laxity, high 
body mass index (BMI), high pain levels, or are older (Sharma et al., 2003). Those with good knee 
strength, good mental health, high self-efficacy and good social supports tend to demonstrate better 
function (Sharma et al., 2003). More than half of people with OA are less physically active than 
recommended (Hootman et al., 2003). Additionally, OA sufferers’ pain and disability scores are 
positively correlated with anxiety and depression scores (Salaffi et al., 1991). Depression is 
associated with a higher risk of symptomatic OA (Kim et al., 2011). Apart from reducing knee pain, 
TKA aims to improve function.  
2.3 Knee osteoarthritis non-surgical management 
A number of non-surgical options exist for the management of knee OA and may be categorised as 
non-pharmacological or pharmacological. 
2.3.1 Non-pharmacological management 
There are numerous purported interventions for the management of knee OA. Perhaps the most 
succinct and recent synthesis of this information is presented in the recent review by March et al., 
(2010) of the Australian (RACGP Osteoarthritis Working Group, 2009), United Kingdom (National 
Collaborating Centre for Chronic Conditions, 2008) and North American (Zhang et al., 2008) non-
surgical OA management guidelines. These guidelines present evidence-based recommendations for 
the following non-surgical interventions for knee OA: patient information and education, weight 
reduction, land-based exercise, and heat and cold therapy for pain relief. There is inconclusive 
evidence across the guidelines regarding the value of acupuncture. Both the Australian and North 
American guidelines provide Level I evidence for acupuncture, whereas the United Kingdom 
guidelines do not recommend this modality. The use of bracing and orthoses has similar conflicting 
recommendations (March et al., 2010). 
More recently, new evidence has emerged that Transcutaneous Electrical Nerve Stimulation 
(TENS) combined with either traditional Chinese acupuncture or sham acupuncture (shallow 
2-4 
needling at non-meridian sites) may equally reduce pain in OA knees (Suarez-Almazor et al., 2010). 
Interestingly, it is thought that the analgesic benefits of acupuncture are partially mediated by the 
acupuncturist’s behaviour (Suarez-Almazor et al., 2010). When the effect of TENS or other electro-
stimulation on knee OA was systematically reviewed and examined in isolation, the quality of the 
trials was poor and there was no evidence to support the effect of these modalities (Rutjes et al., 
2009). For a population with an average BMI of 30, it was shown that 60 minutes of Tai Chi twice a 
week for 12 weeks could reduce pain and disability (Wang et al., 2009). 
2.3.2 Pharmacological management 
Pharmacological management including paracetamol, either oral or topical non-steroidal anti-
inflammatory drugs (NSAIDs), topical capsaicin, opioids or intra-articular corticosteroid injections 
also carry consensus recommendations (March et al., 2010). NSAIDs can cause adverse events in 
the upper gastro-intestinal tract (ulcer, perforation, bleeding, obstruction) (Moore et al., 2006). 
Recent research suggests adverse events in the lower gastro-intestinal tract may have been 
underestimated and further research is required into the use of COX-2 selective NSAIDs versus 
conventional NSAIDs (Berenbaum, 2011). 
Other therapies such as glucosamine, chondroitin sulphate or those included under the banner of 
viscosupplementation demonstrate equivocal evidence or evidence of no benefit (March et al., 
2010). The effects of glucosamine and chondroitin sulphate have traditionally been examined from 
x-ray databases and to date, neither therapy alone or combined has reached clinically important 
differences in changes of joint space width. Furthermore, there is no definitive evidence that they 
reduce joint pain (Wandel et al., 2010).  
2.4 TKA for the management of late stage knee OA 
In attempts to prolong the longevity of joint integrity, other procedures for the management of knee 
OA such as knee arthroscopy, high tibial osteotomy (HTO) or unicompartmental knee arthroplasty 
(UKA) may precede an eventual TKA. Once knee OA progresses throughout the joint, however, 
TKA is considered to be the gold-standard in management and results of positive outcomes include 
relief of pain and enhanced functionality (Liang et al., 1986; Anderson et al., 1996; Ethgen et al., 
2004; 2004; Kane et al., 2005; Räsänen et al., 2007; Hawker et al., 2009). Indeed, at a cost of 
approximately $AUD10,000 per quality of life year gained, it is a highly cost effective solution to 
the management of late stage knee osteoarthritis (Malik et al., 2005). Consequently, due to the 
resources required to perform an increasing number of TKAs and the impact of surgery on 
individual patients, it is important that surgical procedures are optimised to ensure efficient surgery 
and best possible outcomes.  
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2.4.1 History of knee arthroplasty 
Surgical management of knee OA commenced in the late 19th century and is reported to have begun 
in 1861 when Fergusson created what he called a “useful limb” by resecting the articulating 
surfaces and creating a pseudarthrosis (Riley, 1976). The approach consisted of a wide exposure 
followed by debridement and re-shaping of the diseased joint tissue. Interposition of various 
materials (interposition arthroplasty) followed for the management of OA and was thought to have 
originated in 1860 when Verneuil used joint capsule between the opposing joint surfaces (Palmer et 
al., 2010). Reports were made in 1890 of Theophilus Gluck from Berlin implanting units made of 
ivory and stabilised with plaster of paris and colophony (Riley, 1976; Ranawat, 2002). Numerous 
other materials were interposed for the ensuing 90 years including chromicised pig’s bladders 
(Baer, 1918), fascia lata (Putti, 1920), prepatellar bursa (Campbell, 1921), fascia lata and fat (Albee, 
1928), vitallium crowns (Campbell, 1940), cellophane (Sampson, 1949), interposed sheets of nylon 
(Khuns, 1950), and skin (Riley, 1976). Concurrent with the era of interposition arthroplasty, 
arthrodesis was producing predictable and reliable outcomes, and it remained the treatment of 
choice during the era (Riley, 1976). Metallic interposition arthroplasty of the hip reported by Smith-
Peterson in late 1930s preceded the first attempt at such a procedure in the knee by Dr Harold Boyd 
in 1938 (Riley, 1976). Despite further attempts at interposition arthroplasty, which persisted until 
1969 (Platt et al., 1969), surgeons abandoned the technique due to poor outcomes. 
Advances in metallurgy saw hinged prostheses as the theme of the next era in TKA, and it was in 
the 1950s that Waldius (1953) and Shiers (1954) implanted the first hinged knee prosthesis. 
Waldius’ prosthesis was upgraded from acrylic to cobalt-chrome (Co-Cr) in 1958 and was used 
until the 1970s (Ranawat, 2002). Shiers did not patent his prosthesis but rather invited others to 
improve on his ideas. He used a lateral approach and preferred a prosthesis that allowed flexion, 
extension to neutral and provided medio-lateral stability (Shiers, 1954). In 1953 a distal femoral 
mould type prosthesis was reported by surgeons of the Massachusetts General Hospital (Jones et al., 
1967). Hinged prostheses were accepted in the 1960s but the major advances came after hip 
arthroplasty pioneer, John Charnley, discovered that cobalt-chrome and polyethylene prostheses 
could be successful if cemented into bone using methylmethacrylate (Riley, 1976). Hinged 
prostheses did not allow for the small amounts of rotation that are required for normal knee 
movement and these rotational forces ultimately caused loosening of the prosthesis at the bony 
interface. As a solution to this, Gunston in 1968 performed the first polycentric knee arthroplasty. It 
was the first separate metal-on-plastic prosthesis and it retained soft tissue constraints mimicking 
normal knee movements. Subsequent developments saw the Freeman-Swanson cruciate-sacrificing 
“roller into trough” design emerge in 1970, and in 1971, the first geometric unit was used (Coventry 
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et al., 1972). Both polycentric and geometric units were unhinged. In the early 1970s a 
spherocentric, ball and socket prosthesis was the first attempt to address rotation constraints 
associated with cement-bone interface loosening that was experienced with its predecessors (Riley, 
1976). 
The next successful prosthesis was the total condylar design. Three prostheses were developed in 
the early 1970s by the Insall and Ranawat team in New York, USA; the Coventry and Turner team 
in the United Kingdom; and Townley in Michigan, USA (Insall et al., 1979; Ranawat, 2002). All of 
these retained the cruciate ligaments and used polymethylmethacrylate cement. The first prosthesis 
to sacrifice both cruciate ligaments was the Freeman-Swanson knee (Freeman et al., 1973) but this 
was ultimately withdrawn from the market due to tibial fixation issues associated with a short tibial 
peg (Ranawat, 2002). Insall and Ranawat, New York, USA, continued to develop their total 
condylar design with the addition of posterior stabilisation with a tibial peg (Insall et al., 1982). 
This peg was designed to reduce the risk of posterior dislocation and allow more flexion and better 
stair-climbing ability (Fu et al., 1994).  
The first press-fit condylar (PFC) total knee system was implanted in 1984 by Scott and Thornhill 
and it retained the posterior cruciate ligament (PCL). The system was a fixed bearing prosthesis and 
the components could be cemented or uncemented with or without a porous coating (Scott, 2006). 
In 1986, the Low-Contact Stress (LCS) mobile bearing prosthesis was implanted and was the first 
of its kind to include a mobile bearing surface. Prostheses to this point did not have a metal tibial 
plate under the polyethylene. In the early 1990s the use of a metal tibial plate plus the addition of 
longer tibial pegs and deeper femoral boxes saw a reduction in tibial plate loosening and reduced 
rates of posterior subluxation (Fu et al., 1994). The PFC system was further developed in the late 
1990s to eventually incorporate a mobile-bearing rotating platform that could retain, sacrifice or 
substitute the PCL (Scott, 2006). 
Since the mid 1990s there have been many minor, but no major advances in technology, compared 
with earlier in the century. Some of the prosthetic designs with as yet unsubstantiated claims 
include gender specific prostheses, high flexion prostheses and anatomical knee prostheses 
(Ranawat, 2002). The latter claims to facilitate preferential spinning in the medial compartment and 
rolling in the lateral compartment, as happens in vivo in normal knees. Apart from prostheses, 
developments in the last 15 years have addressed fixation, bearing surfaces, kinematics, range of 
motion and instrumentation as well as the advent of computer assisted navigation (Ranawat, 2002). 
Further, the inventory available to the surgeon is substantially larger affording greater choice of 
components. The trend towards minimally invasive surgery (MIS) is enticing and it is being 
performed with regularity by more experienced surgeons. The use of regional anaesthesia and 
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epidural anaesthesia is also now common practice and allows patients to mobilise early post-
operatively with optimal pain relief (Sarridou et al., 2008). 
2.4.2 Indications for total knee arthroplasty 
The only unanimously agreed indicator for TKA is a failure to relieve arthritis related pain with 
pharmacological and non-pharmacological therapy. There is equivocal agreement for TKA for 
conditions or circumstances including septic arthritis less than 12 months, nursing home residency, 
obesity and severe OA (Cross et al., 2006). Crockarell et al. (2003) and Solomon et al. (2010) have 
stated that functional deterioration due to pain, deformity (e.g. flexion contracture >20 degrees) or 
instability in the presence of joint pathology further indicate the need for TKA. As an additional 
consideration, older patients with more sedentary lifestyles may be more suitable for TKA because 
prostheses have a finite survivorship. Younger people with low functional levels due to 
deteriorating systemic arthritis might also be candidates. Current knee sepsis or a well functioning 
arthrodesis are contraindications for TKA (Crockarell et al., 2003; Solomon et al., 2010). 
2.4.3 Indications for referring to an orthopaedic surgeon 
There is little consensus on what clinical indications should be used to determine when to refer 
patients to an orthopaedic surgeon for surgical review (Cross et al., 2006). Indications are largely 
based around the failure of non-surgical management (pharmacological and non-pharmacological) 
to relieve pain and to improve or maintain function. These features can be variably interpreted by 
practitioners, and this has implications for optimising referral times. Knee pain in the presence of 
knee pathology that is not responsive to non-surgical management is the primary indicator for 
referral to an orthopaedic surgeon (Crockarell et al., 2003; Cross et al., 2006). Further indications 
for referral include failed joint preserving procedures such as those described above (e.g. HTO) 
(Cross et al., 2006). There is consensus that a major psychiatric disorder, including dementia, is a 
contraindication as participation in post-operative rehabilitation is required (Cross et al., 2006). 
Whether more objective means such as functional outcome measures can be used to determine the 
appropriate time to refer a patient for surgical review is unknown. This question is addressed in the 
research program in this thesis and is presented in Chapter 6. 
2.4.4 Knee prostheses, bearing surfaces and fixation 
Hinged prostheses are now used rarely in primary TKA due to the pitfalls associated with their lack 
of rotation. When considering the characteristics of contemporary prostheses, therefore, the bearing 
mechanism, stability, fixation, and prosthesis type need to be taken into account.  
The bearing surface describes the articulation between the femoral and tibial component in fixed 
bearing prostheses and the femoral, polyethylene insert and tibial components in mobile bearing 
2-8 
prostheses. A mobile bearing prosthesis has an articulation between the tibial base plate and the 
tibial insert. Contemporary total knee prostheses are mostly mobile bearing and are commonly 
composed of a cobalt-chrome metal femoral component, metal tibial base plate and an ultra-high 
molecular weight (UHMW) polyethylene tibial insert, with or without a UHMW polyethylene 
patella component (Figure 2-2). Occasionally, a fixed bearing all-polyethylene tibial component or 
a metal tibial base plate with a fixed tibial insert may be used. Mobile bearing prostheses have an 
insert that can slide, rotate or slide and rotate (Jacobs et al., 2001; Gioe et al., 2009). The prostheses 
used in the randomised controlled trial presented in Chapter 4 were all of a rotational mobile 
bearing type. 
 
 
Figure 2-2 Low-Contact Stress mobile bearing prosthesis. Medial parapatellar approach. 
Cobalt-Chrome metal femoral component, metal tibial base plate and an ultra-high molecular 
weight tibial insert.  
Stability of the joint is mainly obtained through soft tissue tension and is augmented by two main 
prosthetic features. A flat or dished tibial articulation is considered minimally stabilised whereas a 
posterior stabilised prosthesis has a tibial peg and femoral box design (Insall et al., 1982). Fixation 
of both the femoral and tibial components of the prosthesis may be either cemented or uncemented. 
Hybrid fixation is the term used when only the tibial component is cemented (Rosenberg et al., 
1994). Hybrid fixation of a minimally stabilised prosthesis was the protocol for the trial presented in 
Chapter 4. 
Patella (everted) 
2.4.5 Complications of TKA 
Complications associated with TKA may be localised or more general in nature, and to some extent, 
co-morbidities and the volume of TKAs performed at a facility affect the incidence of 
complications. A greater rate of complication is associated with age greater than 65 years, the 
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number and severity of co-morbidities (e.g. ischaemic heart disease, diabetes mellitus) or if surgery 
is undertaken at a facility that performs less than 25 TKAs annually (Taylor et al., 1997). Mortality 
rates are highest in the first four days post-operatively and are higher in older, obese patients with 
co-morbidities (Parvizi et al., 2007). Table 2-1 outlines the major complications related to TKA 
(Cheung et al., 2008; Australian Orthopaedic Association, 2010; Cross, 2011).  
Mobile bearing prostheses have a higher rate of revision than fixed bearing prostheses. Posterior 
stabilised prostheses have a higher rate of revision, especially if the patella is not resurfaced (Stiehl, 
2009). Regardless of cementing technique, there is no difference in revision rates after 18 months 
(Australian Orthopaedic Association, 2010). 
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Table 2-1 Intra-operative and post-operative complications associated with TKA 
Intra-operative complications 
Local complications 
Poor prosthesis position 
Peri-prosthetic fracture (0.11 – 21.4%) 
Premature cement setting 
Vascular injury (popliteal artery (0.17% )) 
Peroneal nerve injury (associated with flexion contracture, valgus deformity, external leg 
compression, prolonged tourniquet (0.9 – 1.3%))  
Peri-pinhole fracture during computer assisted navigated TKA 
General complications 
Blood loss 
Anaesthetic  
Cardiovascular, renal, respiratory, electrolyte 
Post-operative complications 
Early local complications 
Deep infection (0.5 – 12%) 
Deep vein thrombosis – proximal lower limb (3 – 20%) 
Deep vein thrombosis – calf (23.8 – 60%) 
Pain 
Peroneal nerve injury (associated with post-operative haematoma) 
Stiffness (associated with pain, improper technique or prosthesis size, infection, poor 
compliance with exercise (1.3 – 12%)) 
Wound complications (erythema, superficial infection, skin necrosis) 
Early general complications 
Pulmonary embolism (greater risk if proximal thrombi) 
Post-operative atelectasis 
Late local complications 
Chronic pain 
Patello-femoral pain 
Knee instability or dislocation 
Chronic regional pain syndrome 
Heterotopic ossification 
Stiffness (subacute infection, bonding between cement and implant, painful fibrous intra-
articular bands, arthrofibrosis) 
Prosthesis-related complications 
• UHMW polyethylene wear, synovitis and osteolysis 
• Bearing dislocation of mobile-bearing prostheses 
• Cementless patellar and tibial component loosening 
• Metallosis, metal hypersensitivity 
UHMW = Ultra-high-molecular-weight (polyethylene) 
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2.4.6 Current practice in Australian total knee arthroplasty 
The Australian Joint Replacement Registry is the primary reference for TKA trends in Australia. 
The Registry’s 2011 report presents data on the 269,266 primary TKAs performed since 2003 and 
presents the following information(Australian Orthopaedic Association, 2011): The annual trend for 
total knee arthroplasty is increasing and the female population dominates the demographic, 
representing 57% of patients over the period 2003-2010. Most primary total knee arthroplasties 
have both femoral and tibial components cemented (54.8%) and approximately half involve patellar 
resurfacing (49.5%). The prosthetic system is usually classified by the femoral component and 
those most used in Australia in 2010 were the Triathlon (15.5%), PFC Sigma (11.6%), and Genesis 
II (10.3%), collectively accounting for 37.4% of implants. The Nexgen prosthesis has five separate 
models which accounted for 19.5% of all primary TKA prostheses. The 10 most used prostheses 
represent 83.3% of the market. The NexgenCR/Nexgen prostheses attained the best cumulative 
results by prosthesis as measured by the lowest cumulative revision rate for cemented total knee 
arthroplasty (femoral component/tibial component). The Advantim/Advantim had the best results 
for cementless fixation, while the Vanguard/Vanguard prosthesis was the best performer in the 
hybrid class (Australian Orthopaedic Association, 2011). Primary TKA performed for OA had a 
revision rate of 5.7% at 10 years (Australian Orthopaedic Association, 2010) with the main reasons 
for revision being loosening/lysis (30.7%), infection (22.2%), patellofemoral pain (13.5%), pain 
(9.0%) and instability (5.8%). Persons aged less than 55 years were 4.5 times more likely to require 
a revision than those aged over 75 years (Australian Orthopaedic Association, 2010). 
The Registry does not, however, report on outcomes associated with the surgical approach that a 
surgeon performs. The orthopaedic unit at the hospital where the studies for this thesis were 
undertaken perform between 250-300 TKAs annually. Most of the surgeons routinely perform one 
type of surgical approach, the MPa. The systematic review presented as Chapter 3 summarises the 
evidence comparing the MPa and SVa. To understand how the surgical approach may affect 
outcomes, it is important to comprehend the anatomical structures including blood supply that are 
incised or otherwise insulted during the approach. 
The main blood supply to the patella arises from an extra-osseous anastamotic ring of geniculate 
arteries and the anterior tibial recurrent artery (Scapinelli, 1967). The geniculate arteries include the 
descending geniculate artery (DGA), as well as the supero-medial geniculate (SMG), supero-lateral 
geniculate (SLG), infero-medial geniculate (IMG), and infero-lateral geniculate (ILG) arteries 
(Scapinelli, 1967). They supply an intra-osseous network consisting of mid-patellar and polar 
vessels (Scapinelli, 1967; Benson et al., 1998). An insult to the extra-osseous network will affect 
2-12 
the intra-osseous network. Additionally, deep peri-patellar arteries not arising from the anastamotic 
ring, penetrate the medial, superior and lateral borders of the patella (Bjorkstrom et al., 1980). 
 
2.4.7 Outcome measures for total knee arthroplasty research 
There are numerous outcome measures in research investigating TKA but there is no validated scale 
that measures objective outcome after TKA (Martimbianco et al., 2012). One of the more 
commonly used measures is the American Knee Society score (AKSS). It is broadly applied and 
consists of 100 points each for its functional and objective components (Insall et al., 1989). It 
contains all of the variables in Table and for this reason it was chosen as the primary outcome for 
research presented in this thesis. 
Table 2-2 The American Knee Society score 
Objective AKSS Points Functional AKSS Points 
Pain 
None 
Mild or occasional 
Stairs only 
Walking and stairs 
Moderate 
Occasional 
Continual 
Severe 
 
50 
45 
40 
30 
 
20 
10 
0 
Range of motion 
(5° = 1 point) 
 
25 
Stability 
(maximum movement in any position) 
Anteroposterior 
<5mm 
5-9mm 
10mm 
 
10 
5 
0 
Mediolateral 
<5° 
6° - 9° 
10° - 14° 
15° 
 
15 
10 
5 
0 
Walking 
Unlimited 
>10 blocks 
5-10 blocks 
<5 blocks 
Housebound 
 
Stairs 
Normal up & down 
Normal up, down with rail 
Up & down with rail 
Up with rail, unable down 
Unable 
 
Functional deductions 
Cane 
Two canes 
Crutches or walker 
Other 
 
Functional knee score 
 
50 
40 
30 
20 
10 
 
 
50 
40 
30 
15 
0 
 
 
-5 
-10 
-20 
-20 
 
/100 
Flexion contracture 
5° - 10° 
11° - 15° 
16° - 20° 
>20° 
 
-2 
-5 
-10 
-15 
  
Extension lag 
<10° 
10° - 20° 
>20° 
 
-5 
-10 
-15 
  
Objective knee score /100   
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Although the score was developed by consensus opinion, it has since been found to be reliable 
(Objective AKSS inter-rater (ICC 0.87), intra-rater (ICC 0.80); Functional AKSS inter-rater (ICC 
0.89), intra-rater (ICC 0.81) (Martimbianco et al., 2012). Further the AKSS functional score is 
moderately correlated with Western Ontario and McMaster Universities Arthritis Index (WOMAC) 
functional score (Pearsons 0.36) and shows good correlation (Pearson’s linear correlation 
coefficient (r>0.70 and p< 0.005)) with the Short Form 36’s functional capacity domain (Pearsons 
0.56). Additionally it has adequate convergent construct validity with the WOMAC and is 
responsive for patients undergoing TKA (Lingard et al., 2001). 
 
Oxford knee score 
The Oxford Knee Score consists of 12 items; each allocated a maximum score of five points. This 
self-administered score reports on the following domains: pain, difficulty with washing/drying 
oneself, difficulty with transport, walking duration, pain on standing, limp, kneeling, night pain, 
interference with work, giving way shopping ability, and stair climbing (Dawson et al., 1998). The 
score therefore ranges from 12 (least symptoms) to 60 (worst symptoms) and is recommended as 
one of the most appropriate for assessment of outcome after TKA. It is reliable and sensitive to 
clinical change in one patient over time (Dawson et al., 1998; Davies, 2002). 
 
3-metre Timed up-and-go test 
The 3-metre timed up-and-go test (TUG) is a reliable and valid measure that quantifies functional 
mobility and is sensitive to clinical change over time. The patient is timed for the test in which they 
rise from a chair, walk three meters and return to a seated position (Podsiadlo et al., 1991). 
 
Other outcome measures 
The time post-operatively it takes for a patient to perform a straight leg raise (SLR) is an indicator 
of quadriceps recovery after TKA, while the length of hospital stay post-operatively is an indicator 
of a patients speed of recovery after a TKA. Surrogate measures for the complexity of the TKA 
procedure are the duration of the procedure and the surgeon’s perceived level of difficulty. 
 
2.4.8 Surgical approaches in total knee arthroplasty 
There are a number of surgical approaches in TKA, the most common being the MPa, which affords 
excellent visualisation of the surgical field but insults the extensor mechanism 60-80mm proximal 
to the superior pole of the patella (Stern, 2002). The SVa and midvastus approach aim to improve 
on the MPa by preserving the extensor mechanism and medial blood supply (Hofmann et al., 1991; 
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Engh, 2002), while the less common trivector approach is a combination of the MPa and midvastus 
approach and purports similar benefits (Bramlett et al., 2002). The lateral approach is reserved for 
the valgus knee where sequential surgical releases may be required to re-align the knee (Keblish, 
2002). 
Surgeons select a surgical approach that they deem to be appropriate for the patient; however, there 
is no clinical consensus on which approach provides superior results. There is a tendency for 
surgeons to choose the surgical approach with which they are familiar, which is a potential problem 
if an alternative approach may also be appropriate, or provide better outcomes. As a background to 
the comparison of two surgical approaches (MPa and SVa) in this research, an outline of the salient 
information for surgical procedure for each of the major approaches to the knee for TKA is 
provided. 
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Medial parapatellar approach 
A standard anterior midline incision is performed. The MPa extends from the medial one-third of 
the patella distally, 1cm medial to the tibial tuberosity, and proximally 60-80mm from the superior 
pole of the patella. Further dissection directly through the quadriceps allows visualisation of the 
quadriceps tendon, patella and patellar tendon. Most commonly, a medial reticular approach allows 
the patella to be everted and retracted laterally for the duration of the procedure (Insall, 1971; Stern, 
2002). 
 
Tibial tuberosity 
Patella 
Vastus medialis
Figure 2-3 Medial parapatellar approach  
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Subvastus approach 
A standard anterior midline incision is performed. Dissection is carried out through the superficial 
fascia from the quadriceps tendon distally and medial to the tibial tuberosity, incorporating a medial 
skin flap. The vastus medialis is elevated off the medial femur using blunt finger dissection for a 
distance 10cm proximal to the adductor tubercle. The descending geniculate artery is preserved 
within the belly of vastus medialis. The approach commences posteriorly at a mid-patellar level 
across the medial femoral condyle up to the medial border of the patella. It then continues distally 
1cm medial to the medial border of the patella, ceasing 1cm medial to the tibial tuberosity. The 
patella may or may not be everted and dislocated laterally (Hofmann et al., 1991; Kharrazi et al., 
2001; Vince, 2002; Cushner, 2003). 
 
 
Tibial tuberosity 
Patella 
Vastus medialis
Figure 2-4 Subvastus approach 
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Midvastus or intervastus approach 
A standard anterior midline incision is performed. With the knee in flexion the aponeurosis of the 
vastus medialis at the medial border of the patella is exposed. The incision is then extended distally 
to the tibial tuberosity. The vastus medialis insertion is exposed. With the knee flexed, a 5cm 
incision into the belly of vastus medialis is made, ending at the supero-medial border of the patella. 
The capsule is then opened from the supero-medial border of the patella, distally, releasing the 
insertion of vastus medialis but retaining enough capsule on the patella for repair. The capsule and 
synovium are then reflected laterally and medially before the most medial fibres of the patellar 
tendon are released prior to eversion of the patella (Engh et al., 1997; Engh et al., 1998; Engh, 
2002). 
 
 
Tibial tuberosity 
Patella 
Vastus medialis
Figure 2-5 Midvastus approach 
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Trivector retaining approach 
The trivector retaining approach is less commonly performed and purportedly retains the integrity 
of the vastus lateralis, vastus intermedius and vastus medialis in an attempt to minimally affect the 
patella during TKA. This approach is a combination of the MPa and SVa. A straight anterior 
midline incision is performed. The approach commences approximately 5cm proximal to the 
superior pole of the patella, 1.5cm medial to the insertion of vastus medialis into the quadriceps 
tendon. The approach extends inferior and medial to the patella to the level of the tibial tuberosity 
(Stern, 1994; Bramlett et al., 2002). 
 
 
Tibial tuberosity 
Patella 
Vastus medialis
Figure 2-6 Trivector retaining approach 
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Lateral parapatellar approach 
The lateral parapatellar approach for TKA is reserved for valgus deformity and is approached 
sequentially. A lateral incision is performed. The ilio-tibial band is released or lengthened, followed 
by a coronal plane Z-plasty. The patella is then dislocated medially followed by a tibial sleeve 
release and a femoral sleeve release. This approach preserves medial blood supply to the patella and 
leaves the medial quadriceps intact, but care needs to be taken when re-aligning the knee that 
traction on the peroneal nerve branches does not result in nerve damage (Keblish, 2002).  
 
 
Tibial tuberosity 
Patella 
Vastus medialis
Figure 2-7 Lateral parapatellar approach 
 
In the orthopaedic unit where the studies of this thesis were conducted, pain scores and straight leg 
raising ability of patients having simultaneous bilateral TKA (one surgeon performed the MPa and 
another the SVa) were observed to be better for the SVa. The question of superiority of either 
became a point of debate. The MPa is the most commonly performed approach and is reportedly 
preferred by over 90% of surgeons (Malik et al., 2005), but proponents of the SVa claim better 
outcomes. Given there is much discussion advocating better outcomes for the SVa, it is important to 
compare the literature (Chapter 3), conduct a trial comparing the approaches (Chapter 4), and report 
specifically on how patellar vascularity compares (Chapter 5). Furthermore, there is a need to 
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quantify indications for when patients with knee OA should be referred to orthopaedic surgeons 
(Chapter 6). 
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Late stage knee osteoarthritis (OA) can be successfully managed with total knee arthroplasty 
(TKA). Many variables affect the outcome from TKA, one of which is thought to be the surgical 
approach. Whilst proponents of the subvastus approach (SVa) advocate that it is less painful with an 
earlier return to function than the medial parapatellar approach (MPa) (Hofmann et al., 1991), it 
requires investigation. This chapter presents the results of a systematic review of the literature that 
compared the MPa and SVa in TKA. 
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3.1 Abstract 
This systematic review was performed to compare the outcomes of the MPa and SVa for TKA. Five 
studies, published between 1993 and 2001 met the inclusion quality standards for the review. The 
methodological quality of most studies was poor, and they were not sufficiently homogenous for 
meta-analysis. We found that the evidence was insufficient to demonstrate a clinical or statistically 
significant difference between the MPa and SVa to TKA across all outcomes. Further trials with 
robust methodology, objective and functional outcome measures, and follow-up beyond 6 to 12 
months are required.  
Keywords: knee, subvastus, medial parapatellar, arthroplasty, TKA 
3.2 Introduction 
There were 33,737 TKAs performed in Australia in the 2005/2006 financial year. This was an 
increase of 5.9% compared to the previous year (Australian Orthopaedic Association, 2007), and 
health economists predict the number will continue to increase. Because of the resources required to 
service this increasing number of surgical interventions and the impact of surgery on individual 
patients, it is important to optimise surgical procedures to ensure efficient surgery and best possible 
outcomes. The purpose of this article was to perform a systematic review of the literature 
comparing the outcomes associated with two different surgical approaches to the knee commonly 
used in TKA. The two approaches reviewed were the MPa and SVa. 
The MPa is arguably the most commonly performed approach and has been very successful despite 
disrupting the quadriceps muscle 50 to 60mm proximally from the supero-medial border of the 
patella. The SVa is less commonly performed and arguably more difficult for the surgeon. The SVa 
aims to preserve the quadriceps muscle and patellar vascularity with dissection performed deep to 
the vastus medialis muscle. Preservation of the quadriceps during TKA is argued to result in less 
pain, earlier functional recovery, and shorter length of hospital stay (Hofmann et al., 1991; Faure et 
al., 1993; Matsueda et al., 2000; Cameron, 2001; Roysam et al., 2001; Cila et al., 2002). Other 
proposed advantages of the SVa include a reduction in analgesic requirements, earlier improvement 
in muscle strength and earlier independent straight leg raising (Hofmann et al., 1991; Faure et al., 
1993; Matsueda et al., 2000; Roysam et al., 2001). (von Langenbeck) first described the MPa for 
TKA in 1878. The approach provides excellent exposure and minimises tibial and femoral 
complications. It does, however, violate a major portion of the extensor mechanism, and the 
potential for vascular injury to the patella, with or without a lateral patella release, is uncommon but 
well described (von Langenbeck, 1878; Scuderi et al., 1987; Kayler et al., 1988; Holtby et al., 
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1996). It has also been postulated that patellofemoral instability and maltracking can occur 
following the MPa (Matsueda et al., 2000). 
In an attempt to mitigate these complications, some authors have advocated a more anatomic 
approach to the knee, in the form of the SVa. Although originally described in the German literature 
in 1929 by Erkes, Hoffman introduced the approach into the English literature in 1991 (Erkes, 
1929; Hofmann et al., 1991). He claimed that the SVa preserves the integrity of the extensor 
mechanism and maintains the vascular supply to the patella. It preserves the vascularity of the 
patella by avoiding the articular branch of the descending geniculate artery that lies within the belly 
of the vastus medialis and joins the patella plexus with the medial superior geniculate artery at the 
supero-medial corner of the patella. Despite the proposed benefits of the SVa, a number of 
disadvantages have been reported, such as difficulty everting the patella (Matsueda et al., 2000) and 
more contraindications when compared with the MPa. The latter include obesity, especially 
combined with a short femur or a heavily muscled patient; hypertrophic changes and secondary 
knee stiffness or a large flexion contracture; revision total knee procedures or any previous major 
arthrotomy; previous high tibial osteotomy; patella infera; excessive valgus knees; skin with 
potential ischemic complications; extremely large tibial or femoral component size; severe 
osteopaenia; and rheumatoid arthritis, due to the need to place a retractor over the lateral femoral 
condyle for distal femoral exposure and the subsequent risk of fracture (Hofmann et al., 1991; 
Knezevich, 1992; Cushner, 2003; Sporer, 2006). 
There are many surgeons performing both procedures on appropriate knees; however, there is no 
clinical consensus on which one provides superior results. There are also surgeons performing 
predominantly one approach where the other approach may also be appropriate. The aim of this 
systematic review was to evaluate current literature comparing the MPa and SVa in TKA to 
determine whether one has superior outcomes to the other. 
3.3 Methods 
A written prospective protocol defining search methods, inclusion and exclusion criteria, quality 
assessment, and data extraction was established in accordance with recommendations for systematic 
review research (Higgins et al., 2009). 
3.3.1 Data Sources 
The search strategy included following terms: (1) Arthroplasty, Replacement, Knee [MeSH] or 
“total knee and replac*” or “total knee arthroplasty” or “TKR” or “TKA”; (2) subvastus or souther; 
(3) media* and parapatellar*; (4) quad* and sparing; (5) standard* and approach*; (6) paramedia*; 
(7) #2 or #3 or #4 or #5 or #6; (8) 1 or 7. Articles published between 1950 and April 30, 2008, in all 
3-24 
languages were retrieved from the following electronic databases: Ovid MEDLINE (1950-), 
CINAHL (1982-), preCINAHL, Cochrane Central Register of Controlled Trials 
(CENTRAL/CCTR) (1996-), EMBASE (1966-), Scopus (1966-), Web of Knowledge (including 
Current Content), MetaRegister of Controlled Trials (mRCT), International Standard Randomised 
Controlled Trial Number Register (ISRCTN), and LILACS. No trials were identified between 1950 
and 1993. 
3.3.2 Study Selection 
All studies comparing the outcomes of MPa versus SVa were initially retrieved. One author (MB) 
subsequently excluded articles (based on title and abstract) on the following criteria: (1) minimal 
incision surgery or computer-assisted surgery; (2) primary focus on unicompartmental knee 
arthroplasty; (3) primary focus was not SVa/southern/quadriceps sparing or MPa/standard 
approach; (4) cadaver procedures; (5) research protocol or article describing surgical procedures; 
(6) articles primarily addressing revision TKA; and (7) animal studies. 
The remaining articles were de-identified by removing all references to the journal, author, year, 
and country of publication and distributed to three independent assessors for quality assessment and 
data extraction. The assessors reviewed the de-identified titles and abstracts for the following 
inclusion criteria: (1) the article investigated both the SVa/southern/quadriceps sparing approach 
and the MPa/standard approaches to TKA; (2) the article reported post-operative outcomes; (3) 
there was a follow-up of at least three days to ensure early post-operative outcomes were 
investigated; (4) the sample had at least five participants; and (5) a global knee rating scale was 
used such as the Hospital for Special Surgery (HSS) score or American Knee Society Score (AKSS, 
objective and /or functional components). Where there was ambiguity regarding the inclusion of a 
study in the review, MB supplied de-identified full text of the article to the assessors. If consensus 
between assessors could not be established a fourth reviewer was available to arbitrate; however, 
the fourth reviewer was not required. 
3.3.3 Quality Assessment 
Quality assessment was undertaken on the full de-identified text of included articles by the 
assessors. A quality of methodology component score (Jadad et al., 1996) out of 12 was awarded to 
each article based on the following criteria (score 1 or 0 per criteria) (Appendix 1): 
1. Was there clear concealment of allocation? 
2. Were the inclusion and exclusion criteria clearly defined? 
3. Were the treatment and control groups adequately described at entry and if so were the 
groups well matched or appropriate covariance adjustment made? 
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4. Were the surgeons experienced in the various approaches prior to the trial? 
5. Were the care programs other than trial options identical? 
6. Were the outcome measures clearly defined in the text with a definition of ambiguous terms 
encountered (e.g. range of motion)? 
7. Were the outcome assessors blind to assignment status? 
8. Was a long-term follow-up performed? Minimum of 6 months. 
9. Was the timing of outcome assessment in both groups comparable and appropriate? 
10. Was loss to follow-up reported and if so were less than 5% of patients lost to follow-up? 
11. Was a sample size calculation performed? 
12. Did the trial include an intention-to-treat analysis? 
Articles were then ranked for level of evidence on a scale of I to IV as per the Australian National 
Health and Medical Research Council levels of evidence scale (Appendix 2) (pilot 2005-2007). 
Articles with a score of 4 or more out of 12 on the scale (Jadad et al., 1996; Clarke, 2001; Khan, 
2005) and a designated level of evidence III-1 (pseudo randomised controlled trial) (National 
Health and Medical Research Council, 2007) or above progressed to data extraction. 
3.3.4 Data Extraction 
The following data were extracted independently by the three assessors. The data were then entered 
into a spread-sheet and checked for accuracy to enable data analysis (Appendix 3). 
 Number of participants in the trial 
 Quality of methodology component score: 
1. Allocation was concealed (yes/no) 
Intervention allocation method 
2. Inclusion criteria were clearly defined (yes/no) 
3. Groups were matched at baseline or appropriate covariance adjustment was made (yes/no) 
4. Surgeons were experienced in both approaches (yes/no) 
5. Care programs other than trial options were identical (yes/no) 
6. Outcome measures were clearly defined (yes/no) 
7. Outcome assessors were blind to assignment status (yes/no) 
8. Length of follow-up (months) 
9. Timing of outcome assessment in both groups was comparable and appropriate (yes/no) 
Timing of outcome assessment 
10. Percent lost to follow-up 
11. Sample size calculation details 
3-26 
12. Intention to treat details 
 
Other data 
Type of approaches investigated 
Date of trial 
Location of trial 
Ethnicity of participants 
Sponsor of trial 
Publication status 
Level of evidence 
Complications (numbers – not percent of total) 
 Deep vein thrombosis, pulmonary embolism, haemarthrosis, haematoma, infection deep, 
infection superficial, intra-operative damage to structures (fractures, soft tissue injury), 
lateral release, related to the prosthesis, respiratory, mortality, re-operation, manipulation 
under anaesthetic (MUA), component loosening, polythene wear, patella maltracking, 
subluxation, and other. 
Post-operative outcomes 
Pain, knee scoring system (AKSS, HSS score, Oxford knee score, other), health-related 
quality of life measures, length of hospital stay (days and cost [$]), days to mobilisation, 
discharge destination, walking aids at discharge, quadriceps function (ability to straight leg 
raise [SLR], lag on SLR), flexion, extension lack, blood loss, patellar vascularity, length of 
surgery, perceived operation difficulty reported by surgeon, imaging results, and other. 
Other adverse outcomes 
Other economic data. 
3.4 Results 
The initial search yielded 788 results: MEDLINE (160), CINAHL (20), PreCINAHL (5), Cochrane 
(31), Embase (193), Scopus (205), Web of Knowledge (including Current Contents) (170), mRCT 
(2), ICTRN (2), LILACS (0). Subsequent weekly automated searches identified no additional 
eligible studies. 
Four hundred and three duplicate references were removed, and MB searched the remaining 385 
titles for exclusion criteria. Ninety-six articles remained and were screened for inclusion criteria by 
the three reviewers. Thirteen articles met the inclusion criteria by the three reviewers and were 
included for quality assessment. Five articles were of sufficient quality (4/12 or higher, III-1 level 
of evidence or better). Of the remaining eight articles, the levels of evidence for seven were III-2 or 
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lower (level III-2 (Brodie et al., 1991), level III-3 (Bindleglass et al., 1996; Engh et al., 1996; 
Matsueda et al., 2000; Chang et al., 2002), level IV (Meyer et al., 1998; Ogata et al., 2004)), and 
one article was a reprint of an earlier version (Roysam et al., 2002). Table 3-1 presents the analysis 
of the studies reviewed, and Table 3-2 illustrates the data that were extracted by the three reviewers. 
3.4.1 Participants and Study Characteristics 
Across all trials 284 knee arthroplasties (6 unicompartmental knee arthroplasties, 147 SVa, and 137 
MPa) were performed on 214 participants. The six unicompartmental knee arthroplasties were 
retained as the study was primarily investigating TKA, and it was desirable to include the TKAs in 
the same trial. Levels of evidence (National Health and Medical Research Council, 2007) ranged 
from level II randomised controlled trial (Roysam et al., 2001; Weinhardt et al., 2004) to level III-1 
pseudo randomised controlled trial (Faure et al., 1993; Cameron, 2001; Cila et al., 2002). 
Randomisation method was either of the following: not stated (Weinhardt et al., 2004); conducted 
using sealed envelopes for consecutive participants (Roysam et al., 2001); or conducted by the 
senior surgeon (no method detailed) (Faure et al., 1993; Cila et al., 2002); or by hospital registration 
number (unclear if sequential participants) (Cameron, 2001). The average age of patients was 77 
years (range, 41-88), and women (127) outnumbered men (87). Assessment time frames ranged 
from pre-operative, daily inpatient, to 12 months post-operatively. Four studies followed up 
participants at 3 months and other intervals, except for Weinhardt et al. (2004), whose follow-up 
was conducted during the inpatient period only. Trials were undertaken between 1990 and 2004 in 
the United States (Faure et al., 1993; Cameron, 2001), Turkey (Cila et al., 2002), UK (Roysam et 
al., 2001), and Germany (Weinhardt et al., 2004). Types of prostheses implanted varied across the 
studies (Appendix 4). 
 
Table 3-1 Participants and study characteristics 
Author Participants TKAs Randomisation Level of Evidence 
Quality of 
Methodology
Component 
Score 
Follow-Up Complications Prosthesis 
Cameron, 
   2001 
34 (23 women, 
11 men); age, 
67 (41-88) 
41 
(16 MP, 
25 SV) 
Hospital 
number III-1 4/12 
3 wk and 3, 
6, and 12 mo 
 
Not stated 
Cemented; patella 
resurfaced; posterior 
cruciate sparing 
Cila,  
   2002 
19 (18 women, 
1 man); 
age, 66.4 (58-74) 
22 
(12 MP, 
10 SV) 
Senior surgeon 
decided III-1 6/12 
Pre-operative, 
6 wk, and 
3 and 6 mo 
1 deep infection 
requiring 
revision TKA 
Freeman-Samuelson 
TKA system 
Roysam, 
   2001 
89 (42 women, 
47 men); age 
(MP 70.2, 
SV 69.8), 
deformity and 
range of motion 
matched 
89 
(43 MP, 
46 SV) 
Consecutive 
patients; 
sealed 
envelopes 
II 7/12 1 and 4 wk, 3 mo Not stated 
Insall-Burnstein II 
(Zimmer, 
Warsaw, IN) 
Weinhardt, 
   2004 
52 (33 women, 
19 men); age 
MP 73.7 ± 6.8, 
SV 69.7 ± 9.1 
52 
(26 MP, 
26 SV) 
Randomised 
but not 
stated how 
II 5/12 Daily inpatient Not stated 
Genesis II 
(Smith & 
Nephew) with 
a patella inlay 
Faure, 
   1993 
20 (11 women, 
9 men); 
age 70 (55-81) 
40 bilateral 
(20 MP, 
20 SV) 
Senior surgeon 
decided; patient 
and assessor 
blinded 
III-1 6/12 
Pre-operative, 
1 wk, 1 and 
3 mo 
1 MP haemarthrosis, 
2 SV hematomas; 
lateral releases 
(5 MP, 2 SV); 
2 MUAs in 
1 participant; 
1 patella 
subluxation in 
a valgus knee 
Mixed TKA and 
UKA; all UKA 
cemented. TKA 
hybrid–cemented 
tibia, porous press 
fit femur 
wk = week; mo = month; MP = medial parapatellar; SV = subvastus; TKA = total knee arthroplasty; UKA = unicompartmental knee arthroplasty. 
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Table 3-2 Extracted data  
Author Pain Length of  stay (d) 
Days to  
Mobilisati
on 
Quadriceps  
Function Flexion (°) Extension (°) 
Blood Loss 
(mL) 
Patella 
AVN 
Length of 
Surgery/ 
Tourniquet 
(min) 
Imaging Results Knee Scoring System 
Participant 
Preference 
Cameron, 
    2001 
MP (day 1) 
2.68/10 (1-5), 
SV (day 1) 
5.13/10 (1-8) 
MP 4.73 (3-6), 
SV 4.89 (3-6)  
Days to SLR: 
MP 4.31 (1-8), 
SV 1.12 (0-3) 
MP: 84 (3/52), 
101 (3/12), 
103 (6/12), 
105 (12/12); 
SV: 91 (3/52), 
106 (3/12), 
111 (6/12), 
114 (12/12) 
 
MP 684 
(0-1550), 
SV 519 
(0-2040) 
No patella 
AVN at 
12 mo 
MP 90.81 
(60-120), 
SV 102.48 
(90-125) 
   
Cila,  
    2002   Day 1 
Cybex–6/52 60 
and 180º/s peak 
torque MP p = .02 
and .01 weaker than 
SV p = .09 and .05; 
pre-operative cf 6/52 
peak torque in 
60º F MP weaker 
but SV not p = .007 
      
HSS* 3/12: 
MP p < .013, 
SV p < .017; 
6/12: MP 
p<.01, 
SV p< 0.05 
 
Roysam, 
    2001 
MP 102 mg 
opiate, SV 
78 mg p<.001 
MP 20.7, 
SV 17.3  
Days to SLR: 
MP 12 ± 3.1, 
SV 8.3 ± 2.8 
p<.01 
1/52: MP 55, 
SV 78 P < .001; 
at 4/52 and 3/12 
no difference 
 
MP 748, SV 
527 mL 
p<.0001 
     
Weinhardt, 
    2004 
Both groups 
improved 
pre-operatively: 
MP 6.2 ± 1.4, 
SV 6.3 ± 0.9 
Post-operatively 
pain slightly 
lower in SV 
group (p < .01) 
 Day 2 
Days to SLR: 
MP 12 ± 3.1, 
SV 8.3 ± 2.8 
P < .01 
Days to passive 
90º MP 11 ± 4.2, 
SV 7 ± 2.4 P < 
.01 
Days to full 
passive 
extension 
MP 7.7 ± 7.6, 
SV 2.2 ± 2.6 
MP 264 ± 120, 
SV 243 ± 120 
 
 
Peri-operative 
blood 
substitution 
MP 471 ± 199, 
SV 312 ± 215 
 MP 80 ± 22, SV 75 ± 6 
Correction during 
surgery 
(valgus/varus): 
0º, 4 patients; 1º -5º, 
1 patient; 6º -10º, 
15 patients; >10º, 
24 patients; regardless
of approach AP angle 
improved 
significantly 
p< .01 
  
Faure,  
    1993   
Day 1 or 
day 2 
Quads strength 
(LIDO dynamometer) 
1/52 and 1/12 60º/s 
and120º/s; better in 
SV 
No difference 
between groups 
or to pre-operative 
by 3/12 
  MP 411, SV 375  
MP 71 
(tourniquet) 
SV 74 
(tourniquet) 
  
2 patients 
preferred MP, 
9 patients 
preferred SV, 
9 patients 
no preference’ 
patient 
preference 
SV 4:1 
Italics indicates a statistically significant difference at p<0.05; AVN = avascular necrosis; SLR = straight leg raise; AP = anteroposterior; MP = medial parapatellar; SV = subvastus. 
*Hospital for Special Surgery score 
Postsurgical complications were generally not stated. The following were recorded: one deep 
infection requiring revision (allocation not stated) (Cila et al., 2002), one MPa haemarthrosis, and 
two SVa hematomas (Faure et al., 1993). Trial sponsors were either not stated or there was no trial 
sponsor for any study. Intra-operative damage to structures was not reported except for Faure et al. 
(1993), who reported the need for one MPa and one SVa MUA in the same participant (the reason 
was not stated) and one patella subluxation in a valgus SVa knee 2 months post-operatively. Faure 
(1993) also reported additional interventions for lateral releases in five MPa and two SVa patients. 
3.5 Discussion 
On the basis of this review, it is not possible to draw definitive conclusions about the efficacy of the 
SVa compared with the MPa to TKA largely owing to the paucity of high-quality studies in the 
field. 
Only 13 studies published between 1993 and April 30, 2008, met the initial inclusion criteria for 
this review. No systematic reviews or meta-analyses were found. Of the 13 studies, only five met 
the methodological requirements to be included. Even so, within these five studies, the Quality of 
Methodology Component Scores were comparatively low (range, 4-7/12), and the low evidence 
level (III-1) for three of the five studies reflected deficiencies in the randomisation process where 
allocation was decided by the senior surgeon or was not described (Table 3-1). 
Although statistically significant results have been demonstrated for some outcomes in a number of 
the studies (Table 3-2), the results were not consistent. Neither were the studies sufficiently 
homogenous for meta-analysis because data were collected at different time points post-operatively 
and different outcome measures were used. 
Outcomes were weighted toward physical rather than functional measures in all but one study (Cila 
et al., 2002). Therefore, the implications of the surgical approaches for patients in terms of function 
are difficult to ascertain. The highest quality trial (7/12) by Roysam et al. (2001) involved 89 
participants with approximately equal gender distribution, and follow-up occurred at 1 week, 4 
weeks, and 3 months post-operatively. The outcomes were that the SVa resulted in less pain and 
earlier quadriceps function compared to the MPa. The outcomes of the other four studies reviewed 
were not dissimilar (Faure et al., 1993; Cameron, 2001; Cila et al., 2002; Weinhardt et al., 2004). 
Variously, the five studies reported some statistically significant results in favour of the SVa over 
the MPa for the outcomes of the following: levels of pain (Cameron, 2001; Roysam et al., 2001), 
better quadriceps function (peak torque (Faure et al., 1993; Cila et al., 2002) and time to SLR 
(Cameron, 2001)), gain of knee flexion range (Cameron, 2001; Roysam et al., 2001; Weinhardt et 
al., 2004), limitation of blood loss (Roysam et al., 2001), shorter length of surgery (Cameron, 
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2001), imaging results (Weinhardt et al., 2004), and better HSS scores (Cila et al., 2002) (Table 3-
2). Notably, the reporting of complications was inconsistent, and a confounding factor may have 
been the variety within the prostheses implanted across the studies. The lower methodological 
quality in four of the five studies affected the ability to generalise their findings to the wider 
population. However, in relation to physical outcomes, the better quality studies (Roysam et al., 
2001; Weinhardt et al., 2004) supported the SVa, and on balance; it appears as though less pain and 
better earlier quadriceps function are associated with the SVa, which is consistent with popular 
opinion (von Langenbeck, 1878; Scuderi et al., 1987; Kayler et al., 1988; Holtby et al., 1996). 
There were no significant differences between the SVa and the MPa in patient length of hospital 
stay, days to mobilisation, range of extension motion, patella avascular necrosis, or participant 
preference. Discharge destination, walking aid at discharge, surgeon’s perceived level of difficulty 
of approach, or a health-related quality of life measure were not stated in any study. These are 
important omissions because they indicate the patient’s level of function. In addition, the perceived 
level of difficulty of the surgery may be the strongest predictor for which operative approach will be 
used. 
There are some points to note in interpreting the findings of this review, namely, no trials of 
sufficient quality have been published subsequent to 2004†; no information on skill level of the 
surgeon was reported; and the studies of sufficient quality appear to predate the development of 
alternative approaches to TKA, such as minimally invasive surgery. Further, that one author applied 
inclusion criteria to titles and abstracts is considered a minor limitation of this review article. 
We contend that it remains relevant to investigate the efficacy of the SVa because it is commonly 
performed by many experienced surgeons and trainees worldwide. 
To better assess the impact of MPa or SVa on patient outcome and address the current inadequacies 
in the literature, further prospective double-blind, randomised, controlled trials comparing MPa to 
SVa in TKA are required. The trials should have the following features: adequate sample size based 
on a robust power calculation; pre-operative baseline measures of pain and function as well as 
physical knee measures; data on intra-operative factors such as tourniquet time, operation time and 
blood loss; inpatient and outpatient follow-up for at least six to 12 months; length of hospital stay; 
and surgeon's perceived level of difficulty for each approach. Furthermore, if the MPa and SVa are 
to be adequately compared and the results generalisable to TKA, then both approaches must be 
performed by multiple surgeons and a variety of prostheses need to be tested. 
                                                 
 
† Correct at the time of printing 
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3.6 Conclusion 
The current evidence precludes any comment about the superiority of either the MPa or SVa to 
TKA. Factors such as poor study design, lack of true randomisation, and blinding affect the 
integrity of the currently available data. Future studies must address these methodological 
inadequacies, and studies with follow-up beyond 6 months with a focus on functional outcomes 
may better demonstrate any preference for either the SVa or MPa for TKA and patients’ resulting 
quality of life.  
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4 Comparing the subvastus and medial parapatellar 
approaches in total knee arthroplasty: a randomised 
controlled trial 
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with the exception of minor edits and formatting changes to headings, tables, figures, and references 
to maintain consistency throughout the thesis. 
 
It has been established that the quality of evidence investigating the relative merits of the subvastus 
approach (SVa) compared to the medial parapatellar approach (MPa) are poor. This chapter 
presents a prospective randomised controlled trial comparing the relative physical and functional 
outcomes between the approaches, as well as outcomes relevant to the surgeon and the organisation 
where the procedure is conducted. 
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4.1 Abstract  
The MPa in total knee arthroplasty (TKA) is more common, but the SVa is less insulting to the 
quadriceps. Whether the SVa affords better outcomes was investigated using 90 participants with 
knee osteoarthritis (OA), randomised to receive either SVa or MPa and followed for 18 months. 
The primary outcome was the American Knee Society Score (AKSS); secondary outcomes included 
pain, knee range, quadriceps lag, Oxford Knee Score (OKS), 3-metre Timed Up and Go (TUG) test, 
days to straight leg raise (SLR), surgeon perceived difficulty, operation duration, and length of 
hospital stay. Analysis (n=76) revealed no significant difference in AKSS (p=0.076) or other 
outcomes except: AKSS Functional (AKSSFun) scores at 12 and 18 months favoured the MPa 
(p=0.032; p=0.028 respectively); surgeon perceived difficulty favoured the MPa (p=0.001); and 
days to SLR favoured SVa (p=0.044). This study found the SVa offered no clinical benefit over the 
MPa. 
Keywords: arthroplasty, replacement, knee, medial parapatellar, subvastus 
4.2 Introduction 
Primary and revision TKAs performed in Australia have risen by 37.6% since 2003, and in 2008 
totalled 39,283 ‡(Australian Orthopaedic Association, 2010). With health economists predicting 
continual increases, it is important to optimise surgical procedures to ensure efficiency and to 
produce the best possible outcomes. 
The MPa is arguably the most common approach in TKA, despite disrupting the quadriceps muscle 
up to 50 to 60mm proximally from the supero-medial border of the patella. The SVa is less widely 
used but aims to preserve the quadriceps muscle by bluntly dissecting deep to the vastus medialis 
muscle (Hofmann et al., 1991). Preservation of the quadriceps during TKA is argued to result in 
better quadriceps function post-operatively (Faure et al., 1993; Cameron, 2001; Roysam et al., 
2001; Cila et al., 2002; Weinhardt et al., 2004), less pain (Cameron, 2001; Roysam et al., 2001; 
Weinhardt et al., 2004) and a shorter length of hospital stay (Roysam et al., 2001). Other proposed 
advantages of the SVa include a reduction in analgesic requirements (Roysam et al., 2001) and 
preservation of patellar vascularity (Kayler et al., 1988; Holtby et al., 1996; Matsueda et al., 2000). 
Despite the proposed benefits of the SVa, a number of surgical technical difficulties have been 
reported, for example, it is more difficult to visualise the surgical field and evert the patella 
(Matsueda et al., 2000). Factors such as obesity, muscle bulk and contractures around the knee are 
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also known to make the SVa technically difficult (Hofmann et al., 1991; Knezevich, 1992; Cushner, 
2003; Sporer, 2006). 
A recent systematic review highlighted the paucity of high quality studies providing evidence for 
the efficacy of the SVa compared to the MPa (Bourke et al., 2010). Studies to date have generally 
lacked the methodological rigour required to derive definitive conclusions about the outcomes of 
SVa or MPa. Methodological issues included poor randomisation processes where allocation was 
decided by the senior surgeon (Faure et al., 1993; Cila et al., 2002) and poor complication reporting 
(Cameron, 2001; Roysam et al., 2001; Weinhardt et al., 2004), which affected the generalisability of 
results and contributed to the trials’ relatively low quality methodology component scores (Jadad et 
al., 1996; Crockarell et al., 2003; Khan, 2005; Higgins et al., 2009). The highest quality trial in the 
review reported appropriate randomisation procedures, but their follow up extended only 3 months 
post-operatively (Kayler et al., 1988; Roysam et al., 2001). In one clinical trial published 
subsequent to this review (Bridgman et al., 2009), the SVa was found to be superior to the MPa on 
the outcomes of range of motion and American Knee Society Scores (AKSS) at 1 week and the 
Western Ontario and McMaster Universities index of osteoarthritis (WOMAC), 36-Item Short Form 
Health Survey (SF-36) and European quality of life questionnaire (EuroQol) scores at 1 year. This 
trial did not investigate immediate inpatient outcomes in the first few days post-operatively nor did 
it follow up beyond 12 months. Therefore further trials are required to investigate if there are any 
definitive benefits of the SVa compared to the MPa in the immediate post-operative phase as well 
as in the medium term. 
To this end, a single centre, prospective randomised controlled trial was conducted in a 
metropolitan hospital to further compare the SVa and MPa. Outcomes were assessed pre-
operatively, intra-operatively (for some outcomes), on days 1 to 3 post-surgery, and at discharge as 
well as at 6 weeks, 6 months, 12 months and 18 months post-surgery. It was hypothesised (i) that 
participants receiving the SVa would experience better early outcomes than those receiving the 
MPa, and (ii) that outcomes would converge by 18 months after surgery. 
4.3 Methods 
The study was conducted in a hospital in Brisbane, Queensland, Australia from May 2006 to 
November 2009. Institutional ethics committee approval was granted for this trial (Appendix 5) and 
written informed consent was obtained from each participant (Appendix 6). The trial was registered 
on the Australian and New Zealand Clinical Trials Registry (ACTRN12606000376549) and there 
were no external sources of funding. 
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4.3.1 Participants 
Eligible participants were recruited by the participating orthopaedic surgeons from patients 
attending their outpatient clinics and who were subsequently scheduled to undergo a TKA at the 
hospital. To be included, the participants were required to be aged 18 years or over, diagnosed with 
knee OA and scheduled to undergo primary unilateral TKA and were appropriate for either the MPa 
or SVa. Participants were also required to possess normal mentation‡; be able to attend supervised 
outpatient physiotherapy rehabilitation sessions over a period of 6 weeks; and be able to provide 
signed informed consent. Persons excluded were those: with comorbidities preventing participation 
in rehabilitation (e.g. severe obstructive pulmonary disease, hemiplegia following stroke); 
undergoing revision or bilateral TKA; having knee stiffness with less than 70 degrees of flexion or 
flexion contracture of greater than 20 degrees; or having undergone previous high tibial osteotomy 
or major arthrotomy on the operative knee (indicating inability to perform SVa as originally 
described) (Hofmann et al., 1991). Also excluded were persons who were unable to pre-operatively 
mobilise full weight bearing in a bipedal manner with or without a walking aid or who were 
unlikely to be able to follow the TKA clinical pathway (Appendix 7). Additionally, participants 
were excluded intra-operatively if they required an intervention outside the standardised surgical 
protocol, for example, requiring a femoral nerve block or a lateral surgical release. This enabled a 
better comparison of successfully completed SVa and MPa procedures.  
4.3.2 Randomisation and Blinding 
Randomisation was undertaken using a computer generated randomisation sequence which was 
created with stratification to surgeon and a 1:1 allocation using a block size of 4. Block 
randomisation was used to ensure an equal number of participants in each group as the trial 
progressed and the stratification ensured each surgeon had a similar number of participants in each 
surgical group. The allocation sequence was generated by a research team member (TR) who was 
not involved in participant contact or data collection. The allocations were placed in sequentially 
numbered, sealed envelopes and the envelope drawn out by a theatre nurse. Group allocation was 
revealed to the orthopaedic surgeon in the operating suite immediately prior to surgery.  
The assessors, physiotherapists and nurses providing the post-operative care and participants were 
blind to the surgical procedure received by the patient. The operating surgeon was unblinded. The 
surgical approach and procedure was described in the original operation report, which was then 
placed in a sealed envelope and not opened until the conclusion of the trial. To maintain blinding of 
                                                 
 
‡ Normal mentation was assumed to be someone of sound mind as defined by their ability to provide informed consent 
for surgery as determined by the treating surgeon. 
4-37 
the physiotherapists and nurses, a second printed temporary operation report with the surgical 
approach blackened on both sides was placed in the medical record following surgery. 
4.3.3 Procedure 
All participants who had agreed to enter the study attended a pre-operative education clinic 
conducted approximately 4 weeks prior to surgery. A pre-operative assessment of all baseline 
measures was undertaken and participants were randomised at this point.  
All participating surgeons, regardless of experience with either operative approach, completed five 
supervised sessions with the senior consultant surgeon (JD) to standardise the SVa, which is less 
commonly performed than the MPa. All six surgeons performed both procedures to enhance the 
generalisability of the results.  
Surgical procedure and post-operative care (Appendix 8) 
Surgeons used their preferred prosthesis from the choice of either the Smith and Nephew Genesis II 
or the LCS® Depuy Mobile-Bearing total knee prosthesis. A tourniquet was fitted but only inflated 
for cementing of the prostheses. An identical midline skin incision was used in both procedures to 
ensure blinding of the other researchers in the post-operative period. For the SVa the knee was 
flexed for the skin incision and incision of the inferior aspect of the capsule. The vastus medialis 
was then dissected with the knee flexed or extended. The patella was not everted, but rather 
subluxed laterally. The femur and tibia were prepared and the prosthesis inserted. For the MPa, the 
knee was flexed and a medial parapatellar incision extending 60-70mm above the proximal pole of 
the patella was performed. The incision was extended inferiorly to the medial aspect of the tibial 
tubercle. The patella was everted for the duration of the surgery if required. As for the SVa, the 
femur and tibia were prepared and the prosthesis inserted. For both the MPa and SVa, wound drains 
exited laterally avoiding the vastus lateralis where possible and were removed on the first day after 
surgery. Incisions were closed with the knee in flexion of approximately 90 degrees. 
Post-operative pain relief for all participants was administered via intravenous patient controlled 
analgesia for the first 48 hours and then subsequently by oral analgesia. Post-operative nursing care 
(including the use of thromboembolic deterrent stockings and removal of surgical drain) and length 
of hospital stay criteria were standardised for both groups. The rehabilitation of all patients was 
standardised according to the hospital’s clinical pathway (Appendix 7) for TKA and physiotherapy 
guidelines for rehabilitation (Appendix 9). Following discharge, all patients attended at least two 
post-operative physiotherapy rehabilitation sessions prior to their 6 week review, as is conventional 
practice at the hospital. 
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4.3.4 Outcomes 
The primary outcome measure was the AKSS (x/200 points) (Insall et al., 1989). For better 
discrimination, its component scores, the AKSS Objective (AKSSObj) (x/100 points) and 
AKSSFun (x/100 points) scores were also considered. Secondary outcome measures included the 
OKS (12-60/60 points) (Dawson et al., 1998), 3-metre TUG (seconds) (Podsiadlo et al., 1991), knee 
flexion and extension range of motion (ROM, degrees), quadriceps lag on SLR (degrees), days to 
SLR, pain (Numerical Assessment Scale [NAS, 1-10]), and knee girth (mm). These outcomes were 
measured at time-points 4 weeks pre-operatively (baseline), post-operatively on each of days 1-3, 
on discharge, 6 weeks, 6 months, 12 months, and 18 months. Intra-operative secondary outcome 
measures were knee flexion and extension range of movement, operation duration (minutes), 
surgeon’s perceived level of difficulty with the operative approach (Numerical Assessment Scale 
[NAS, 1-10]) and tourniquet duration (minutes). Length of post-operative stay in the orthopaedic 
ward (days) was also recorded.  
All data were collected on an electronic personal digital assistant (PDA) by physiotherapists and 
surgeons who were trained in its use, with the exception of the self-rated OKS which was collected 
as a paper-based questionnaire. Flexion, extension and quadriceps lag were measured using 
software on the PDA which was adapted from telerehabilitation research (Russell, 2007). This 
software has demonstrated criterion validity (Limits of Agreement = –1.66 to 1.76 degrees for the 
measurement of knee joint excursion from extension to flexion) and excellent intra-rater (ICC(2,1) 
= 0.97 to > 0.99) and inter-rater (ICC(2,1) = 0.93 to > 0.99) reliability. 
4.3.5 Sample Size 
A sample size calculation was conducted using the AKSS data from the first 22 participants from 
the MPa group (AKSS: 56.75 ± 14.19) and 21 participants from the SVa group (AKSS: 51.82 ± 
14.04). In the absence of literature defining a minimal clinical important difference (MCID) for the 
AKSS, a difference of 5% was asserted to be clinically relevant for the current randomised 
controlled trial and the trial was powered as such. To detect a 5% improvement in the AKSS (10 
points) with a two-sided 5% significance level and a power of 80%, a sample size of 32 participants 
per group was necessary (total n =64). Sufficient recruitment (final n=90) was undertaken to allow 
for a dropout rate of at least 10% over the 18-month follow-up period as well as any loss to the trial 
due to variations from the surgical protocol. 
4.3.6 Statistical Methods 
The data retained for analysis was of the participants who underwent the MPa or SVa surgical 
procedure as per the study protocol. All data were inspected for normality and transformed as 
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required prior to analysis (Appendix 10). Linear Mixed Models (LMM) were performed for analysis 
of continuous variables (AKSS, AKSSObj, AKSSFun, OKS, TUG, flexion, extension, quadriceps 
lag, pain, and girth), using surgical approach (SVa or MPa) and outcome assessment points (and 
their interaction effect) as fixed effects. LMM was favoured over Student’s t-tests due to its ability 
to correctly handle correlation errors observed with repeated measures, its ability to support the 
random effects and hierarchical effects of the variables, and its ability to account for baseline 
differences (Garson, 2011). Analysis of secondary outcomes (days to SLR, operation time, 
tourniquet duration, surgeon rated difficulty with the procedure, length of hospital stay) was 
performed using one-way analysis of variance (ANOVA) to determine differences between the two 
treatment groups. Independent-samples Mann-Whitney U tests were used to analyse baseline 
demographics. A significance level of p<0.05 was chosen for all analyses. 
4.4 Results  
Ninety participants were randomized into the trial between 11 May 2006 and 18 October 2007. The 
follow-up of all participants ended on 12 November 2009. Figure 4-1 illustrates participant 
recruitment and the flow of participants throughout the study. Of the original 90 participants, 81 
received the intervention and 76 were retained in the study for analysis. Nine participants, although 
randomised, did not receive surgery within the study period because they subsequently declined the 
procedure or experienced medical complications subsequent to recruitment (MPa group = 4; SVa 
group = 5). Five participants had unplanned interventions intra-operatively. In the MPa group, one 
participant received a unicompartmental knee replacement. In the SVa group, four participants 
variously received: simultaneous bilateral TKA; femoral nerve block; femoral nerve block and 
lateral release; post-operative bracing; and restricted weight bearing due to intra-operative medial 
collateral ligament avulsion. As these interventions/complications contravened the standardised 
surgical protocol, these participants were excluded from further statistical analysis. Therefore, the 
per protocol analysis was performed using the data from 76 participants. Within the cohort of 76, 
three participants were lost to follow-up, one from the MPa group at 6 months and another at 12 
months and one from SVa at 6 weeks. The data of these participants was included in the analysis for 
the time points for which it was available. 
Baseline analysis revealed no significant between group differences for gender (MPa: female 26, 
male 14; SVa: female 19, male 17: p=0.282) or age (MPa: 67.7±6.5; SVa: 68.1±8.2: p=0.83). There 
were no significant differences between groups in baseline functional or clinical characteristics 
(Table 4-1). 
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Table 4-1 Baseline comparisons 
Physical and functional outcome measures in the MPa and SVa groups. There was no significant 
between group differences for any baseline measure. 
MPa (n=40) SVa (n=36) 
Outcome 
n 
Mean and 
Standard 
Deviation 
Range n 
Mean and 
Standard 
Deviation 
Range 
Primary Outcome 
AKSS (x/200) 40 100.5±30.6 35-173 36 102.3±32.6 36-179 
AKSS - Objective 
(x/100) 40 55.7±13.7 34-93 36 54.6±15.5 24-9 
AKSS - Functional 
(x/100) 40 44.6±22.2 0-90 36 44.7±23.1 0-9 
Secondary Outcome 
Pain (x/10) 40 4.9±2.0 1-8 36 4.9±2.1 1-7 
Extension (degrees) 40 6.5±5.0 -5.7-20.0 36 7.6±5.7 0.0-20.0 
Flexion (degrees) 40 117.6±12.0 88.5-140.0 36 119.0±12.5 88.5-140.0 
Quadriceps Lag 
(degrees) 40 2.7±4.1 -5.6-13.8 36 2.4±3.5 -3.1-10.0 
Girth (mm) 38 425±38 344-510 33 425±40 360-535 
Oxford Knee Score 
(12-60/60) 30 38.6±8.6 23-53 26 38.1±8.3 25-52 
TUG (3m course - 
seconds) 40 13.7±13.5 8.0-29.3 34 15.9±7.2 7.7-34.6 
AKSS =  American Knee Society Score; TUG = Timed Up and Go test 
The values for the primary and secondary outcomes for the MPa and SVa groups at each follow-up 
time point along with results of LMM analysis for normally distributed outcomes are presented in 
Table 4-2. Compared to baseline values (Table 4-1), all outcomes progressively improved from 6 
weeks post-operatively onwards in both the MPa and SVa groups. However, there were no 
statistically significant differences overall in the primary outcomes between the groups based on 
LMM analysis (against fixed effects of group and outcome assessment point). Post hoc analysis 
revealed significant differences at three specific time points. On Day one post-operatively, the SVa 
group demonstrated a significantly better AKSSObj score (p=0.029) (Appendix 11). However, the 
MPa group demonstrated significantly better AKSSFun score at 12 months (p=0.032) and 18 
months (p=0.028) (Appendix 12). There was also a trend towards greater improvement in the MPa 
group on AKSS (p=0.076) at 18 months. 
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Assessed for eligibility (n=158) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-1 Participant Flow 
 
 
Excluded (n=68) 
• Declined to participate (n=51) 
• Other (n=17) 
Randomised (n=90)
Allocated to SVa group (n=45)  Allocated to MPa group (n=45) 
Received MPa (n=41) 
Included in analysis (n=40) 
 
Lost to follow-up (n=2) 
• Lost after 6 months (n=1) 
• Lost after 12 months (n=1) 
No operation within study period 
(n=5) 
No operation within study period 
(n=4)  
Received SVa (n=40) 
Intra-operative complications 
contravening standardised 
surgical protocol e.g. required 
lateral release (n=1) 
Intra-operative complications contravening 
standardised surgical protocol e.g. required 
lateral release (n=4) 
Included in analysis (n=36) 
 
Lost to follow-up (n=1) 
• Lost after 6 weeks (n=1) 
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Analysis of secondary outcomes revealed two significant differences only. There was a significant 
difference in days to SLR (MPa 2.76±1.89 versus SVa 1.92±1.59 p=0.044), indicating an earlier 
return of quadriceps function in the SVa group. There was a difference in surgeon perceived 
difficulty between surgical approaches (MPa 3.32±1.89 versus SVa 5.38±2.33: p=0.001), indicating 
that surgeons considered the SVa to be more technically difficult (Appendix 13). There were no 
differences in other secondary outcomes, including operation duration, tourniquet duration and 
length of hospital stay (Table 4-3), but there was a trend towards less pain in the MPa (MPa 1.66/10 
versus SVa 2.63/10: p=0.097) group at 6 weeks. 
Within the 18 month follow-up period there were six knee related adverse effects. In the SVa group 
there were two complications; aseptic loosening requiring revision and stiffness requiring 
manipulation under anaesthetic (MUA). In the MPa group, the four complications were aseptic 
loosening requiring revision, deep vein thrombosis, stiffness requiring MUA and wound breakdown 
requiring intravenous antibiotics. 
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MPa and SVa groups at all follow-up points including results of linear mixed modelling (LMM) analysis for normally distributed outcomes, presented 
for time by allocation intervention effect. 
 
Table 4-2 Physical and functional outcome measures 
Bold italic font indicates significance p<0.05 
*All participants scored 0/100 at this time point 
AKSS = American Knee Society Score; Obj = objective; Fun = functional; MPa = medial parapatellar approach; SVa = subvastus approach. 
Table 4-3 Results of analysis for interval outcome measurements 
MPa 
(n=40) 
SVa 
(n=36) Outcome 
n Mean ± SD n Mean ± SD 
Days to straight leg raise 37 2.8±1.9 36 1.9±1.6 
Surgeon perceived 
difficulty (x/10) 
28 3.3±1.9 (n=28) 26 5.4±2.3 (n=26) 
Operation duration 
(minutes) 
40 91.6±20.1 (n=40) 36 97.9±18.1 (n=36) 
Tourniquet duration 
(minutes) 
40 28.8±14.4 (n=29) 36 34.1±20.71 (n=31) 
Length of hospital stay 
(days) 
39# 4.5±1.2 (n=39) 35# 4.7±1.2 (n=35) 
Bold italic font indicates significance p<0.05 
#One participant from MPa received inpatient rehabilitation (Length of stay 37.5 days). One participant from SVa 
received inpatient rehabilitation (Length of stay 14.5 days). These statistical outliers were removed from analysis. 
MPa = medial parapatellar approach; SVa = subvastus approach. 
4.5 Discussion  
The proposed clinical benefits of the SVa such as less pain, earlier quadriceps function, the 
potential to reduce length of hospital stay, and costs make this approach an attractive option. 
Although the SVa group was significantly better on Day one AKSSObj scores, at all other time 
points there was either no difference between the approaches, or the difference or trend favoured the 
MPa group. Therefore, the trial hypotheses of better early outcomes with the SVa was rejected and 
the convergence of SVa and MPa group outcomes at 18 months was conditionally accepted as 
AKSSFun scores were better in the MPa group by 12 months post-operatively. The results of this 
trial showed both groups made marked improvements in the primary outcomes measured over the 
course of the study when compared to baseline values. We are not aware of any studies which have 
investigated the minimum clinically important difference for the AKSS, therefore, it is difficult to 
rate the improvement in this study on these terms.  
While the LMM did not demonstrate any difference for AKSSFun scores on the factor of group by 
outcome assessment point, post hoc analysis revealed a significant difference favouring the MPa at 
12 and 18 months post-operatively. Inspection of the raw data revealed a generalised improvement 
in the MPa group which cannot be attributed to a small number of cases. Given that no significant 
difference at these time points was found with any other variable in the study, we are left to 
attribute this improvement in the AKSSFun score to the MPa surgical approach, assuming that other 
confounding factors that may have influenced the post-operative recovery were the same in both 
groups. Examples of such factors may have been the level of physical activity, medication intake, 
health services utilization, social support, etc. 
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This trial found no statistically significant differences in pain scores but did reveal a trend favouring 
the MPa group at 6 weeks post-operatively, similar to Bridgman et al. (2009). The results for pain 
did not agree with earlier studies that found less pain associated with the SVa (Faure et al., 1993; 
Cameron, 2001; Weinhardt et al., 2004; Bridgman et al., 2009). For example, a trial conducted by 
Cameron, (2001) found less pain in the SVa group at day one post-operatively, but did not state 
whether the patient or assessor was blinded to the approach, which may have affected the outcome. 
The result of earlier SLR in the SVa group concurs with pre-existing literature describing earlier 
quadriceps function with the SVa (Cameron, 2001; Roysam et al., 2001; Weinhardt et al., 2004). 
Despite this difference, earlier SLR did not result in significantly better outcomes on the AKSS or 
other measures (e.g. quadriceps lag on SLR, TUG), or a reduction in length of hospital stay for the 
SVa group in this trial. Some of the outcomes on which previous study conclusions were based (i.e. 
Cybex™ isokinetic dynamometer system (Cila et al., 2002) and LIDO™ isokinetic dynamometer 
(Faure et al., 1993)) were not performed in this trial. 
Our study found no significant differences in ROM overall, or at any isolated time points, between 
the MPa and SVa groups. This is in contrast to earlier studies which found improved ROM with the 
SVa. Of these, two studies found differences favouring the SVa group at or earlier than 4 weeks. 
One used outcomes that we did not (days to full passive extension, days to passive 90°) (Weinhardt 
et al., 2004) and the other had unusually low flexion range in both groups (MPa 55° versus SVa 78° 
at 1 week) (Roysam et al., 2001). The third study found small but significant differences in ROM at 
6 months and 12 months (Cameron, 2001). A more recent randomised controlled trial by Bridgman 
et al. (2009) with 231 participants, found that the SVa group had greater ROM at 1 week (7° greater 
increase in SVa group compared to baseline) although the scores for both groups were also 
relatively low (MPa 57.2° versus SVa 61.2°) compared with current results (MPa 84.2° versus SVa 
84.0°, at discharge). The population demographics of Bridgman et al.’s (2009) study were similar to 
the present study, however, the larger sample and use of a standardised prosthesis may have 
contributed to their findings. 
The significant difference in surgeon perceived difficulty between surgical approaches is consistent 
with Bridgman et al. (2009) where ‘ease of exposure’ scores were significantly worse in the SVa 
group. A surgeon’s perceived difficulty with the SVa is a major reason given for undertaking the 
more common MPa. Even though the SVa was reported as more difficult in the current randomised 
controlled trial, this did not translate to a higher complication rate; in fact, there were more 
complications in the MPa group (n=4) than in the SVa group (n=2).The more experienced surgeons 
rated the SVa less difficult than did the inexperienced surgeons. Notably, despite the difference in 
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difficulty scores, neither the operation duration nor tourniquet duration differed significantly 
between the groups. 
The OKS is a widely used measure in TKA research, with evidence supporting its reliability, 
construct validity and freedom from bias (Dawson et al., 1998; Conaghan et al., 2007). We did not 
find any significant differences between the MPa and SVa groups, although we feel it is probably 
less suited as an inpatient questionnaire and less sensitive at these time points. This relates to the 
seven measures pertaining to function. Five of these had usually not been attempted by participants 
before hospital discharge. We are only aware of one other paper investigating surgical approach in 
TKA which used the OKS at such an early time post-operatively but this paper did not investigate 
SVa outcomes (Karachalios et al., 2008). 
Learning from the limitation of previous trials, great care was exercised in this study to maximise 
its methodological rigour. This included prospective randomisation, blinding of participants and 
assessors, and power analysis to determine sample size. It is possible that some findings are in 
contrast to existing literature because of the enhanced methodology. The quality of methodology 
component score described by Bourke et al. (2010) is undoubtedly higher than existing literature 
which ranged between 4/12 and 7/12 (Bourke et al., 2010). Although 18-month follow up is 
arguably short for an arthroplasty study, the primary intention of this trial was to investigate early 
outcomes as it was anticipated that this was where the differences would occur between the groups. 
Attempts were made to mitigate the influence of the type of prosthesis with a stratification process, 
ensuring that each surgeon had a similar number of participants in each group.  
A systematic review comparing the efficacy of the SVa and MPa recommended that blood loss be 
collected alongside the outcomes used in this study (Bourke et al., 2010). An attempt to collect 
these data was made however this was not feasible due to trial resources. Future trials should 
include the collection of blood loss data and should also record the volume and type of pain 
medication. 
4.6 Conclusions 
This study aimed to investigate the physical and functional outcomes of the SVa compared to the 
MPa for TKA. We found no evidence on primary outcome (AKSS) to support the original 
hypothesis that the SVa affords better early outcomes when compared to the MPa. Additionally, it 
was evident from the randomised controlled trial that surgeons found the SVa a more technically 
difficult surgical approach and that the AKSSFun scores favoured the MPa group by 12 months 
post-operatively. 
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Although the results of the randomised controlled trial in Chapter 4 showed no overall difference on 
physical or functional outcomes between the medial parapatellar approach (MPa) and subvastus 
approach (MPa) in total knee arthroplasty (TKA), it did not investigate the assertions that the SVa 
affords better patellar vascularity and less anterior knee pain than the MPa. Vascularity was 
therefore examined in a subset of the population participating in the randomised controlled trial. 
Two novel vascularity scoring systems were developed for this study to better quantify vascularity, 
namely a pat:fem ratio derived from radionuclide bone imaging and a Bone Vascularity Scale 
(BVS). 
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5.1 Abstract 
A complication of total knee arthroplasty (TKA) is patellar avascular necrosis (AVN). Surgical 
approaches for TKA include the medial parapatellar approach (MPa) and less commonly the 
subvastus approach (SVa). The argument that SVa retains better patellar vascularity than the MPa 
was investigated on 20 participants, (SVa n=10; MPa n=10) 18 months post-operatively. Outcomes 
were a radionuclide bone imaging technique, a new bone vascularity scale (BVS) and an anterior 
knee pain numerical assessment scale. Results indicated no significant difference between groups 
on imaging (p=0.935); the components of the BVS or anterior knee pain (p>0.999). The SVa 
appears to offer no benefit over the MPa in terms of patellar vascularity or anterior knee pain. 
Key words: arthroplasty, replacement, knee, subvastus, medial parapatellar, avascular necrosis, CT 
 
5.2 Introduction 
With the ageing population, total knee arthroplasties (TKA) are increasing (Australian Orthopaedic 
Association, 2010). Clinical outcomes are usually good but 5% to 30% of poor outcomes are 
associated with the patella. (Hofmann et al., 1991) There is a 10-15% incidence of patellar vascular 
compromise in the early stages (up to seven days) after TKA (Wetzner et al., 1985; Scuderi et al., 
1987) and anterior knee pain is a complication related to avascular necrosis (AVN) (Brick et al., 
1989; Stoffel et al., 2007). The main patellar blood supply arises from an extra-osseous anastamotic 
ring of geniculate arteries, intra-tendinous circulation (Scuderi et al., 1987) and the anterior tibial 
recurrent artery (Scapinelli, 1967).  
 
There are a number of surgical approaches for TKA with the medial parapatellar approach (MPa) 
being the most common. It divides the descending geniculate artery (DGA), supero-medial 
geniculate (SMG), infero-medial geniculate (IMG) (Kayler et al., 1988; Brick et al., 1989) and 
infero-lateral geniculate (ILG) arteries, leaving the supero-lateral geniculate (SLG) patent. Hoffman 
et al.(1991) (Hofmann et al., 1991) promote the subvastus approach (SVa) as an alternative 
procedure which results in superior vascularity of the patella when compared to the MPa by 
retaining the patency of both the DGA and SMG.  
 
The literature supports a higher incidence of impaired patella vascularity in the MPa when a lateral 
release is performed (Scuderi et al., 1987) as a lateral release divides the SLG thus disrupting the 
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majority of extra-osseous and subsequent intra-osseous patellar blood supply (Wetzner et al., 1985). 
A study using three-phase bone scans in the very early (6-17 days) and early (2-3 months) post-
operative period found that the SVa maintains better patellar vascularity (Wetzner et al., 1985). 
However, the literature is silent regarding the superiority of the SVa in the absence of a lateral 
patella release.  
 
The aim of this study was to investigate if TKAs performed without a lateral release using the SVa 
maintained vascularity to the patella at 18 months, better than the MPa thereby reducing the risk of 
AVN and anterior knee pain. It was hypothesised that the SVa would have better outcomes for 
vascularity and anterior knee pain than the MPa due to the extensive dissection of the patellar 
arterial blood supply in the latter approach. Two methods of measurement derived from a nuclear 
medicine bone scan were used; (i) photon count ratio of the patella relative to the femur (pat:fem 
ratio) and (ii) a clinical rating scale, the bone vascularity scale (BVS) developed for this study. 
5.3 Methods 
This study reports the results of a secondary outcome from a larger randomised controlled trial 
investigating the physical and functional outcomes of the MPa and SVa (Bourke et al., 2011), as no 
previous research has provided empirical data on patellar vascularity from different TKA 
approaches. The larger randomised controlled trial was conducted from May 2006 to November 
2009. Institutional ethics committee approval was granted for this trial (Appendix 14). Written 
informed consent for all procedures was obtained from each participant. The trial was registered on 
the Australian and New Zealand Clinical Trials Registry (ACTRN12606000376549) and there were 
no external sources of funding. 
5.3.1 Participants 
The first 20 participants randomised to the MPa (n=10) and SVa (n=10) groups in the main 
randomised controlled trial were included in this study. The number was restricted to 20 due to 
financial constraints. Full details of the randomised controlled trial methodology are reported in 
Bourke et al. (2011). In brief, inclusion criteria were persons with knee osteoarthritis (OA) 
requiring a primary TKA that was to be performed at a metropolitan hospital. Participants were 
required to be over 18 years of age, have a diagnosis of knee OA requiring TKA that could be 
performed with either a SVa or a MPa, have no co-morbidities that would prevent participation in a 
standardised rehabilitation program that included supervised physiotherapy sessions for 6 weeks 
post-operatively, possessed normal mentation and could provide informed consent. Patients were 
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excluded if they were not expected to follow the TKA clinical pathway or were to require a lateral 
release or be ineligible to receive a SVa.  
Participants (blinded to the surgical approach) were randomised to the MPa or SVa using a 
computer generated sequence. The operative and peri-operative procedures for the SVa and MPa 
were standardised between the five participating orthopaedic surgeons to reduce any practice effect 
or variation that may have affected the outcomes. 
5.3.2 Surgical procedure and post-operative care 
Full details of the surgical procedures, standardisation and post-operative care have been reported 
(Bourke et al., 2011). The MPa was undertaken as described by Stern (2002), while SVa was 
undertaken as described by Hoffman and Plaster et al. (1991). No patellae were resurfaced. With 
respect to patellar vascularity, the key difference between approaches is that the SVa preserves the 
DGA within vastus medialis whilst the MPa dissects the DGA and interrupts medial patellar blood 
flow. 
5.3.3 Outcomes 
Radionuclide bone imaging was chosen as the outcome measure for assessing patellar vascularity. 
A nuclear medicine bone scan has the ability to detect early AVN (Matin, 1983; Wetzner et al., 
1985; Soucacos et al., 2004) as its method of bone uptake is proportional and sensitive to alterations 
in blood flow and the extraction efficiency from blood to bone (Ell et al., 2004). It is also affordable 
and non-invasive (Matin, 1983; Wetzner et al., 1985; Brick et al., 1989; Ell et al., 2004). After a 
TKA is performed the surrounding bone responds with increased osteoblastic activity. Should 
surgery disrupt blood supply to bone, there will be ischemic osteocyte death and a delay in healing 
with possible AVN within 12 months (Matin, 1983). For this reason imaging was undertaken at 18 
months after each participant’s surgery when any vascular insufficiency would be evident. 
Eight-hundred Megabecquerels (MBq) of the radiopharmaceutical Tc99m hydroxymethane 
diphosphonate (HDP) was administered intravenously. Three to four hours after the injection, 
images for the third phase of the bone scan were taken to allow sufficient time for osteoblast 
absorption and retention of radionuclide in bone (Feiock et al., 2005). These images were acquired 
using a General Electric (GE) Infinia Hawkeye-4 camera with low energy high resolution (LEHR) 
collimators. A Xeleris Workstation equipped with 3D volumetrix software was used for processing 
and quantitative analysis of the images. Imaging parameters included a static 256 x 256 matrix, 
single photon emission computed tomography system (SPECT) 128 x 128 matrix and whole-body 
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(WB) 256 x 1024 matrix. The three dimensional SPECT/CT images were used to quantify the 
uptake of Tc99m HDP within the patella and femur. 
Patella:Femur photon count ratio (pat:fem) 
Tc99m HDP accumulates in bone in proportion to blood flow. This creates a direct relationship 
between the density of emitted photons measured in any region of interest (ROI) and the underlying 
blood flow. Photon density was measured by counting the number of photons recorded per sensor 
pixel within the ROI which was 10 centimetres from the distal end of the femur. However, it is well 
known that the metabolic activity of the patient (i.e. influenced by patient size, activity level), time 
of day, fasting and peripheral circulation can affect absolute photon counts. To minimise the effect 
of these confounding factors, a patella photon count to femur photon count ratio (pat:fem) was 
collected from the third phase of three phase bone scans. All femoral ROIs were healthy and 
without pathology. To establish the pat:fem, ROIs were drawn around the entire patella and an 
equally sized area on the ipsilateral distal femoral shaft, 10cm proximal to the femoral condyles; an 
area with relatively stable osteoblastic activity. These were standardised by noting photon counts 
and number of pixels per ROI, thus enabling calculation of photon counts per pixel (Ct/Px). A 
blinded nuclear medicine technologist calculated the Ct/Px in each ROI and expressed them as kilo 
counts (kcts) which reflected Tc99m HDP activity. These Ct/Px were checked for accuracy by a 
second blinded nuclear medicine technologist. As the nuclear medicine technologists’ counts were 
equal, an arbitrator was not required. The ratio of patella Ct/Px to femoral reference point Ct/Px 
(pat:fem) was used to represent patellar vascularity with a ratio of one indicating equal vascularity 
of the patella and femoral ROI. A ratio of less than one indicated lower vascularity in the patella 
than the femur, conversely a ratio greater than one indicated higher vascularity in the patella relative 
to the femoral ROI. It was not possible to use the contra-lateral patella as a reference point as some 
participants had undergone a previous TKA on that side.  
Bone Vascularity Scale (BVS) 
An objective method to quantify the observation for the patella the Bone Vascularity Scale (BVS) 
was developed as a clinical rating scale for this study. Two blinded nuclear medicine radiologists 
scored patellar vascularity from SPECT/CT images for six regions of each patella giving a BVS for 
each region. These regions were the superior pole, inferior pole, supero-medial quadrant, supero-
lateral quadrant, infero-medial quadrant and infero-lateral quadrant of the patella. A five-point scale 
was used to rate patellar vascularity where: 0 = Absent, 1 = Decreased (photopenic), 2 = Normal, 3 
= Mildly increased and 4 = Moderately increased. Intra-rater reliability of the BVS was established 
using the data of nuclear medicine radiologist 1 who examined and scored the images at the time of 
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the scan and then again at least 12 months later. Nuclear medicine radiologist 1 was blind to the 
results of the first assessment when undertaking the second assessment. To establish inter-rater 
reliability of the BVS, a second nuclear medicine radiologist independently scored the regions of 
the patella on all 20 participant patellae.  
Anterior knee pain 
Patients with avascular necrosis of the patella usually present late with localised anterior knee pain 
(Soucacos et al., 2004). The Numerical Assessment Scale (NAS) for pain (Williamson et al., 2005) 
was used to measure the participants’ subjective experience of average anterior knee pain on a scale 
of 1 to 10 (no pain to worst pain). This outcome was administered by an experienced 
physiotherapist 18 months post-operatively. 
5.3.4 Statistical Analysis 
All data were analysed using Stata 10, Statacorp LP (Statacorp, 2007). Intra and inter-tester 
reliability were calculated using quadratically weighted Kappa statistics and percent agreement was 
calculated. Pat:fem data and NAS anterior knee pain values were inspected for homogeneity of 
variance and normality and were analysed with a one-way Analysis of Variance (ANOVA). The 
categorical data of the BVS were analysed with a non-parametric statistic, the two-sample 
Wilcoxon rank-sum test. A significance level of p<0.05 was set for all analyses. 
5.4 Results 
The 10 participants in the SVa group comprised three females and seven males (mean age 69.7 
years; range 56-83 years), while those in the MPa group included seven females and three males 
(mean age 69.8 years; range 64-86 years). All 20 participants received their allocated surgical 
approach and participated in the planned post-operative care and rehabilitation. There were no 
complications, lateral releases or other contraventions to surgical protocol or follow up in either 
group. The raw data for all outcomes is presented in Table 5-1. 
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Table 5-1 Bone Vascularity Scale (BVS) scores  
(Presented by quadrant of the patella with corresponding pat:fem and anterior knee pain scores for 
the MPa and SVa.) 
BVS rating (Possible score range 0-4)* 
Participant 
number 
Surgical 
approach 
Supero-
lateral 
quadrant 
Supero-
medial 
quadrant
Infero-
lateral 
quadrant
Infero-
medial 
quadrant
Sup 
pole 
Inf 
pole 
pat:fem 
Pain
x/10 
1 MPa 3 2 2 2 2 2 1.50 1 
2 MPa 3 2 3 1 2 2 4.33 1 
3 MPa 1 2 1 1 2 2 6.10 1 
4 MPa 2 2 2 2 2 2 1.12 1 
5 MPa 2 2 3 2 2 2 5.30 6 
6 MPa 3 3 3 3 2 2 2.33 1 
7 MPa 2 2 2 2 2 2 0.96 1 
8 MPa 2 2 2 2 2 2 0.80 1 
9 MPa 3 1 1 3 2 2 2.07 1 
10 MPa 2 2 3 2 2 2 0.93 1 
11 SVa 3 3 3 3 2 2 2.01 1 
12 SVa 1 2 2 2 2 2 5.24 1 
13 SVa 1 3 2 3 2 2 2.00 4 
14 SVa 2 3 1 2 2 2 1.65 2 
15 SVa 2 2 2 2 2 2 1.07 1 
16 SVa 2 1 2 2 2 2 1.01 1 
17 SVa 1 1 1 3 2 2 2.27 2 
18 SVa 2 2 3 2 2 2 1.77 1 
19 SVa 1 2 1 1 2 2 0.98 1 
20 SVa 2 3 3 2 2 2 6.64 1 
*There were no scores of zero or four on the BVS. MPa = medial parapatellar approach; SVa = subvastus 
approach. 
The pat:fem measured in this study ranged from 0.80 to 6.64. Analysis of the pat:fem revealed no 
significant difference between groups (MPa 2.54±1.97; SVa 2.46±1.92; p=0.935). Sample sizes 
were not calculated a priori for this study. Post hoc calculations based on the data in this study 
indicated that the effect size of the TKA approach on pat:fem was 0.041. Given this effect size, it 
was estimated that for an appropriately powered study, a sample of 18,866 participants would be 
required to achieve 80% power with an alpha of 0.05. 
The results (Kappa, κ) for the intra- and inter-tester reliability and percent agreement for the BVS 
are presented in Table 5-2. They indicate very good intra-rater reliability for the BVS (κ>0.81). The 
results for inter-tester reliability indicate either very good (superior quadrants κ>0.81) or good 
(inferior quadrants κ>0.61) reliability of the BVS (Altman, 1991). 
5-54 
Table 5-2 Kappa values for intra- and inter-tester reliability for the BVS  
Intra-rater reliability 
 Superior 
pole 
Inferior 
pole 
Supero-
medial 
quadrant 
Supero-lateral 
quadrant 
Infero-medial 
quadrant 
Infero-lateral 
quadrant 
Quadratically 
weighted 
Kappa  
(95% CI) 
Standard error 
* * 
0.853 
(0.653 to 1) 
0.102 
0.947 
(0.845 to 1) 
0.052 
0.853 
(0.653 to 1) 
0.102 
0.955 
(0.869 to 1) 
0.044 
Percent 
agreement  
100 100 90.0 95.0 90.0 95.0 
Inter-rater reliability 
Quadratically 
weighted 
Kappa  
(95% CI) 
Standard error 
* * 
0.853 
(0.653 to 1) 
0.102 
0.824 
(0.639 to 1) 
0.094 
0.758 
(0.507 to 1) 
0.128 
0.792 
(0.604 to 0.979)
0.096 
Percent 
agreement 
100 100 90 85 85 80 
* Unable to calculate due to insufficient variability 
The BVS indicated that patellar vascularity was centred about a normal score of two for each 
quadrant of the patella in both the MPa and SVa groups. Both groups contained a proportion of 
abnormal vascularity scores (MPa 17/40 (BVS1 n=6, BVS3 n=11); SVa 21/40 (BVS1 n=10, BVS3 
n=11) where 1 = decreased and 3 = mildly increased). There were no patellae where vascularity was 
absent (Score 0) or moderately increased (Score 4). Two-sample Wilcoxon rank-sum analysis 
revealed no significant difference in vascularity between the MPa and SVa groups on the five-point 
BVS for either pole or any quadrant of the patella (supero-lateral quadrant p=0.064; supero-medial 
quadrant p=0.437; infero-lateral quadrant p=0.573; infero-medial quadrant p=0.490; superior pole; 
inferior pole (not calculated due to insufficient variability). 
The anterior knee pain NAS scores were likewise no different between groups (MPa 1.5±1.6; SVa 
1.5±0.97; p>0.999). Only one of the 10 participants (10%) receiving the MPa reported pain (see 
case 5, Table 5-1; NAS 6/10) whereas three of 10 participants (30%) receiving the SVa reported 
pain though of lesser rated intensity (see cases 13, 14, 17 Table 5-1; two scores of 2/10 and one of 
4/10).  
5.5 Discussion  
This study found no significant difference between the SVa and MPa for the outcomes of patellar 
vascularity assessed using radionuclide bone imaging and the clinical BVS. There was also no 
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between group difference in the mean rating of anterior knee pain at 18 months post-operatively. 
The hypothesis that the SVa would afford better results for vascularity and anterior knee pain than 
the MPa due to the extensive dissection of the patellar arterial blood supply in the latter approach 
was rejected. 
Previous literature has suggested a link between anterior knee pain and avascular necrosis of the 
patella (Holtby et al., 1996; Soucacos et al., 2004). In this study we failed to see a strong link. Of 
the 20 participants, 20% (4 of 20) experienced anterior knee pain (Table 1). This is consistent with 
existing literature which reports pain rates from 5-30% (Hofmann et al., 1991). Each of these four 
cases demonstrated some changes in vascularity on the BVS, with three participants showing 
decreased vascularity in at least one quadrant, and indeed one with increased vascularity in one 
quadrant. However, 12 participants (60%) without anterior knee pain also demonstrated some 
changes in vascularity on the BVS bringing the total percentage of participants with vascularity 
changes to 80%. Notably, there were no avascular patellae (BVS = 0), and perhaps severe localised 
anterior knee pain is only present once AVN is well established. There are many factors other than 
AVN that may contribute to anterior knee pain in patellae that are not resurfaced, including 
osteoarthritis and patellar mal-tracking. Therefore, given that there was no difference between 
groups on either vascularity measure it was not surprising that no difference in anterior knee pain 
rates was found between the groups. With so few cases of anterior knee pain in this study, it is not 
possible to further explore the relationship between pat:fem ratio, BVS vascularity measures and 
anterior knee pain. Future studies with a specific focus on exploring this relationship should include 
a larger number of cases with anterior knee pain. 
Angiography as a direct method for measuring patellar vascularity was not used in this study due to 
cost and risks associated with femoral artery cannulation, contrast reactions and the higher dose of 
radiation relative to radionuclide bone imaging. Thus radionuclide bone imaging was used to 
indirectly measure the arterial perfusion of the underlying bone. It is clear that absolute photon 
counts per sensor pixel are of little value given the numerous variables that can affect radiotracer 
uptake (e.g. metabolic rate). We therefore used a ratio of counts in the patella compared to a normal 
area of bone to address this problem. It is not possible at this point to state what confidence 
intervals for the pat:fem ratio constitute “normal” until this method is validated against a gold 
standard such as angiography. However, for the purposes of this study, it was possible to compare 
ratio data between groups to infer that if blood flow was compromised in one compared to the other 
group. 
As an adjunct to the pat:fem ratio, the BVS was developed to enhance and rate subjective reporting 
of vascularity status. The scale demonstrated good intra and inter-rater reliability for practitioner 
5-56 
ratings of vascularity on SPECT/CT scans. The fact that the results produced by the BVS are 
consistent with previous findings (Wetzner et al., 1985; Scuderi et al., 1987) is encouraging and 
when combined with the high level of inter and intra-rater reliability, the BVS may present as a 
useful outcome measure for evaluating patella vascularity.  The mildly increased vascularity in 26% 
of cases was an unexpected finding and to the authors’ knowledge there is no literature that reports 
increased vascularity in the patella as late as 18 months post-operatively. One potential explanation 
may be residual increased osteoblastic activity or OA of the patella (Stern, 2002), in which case, 
scans at a later interval may be appropriate.   
As the clinical meaning of relative pat:fem ratios is unknown, there was some concern when the 
magnitude of these ratios was compared visually to the clinical BVS rating of vascularity. For 
example, on occasions where high BVS scores were used to describe increased vascularity in the 
patella (see case 11, Table 1) a relatively low pat:fem ratio of 2.01 was observed. This is in contrast 
to occasions where low BVS scores, indicating a reduction in patella vascularity (see case 3, Table 
1) were coupled with higher a pat:fem ratio of 6.10. In support of future investigation of the utility 
of the pat:fem ratio as a quantitative measure derived from radionuclide bone imaging, it is possible 
that the occasional and mild degrees of patellar avascularity observed overall in the study sample 
meant that pat:fem ratios were clustered within a potentially normal range. It is notable that the 
clinical rating scale (BVS) and the pat:fem ratio were concordant on their findings of no between 
groups differences in patellar vascularity. 
A major concern is the very low statistical power associated to the pat:fem ratio. Further 
investigation of the reliability and validity of both the BVS and the pat:fem ratio must be 
undertaken with larger sample sizes (to increase statistical power) to establish their utility as robust 
outcome measures for patella vascularity.  
The lack of difference in vascularity or anterior knee pain between groups in this study may have 
been influenced by the exclusion of participants requiring a lateral release. While this was a 
necessary criterion for the larger RCT, it is probable that by excluding this procedure from this 
study the SLG was retained in both groups. Consequently, blood supply to the patella may have 
been retained through the SLG, and as reported by Kayler et al. (1988) (Kayler et al., 1988), this 
may be sufficient to retain patella vascularity hence there was no difference between groups on 
vascularity or anterior knee pain. This is in spite of the fact that the DGA and SMG would be 
augmenting the supply in the SVa group. Future studies should include a broader TKA sample 
including those who require lateral release procedures as this will enable a more accurate 
examination of the effect the SLG has on retaining patellar vascularity. No a priori sample size 
calculation was performed for this study, therefore, results cannot be generalised to a broader TKA 
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population. However, data from the participants in this study suggests that 18,866 participants 
would be required in a future study for it to be adequately powered to detect a difference between 
the groups. Studies of this magnitude are improbable and therefore future research is unlikely to 
reach a different conclusion.  
Although the results of this study are not definitive, no difference was detected and they provide 
preliminary evidence for no difference between the SVa and MPa on the outcomes of patellar 
vascularity and anterior knee pain. 
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6 Towards a model that determines when a patient with 
knee osteoarthritis should be referred for specialist 
attention: a case control study 
The baseline measures of the patients recruited for the randomised controlled trial presented the 
opportunity to undertake novel research. This research investigated an indication for when to refer a 
patient with knee osteoarthritis (OA) to an orthopaedic surgeon for assessment of their suitability 
for total knee arthroplasty (TKA). This chapter presents work that is building towards a method to 
assist primary health practitioners to quantify the circumstances when referral to an orthopaedic 
surgeon is warranted (without consideration of surgical approach).  
6.1 Background 
Demand for TKA is expected to increase in line with an increase in the prevalence of knee OA 
(National Institute of Health, 2004). The role of TKA as an effective treatment for patients with end 
stage OA of the knee is well established (Callahan et al., 1994, 1995; Dieppe et al., 1999). Figures 
published by the Australian Orthopaedic Association indicate that in the 2009 calendar year there 
were 40,675 knee related prosthetic procedures carried out in Australia. This was an increase of 3% 
on the 2008 calendar year. Of these, 80% were primary TKA. In the nine years from September 
1999 to December 2008, 289,274 knee related prosthetic procedures were performed (Australian 
Orthopaedic Association, 2010). 
In Australia, patients requiring TKA are referred to an orthopaedic surgeon by a primary health care 
provider (e.g. general medical practitioners). By this stage, patients have often exhausted 
conservative management for OA including non-steroidal anti-inflammatory drugs (NSAIDs), 
physiotherapy and intra-articular corticosteroid injections (Cross et al., 2006). There are various 
opinions on when to refer for TKA amongst orthopaedic surgeons, rheumatologists and primary 
health care providers (Dieppe et al., 1999; Australian Orthopaedic Association, 2010). Pain 
(Mancuso et al., 1996; Naylor et al., 1996; Hadorn et al., 1997), loss of joint space or joint damage 
(Mancuso et al., 1996; Hadorn et al., 1997), high patient motivation (Mancuso et al., 1996), 
functional impairment (Naylor et al., 1996; Hadorn et al., 1997), radiographic severity (Kellgren et 
al., 1957; Ahlback, 1968), and problems with care giving (Naylor et al., 1996; Hadorn et al., 1997) 
have all been cited as potential indicators. However, there are currently no definitive quantitative 
criteria to assist primary health care providers in determining when patients warrant referral to an 
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orthopaedic surgeon for consideration for surgical intervention. This may result in either 
inappropriately early or delayed referral. 
There are a large number of patient-assessed scoring instruments for knee joint disorders (Garratt et 
al., 2004) as well as a number of clinical rating systems for TKA (Davies, 2002). To date these 
instruments have been used predominantly to measure TKA outcomes (Anouchi et al., 1996; 
Mizner et al., 2005; Lim et al., 2006) and, to the authors’ knowledge, have not been assessed for 
their use in guiding referral for TKA. The conduct of the randomised controlled trial with its 
attendant outcome measures provided data and an opportunity to preliminarily investigate these 
measures to inform suitability of patient referral to surgical consultation.  
The aim of this study was to conduct modelling to determine if physical measures, patient-assessed 
scoring instruments and/or clinical rating systems could be indicators for the timely referral of 
patients to an orthopaedic surgeon for surgical consideration. 
6.2 Methods 
Ethical approval was provided by the relevant tertiary institutional and hospital medical ethics 
committees (Appendix 15) and all participants provided written informed consent (Appendix 16). A 
case control study was undertaken in the process for a randomised controlled trial (Trial registration 
ACTRN12606000376549/2009). 
6.2.1 Participants 
Fifty participants per group were recruited. The TKA group comprised 50 patients from a hospital 
outpatient orthopaedic clinic who were invited to participate in the randomised controlled trial after 
they were assessed by an orthopaedic surgeon as being appropriate for TKA surgery with the 
following inclusion criteria. They were required to be at least 18 years of age, have a primary 
diagnosis of OA, be suitable for either a MPa or SVa and have normal mentation. Participants for 
the control group (n = 50) were recruited over a one month period through local advertising, and 
were age and gender matched as closely as possible to the TKA group. Control group participants 
were required to have no knee pain with daily activities, no history of knee pathology or surgery 
and have normal mentation. Participants in both groups were excluded if they had concomitant 
medical conditions that would prevent them from performing the required assessments, were unable 
to mobilise bipedally with or without the use of a walking aid or were unable to provide informed 
consent. Recruitment of control participants was limited due to financial restrictions. 
6.2.2 Outcomes 
Measures of the following independent variables were collected. 
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1. American Knee Society Score (AKSS x/200)(Insall et al., 1989). The AKSS is a simple, 
concise, health practitioner rated system incorporating functional and objective measures of 
knee function (Insall et al., 1989; Davies, 2002). Each of the AKSS subscales is scored on a 100 
point scale where higher scores reflect better performance. The objective knee score (AKSSObj 
x/100) awards points for parameters of pain, stability, strength, alignment and range of motion. 
The functional score (AKSSFun x/100) awards points for walking distance and stair-climbing, 
but deducts points for the use of walking aids. 
2. Three-metre Timed Up and Go (TUG, seconds) test (Podsiadlo et al., 1991). The TUG is a self-
paced timed test of functional mobility. The reliability and validity of the TUG in the elderly 
population has been demonstrated (Podsiadlo et al., 1991). Participants are timed from when 
they rise from a standard armchair, walk three metres, turn and return to the original sitting 
position.  
3. Passive knee flexion and extension range of movement (degrees). 
4. Quadriceps lag on straight leg raise (SLR, degrees). This was used as an indicator of quadriceps 
strength, defined as the difference between knee joint angle when the knee was passively 
extended and when an active SLR was performed to a degree where the heel was no longer in 
contact with the bed. 
Data pertaining to the questionnaire and physical tests were collected on electronic personal digital 
assistants (PDA) by physiotherapists trained in their use. Knee flexion and extension range of 
movement and quadriceps lag were measured using software on the PDA which was adapted from 
telerehabilitation research (Russell, 2007), as noted in Chapter 4, Section 4.3.4 – Outcomes. 
6.2.3 Statistical Methods 
Statistical analysis was conducted using STATA Version 10.0 (Statacorp, Texas, USA) (Statacorp, 
2007). Univariate logistic regression models were fitted for each variable (with TKA/control group 
as the dependent variable) to determine their predictive ability. Participants with outlying scores (>3 
standard deviations from the mean) for any variable were excluded from further analysis, along 
with their matched control in order to maintain a balanced design. 
At the modelling stage, multivariate logistic regression models were constructed from the most 
strongly predictive variables (based on the univariate analyses). Other variables were added 
systematically and Wald tests were used to examine the significance of each variable included in 
the model. If a term was not shown to be significant (p<0.05), it was removed and an alternative 
term was entered. The best fitting models were compared based on their ability to accurately predict 
the TKA outcome (predictive probability ≥ 0.50) for each patient, and the interpretability of the 
odds ratios. Intuitive judgement was used in the model building process. For example, when odds 
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ratios were tending to infinity or zero, this was considered implausible. Similar judgement was used 
when comparing models during sensitivity analysis, where each range of motion parameter was 
systematically varied by 1° and 5°. Thus when odds ratios were considered implausible, a model 
was deemed to be less clinically applicable. 
6.3 Results 
Data were collected for the TKA group prior to surgery at a mean of 52.5 +/- 7.5days. Cases (n=2) 
and controls (n=6) with outlying data for any outcome were excluded from further statistical 
analysis. Thus the analysis was conducted on 84 participants, 42 in each group, with six different 
surgeons performing variable numbers of procedures. Sample characteristics and outcomes of these 
participants are displayed in Table 6-1. 
Table 6-1 Sample characteristics and variables. 
Group 
 
TKA Control 
No. of participants 42 42 
Age (years ± SD) 68.2 ± 6.8 67.7 ± 6.4 
Gender (male; female) 18; 24 18; 24 
Flexion (degrees) (mean ± SD) 117.77 ± 12.40 140.42 ± 7.77 
Extension (degrees) (mean ± SD) 7.67 ± 3.82 0.74 ± 2.78 
Lag (degrees) (mean ± SD) 2.34 ± 2.71 1.34 ± 1.25 
AKSSObj median (range) 54 (35 – 82) 91 (78 – 100) 
AKSSFun median (range) 50 (0 – 90) 100 (70 – 100) 
TUG (seconds) (mean ± SD) 13.55 ± 3.43 7.26 ± 1.46 
AKSS = American Knee Society Score; Obj = objective; Fun = functional; TUG = Timed Up and Go test. 
Control group participants were selected if they had no knee pain with daily activities and if the 
AKSSObj featured pain in 50/100 points, then only the AKSSFun was retained in the analysis. 
Univariate logistic regression modelling was undertaken on five variables (flexion, extension, lag, 
AKSSFun and TUG). The four strongest predictors of probability (p<0.001) used as ‘bases’ for the 
model-building process were extension, flexion, AKSSFun and TUG. Lag (p=0.366) was not used 
as a base for model building, but was included as a subsequent term (Appendix 17). 
Two models were identified which predicted TKA with plausible odds ratios for each variable and 
with greater than 95% accuracy.  
6.3.1 Model 1 
Statistical analysis found Model 1 to be: 
Prob(TKA) = ℮ [16.440 + -0.266*AKSSFun + 0.770*Ext]/(1 + (℮ [16.440 + -0.266*AKSSFun + 0.770*Ext])) 
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It was based on AKSSFun/extension components and correctly predicted whether patients required 
TKA in 82 out of 84 instances (2.4% failure rate) (Table 6-2).  
Table 6-2 AKSSFun/extension probability model (Model 1) and characteristics. 
Model accuracy Model variables Odds ratio 95% CI p value 
TKA group Control group 
Extension (degrees) 2.16 1.13 - 4.12 0.02 
AKSSFun 0.77 0.60 - 0.98 0.03 
41/42 
(97%) 
41/42 
(97%) 
AKSS = American Knee Society Score; Fun = functional. 
6.3.2 Model 2 
Statistical analysis found Model 2 to be: 
Prob(TKA) = ℮[43.591 + -0.143*AKSSFun + -0.245*Flex]/(1 + (℮[43.591 + -0.143*AKSSFun + -0.245*Flex])) 
It was based on AKSSFun/flexion components and correctly predicted whether patients required 
TKA in 81 out of 84 instances (3.6% failure rate) (Table 6-3). 
Table 6-3 AKSSFun/flexion probability model (Model 2) and characteristics. 
Model accuracy Model variables Odds ratio 95% CI p value 
TKA group  Control group 
Flexion (degrees) 0.78 0.62 – 0.99 0.04 
AKSSFun 0.87 0.79 – 0.95 <0.001 
40/42 
(95%) 
41/42 
(97%) 
AKSS = American Knee Society Score; Fun = functional. 
To evaluate the sensitivity of the two models, the extension parameter was systematically varied by 
1° and 5° for model 1, and the flexion parameter by 1° and 5° for model 2, while maintaining a 
constant AKSSFun score. The odds ratio for Model 1 was found to be 2.16 and 47.06 for 1º and 5º 
parameter changes in extension, respectively. The change in Model 2 was more clinically plausible 
with an odds ratio of 1.28 and 3.40 for 1º and 5º parameter changes in flexion, respectively. 
Although neither model demonstrated complete accuracy in prediction, failure to predict the correct 
outcome was most frequently observed in atypical presentations. For example, one control group 
participant scored poorly on the AKSSFun (80 points) and demonstrated considerable loss of 
extension range of motion (7.4º) compared with other control participants. Their predictive 
probability was calculated as 0.70 and, as this was above 0.50, they were considered to have been 
assigned to the TKA group. The details of five participants who were incorrectly assigned and their 
respective predictive probabilities are displayed in Table 6-4.  
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Table 6-4 Probability model testing: Incorrect predictions for five participants. 
Model Participants Group Membership 
AKSSFun
(points) 
Extension 
(degrees) 
Flexion 
(degrees) 
Probability 
(of TKA)# 
Predicted 
group 
1 Control 80 7.39  0.70 TKA Model 1 
AKSSFun/ 
extension 2 TKA 80 3.48  0.10 Control 
3 Control 70  130.93 0.82 TKA 
4 TKA 90  134.51 0.10 Control 
Model 2 
AKSSFun/ 
flexion 5 TKA 90  135.00 0.09 Control 
# Probabilities >0.50 were assigned to the TKA group. 
AKSS = American Knee Society Score; Fun = functional. 
Two additional models were obtained which predicted TKA with equivalent or slightly better 
accuracy than Models 1 and 2. These were the extension/AKSSFun/TUG and 
extension/AKSSFun/Lag Models. However, the additional terms (TUG and Lag) did not achieve 
significance in the model, based on the Wald test and odds ratio confidence intervals and were 
therefore removed. Furthermore, as they did not achieve significance, the extra time it would take to 
clinically obtain the third variable was deemed unjustified. 
6.4 Discussion 
Two statistical models, based on physical measures of knee movement and clinical rating systems, 
were found to accurately predict the correct group membership to either TKA or control, for 
participants in the study. These models can be administered rapidly as they incorporate indicators of 
knee disease and dysfunction that are routinely assessed in clinical settings. The use of such models 
may provide primary health care practitioners with an objective, quantifiable method of determining 
when patients warrant referral to an orthopaedic surgeon for consideration for TKA. The 
AKSSFun/flexion model may be administered in a clinical setting using the website 
www.uq.edu.au/tru/tkrprob  (Appendix 18) 
It was not surprising that the functional component of the AKSS (stair climbing ability, walking 
distance and walking aid use) was retained in both models as pre-operative function is frequently 
reported as a predictor for TKA and TKA outcome (Fortin et al., 1999; Jones et al., 2003; 
Desmeules et al., 2009). Patients awaiting TKA have poor function and quality of life (Desmeules 
et al., 2009) which is likely to be reflected in this outcome measure. The opposite is also true; 
participants with no or mild knee pathology will perform to a higher level on this outcome measure. 
For this reason a higher score on the AKSSFun appears to be a protective factor, reducing the 
likelihood of a TKA allocation, in both models. 
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Both proposed models also incorporate a measurement of knee range of motion, either extension or 
flexion. Again, this was not surprising as loss of knee range of motion is a common element of the 
osteoarthritic disease process (Tanzer et al., 1989) and a factor which is significantly improved with 
TKA intervention (Aderinto et al., 2005). As expected, both the presence of an extension lack (or 
fixed flexion deformity) and a loss of flexion were factors linked with the need for TKA. A 
sensitivity analysis, whereby the flexion and extension parameters were systematically varied by 1 
degree and 5 degrees respectively, while maintaining a constant AKSSFun, assisted in determining 
which model was the most sensitive to change while maintaining predictive ability and plausible 
odds ratios. The odds ratio for Model 1 was found to increase to 47.06 for a 5 degree change in 
extension. It was considered less plausible that a 5 degree change in extension would be associated 
with an odds ratio as high as 47 (Model 1), therefore it appears that Model 2, that is, 
AKSSFun/flexion, demonstrates the greatest clinical applicability. 
Using the model presented in this paper, a primary health care provider such as a general medical 
practitioner or physiotherapist may gain an indication of when they should refer a patient with knee 
OA to an orthopaedic surgeon. The model is not presented as a definitive guide for patient referral, 
but could contribute to decision making. Ultimately, the surgeon will consider a multitude of factors 
such as knee pain, diagnostic imaging, joint deformity and functional impairment and other 
psychosocial factors when determining suitability for TKA.  
A number of limitations were identified in this work which affects the applicability of the results. 
The potential for selection bias with respect to selection of TKA cases is acknowledged, although 
this was at least partially mitigated by the involvement of six different surgeons in the selection 
process. The use of volunteers for the control group, rather than a random sample of the population, 
may have also introduced an element of volunteer bias (Bland, 2000). The TKA group (n=52) were 
participants in a larger randomised trial currently being undertaken by the authors. Therefore the 
outcomes explored in this research were limited to those of the existing trial. Additionally, the 
modelling process was only conducted on outcomes that demonstrated a normal distribution, and 
participants with outlying data (>3 SD) were excluded from further statistical analysis. This meant 
that six participants from the control group were excluded: one with a TUG of 16.0 seconds, one 
with loss of extension of 9.9° and four with a lag (6.7°, 7.3°, 8.5° and 11.5°). Two participants from 
the TKA case group were also excluded: one with a TUG of 29.7 seconds and one with loss of 
extension of 23.3°. The ability of the models to accommodate such extreme values is unknown.  
Another limitation is that the sample used for testing the predictive ability of the models was the 
same as that which was used to generate the model, thus limiting the generalisability of the results. 
Given the potential value of the quantifiable elements of the model, future studies are warranted to 
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investigate the ability of the model to accurately predict the need for referral to surgeons in patients 
with varying (very mild to severe) levels of OA. Prospective testing on a larger sample size, 
including patients with a full spectrum of knee pathologies, should be undertaken to determine the 
accuracy of these models in the clinical setting. The modelling of additional variables such as the 
Western Ontario and McMaster Universities Index of Osteoarthritis (WOMAC), Medical Outcomes 
Study (MOS), 36-Item Short Form Health Survey (SF-36) and the European quality of life 
questionnaire (EuroQol) may result in alternative models and should be included in future studies.  
It is important to emphasise that the model is not absolute and is not designed to reduce the decision 
to a simple mathematical formula. It is presented as a way to interpret multiple, and sometimes 
incongruous, (e.g. poor knee flexion but can ascend/descend stairs normally) outcomes succinctly. 
The model attempts to synthesise commonly measured outcomes which can then be used in the 
decision making process surrounding referral to an orthopaedic surgeon. 
6.5 Conclusion 
A model has been identified that includes the AKSSFun component and knee flexion range of 
motion (AKSSFun/flexion). In limited testing, it accurately predicted the probability of undergoing 
TKA in over 95% of the sample in this study. This model shows promise to be used as an adjunct to 
conventional indicators by clinicians who are deliberating when to refer a patient with knee OA to 
an orthopaedic surgeon for a surgical consultation. Further research is required to addresses the 
limitations outlined for the current model. 
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7 Discussion 
Total knee arthroplasty (TKA) is an effective surgical procedure for the management of end stage 
knee osteoarthritis (OA). In the context of an ageing population and increasing incidence of knee 
OA, the frequency of TKA is increasing and, based on the Australian TKA joint registry data, the 
trend is expected to continue (Australian Orthopaedic Association, 2010). It is important to optimise 
surgical outcomes and minimise both the impact on individual patients and the limited resources in 
health care systems. The author is a senior physiotherapist in orthopaedics in a metropolitan 
hospital. The interest in outcomes of TKA with different surgical approaches was initiated by the 
clinical observations of earlier straight leg raise (SLR) ability observed following the subvastus 
approach (SVa) in patients having simultaneous bilateral TKA (one SVa and one medial 
parapatellar approach (MPa)) and seemingly faster return of function in this knee during the 
patients’ hospital stay. It followed that perhaps these findings may translate to earlier function, 
shorter length of hospital stay and consequent reduction in health care expenditure. This anecdotal 
observation was biologically plausible and was consistent with proponents of the SVa in TKA who 
have historically claimed earlier quadriceps function and less pain associated with this approach 
over the MPa (von Langenbeck, 1878; Scuderi et al., 1987; Kayler et al., 1988; Holtby et al., 1996). 
However, a search of the literature revealed little evidence to support this clinical observation which 
prompted the research program presented in this thesis. This chapter presents the important findings 
of the research, discusses the implications and limitations of findings and outlines future research 
directions. 
7.1 Systematic review of MPa and SVa in TKA 
A systematic review of the literature was undertaken in order to gain a greater understanding of the 
effects of surgical approach in TKA. This review was the first published review in the field to 
compare the outcomes of the MPa and SVa in TKA. An in-depth analysis of five papers included in 
the review revealed promising results in favour of the SVa. Of the papers that reported the results of 
a knee scoring system (Cila et al., 2002; Weinhardt et al., 2004) or quadriceps function (Faure et al., 
1993; Cameron, 2001; Roysam et al., 2001; Cila et al., 2002; Weinhardt et al., 2004), all were in 
support of better outcomes in the SVa group. As outlined in Chapter 3, some studies found 
favourable outcomes at different time-points in the SVa group on the outcomes of pain (two out of 
three), knee flexion (one out of two), blood loss (one out of four), and tourniquet duration / length 
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of surgery (one out of three) (Table 3-2). While these results seemed to support the efficacy of the 
SVa, the methodological quality of most studies was poor, as they either failed to randomise 
appropriately, adequately conceal allocation, report complications, define inclusion and exclusion 
criteria, or define outcomes. In addition, the use of heterogeneous outcomes prevented pooling of 
data for meta-analysis which may have revealed stronger conclusions. The papers investigating 
length of hospital stay (Cameron, 2001; Roysam et al., 2001) and patellar avascular necrosis 
(Cameron, 2001) found no difference between the groups. That one author applied inclusion criteria 
to titles and abstracts is considered a minor limitation of this review article. 
Following the publication of the systematic review, Bridgeman et al. (2009), published a high 
quality manuscript which revealed a favourable result for the SVa over the MPa 12 months post-
operatively on the American Knee Society Score (AKSS). This paper addressed many of the 
limitations of previous trials that compared the two approaches, however, it did not report on days 
to straight leg raise (SLR) which is commonly used as an indicator of early quadriceps function 
(Cameron, 2001; Weinhardt et al., 2004). The authors acknowledged these limitations and 
concluded that there was “some evidence” that patients with a SVa have better outcomes than those 
with a MPa at one week and one year following surgery. Given the evidence to date, there was 
insufficient or equivocal evidence upon which to claim the SVa affords better outcomes than the 
MPa. 
7.2 Comparing the SVa and MPa in TKA: a randomised controlled trial 
In order to address deficiencies identified in the existing literature, a randomised controlled trial 
was designed with robust methodology, industry standard physical and functional outcome 
measures, and follow-up to 18 months post-operatively. To facilitate the validity and transparency 
of the trial, it was designed, conducted and reported according to the principles of the Consolidated 
Standards of Reporting Trials (CONSORT) statement (Moher et al., 2001). 
Physical and functional outcomes were collected pre-operatively and at 10 time-points which 
extended to 18 months post-operatively. The primary outcome was the AKSS (Insall et al., 1989), 
which is knee specific and incorporates physical (pain, range of motion, stability, alignment, lag on 
SLR, extension lack) and functional (walking distance, stair climbing ability, walking aid) measures 
proportionately, and is commonly used in TKA trials (Gioe et al., 2009; Juosponis et al., 2009; 
Bonutti et al., 2010). The Oxford Knee Score (OKS) (Dawson et al., 1998) was collected pre-
operatively and from day three onwards. It is reliable, valid and widely used in TKA research 
(Conaghan et al., 2007). The inclusion of these two outcomes addressed a deficit in knee specific 
7-68 
scoring systems which were absent from four of the five papers in the systematic review (Faure et 
al., 1993; Cameron, 2001; Roysam et al., 2001; Weinhardt et al., 2004) (see Table 3-2).  
The Three Metre Timed Up and Go (TUG) test (Podsiadlo et al., 1991), a valid and reliable measure 
of functional mobility, was included to augment the AKSS Functional (AKSSFun) score as were 
the separate measures of knee flexion and extension range of motion, quadriceps lag on SLR, and 
pain. Days to SLR was the preferred indicator used to compare the approaches on the outcome of 
early quadriceps function, as this is a benefit commonly given to the SVa. It is also a better 
indicator of quadriceps function than days to mobilisation which is often reported, as the latter can 
be impacted by a multitude of other factors including surgeon protocol, pain and nausea. Knee girth 
measurement was chosen as the simplest and most cost-effective quantifiable method of comparing 
swelling of the knee. Additionally, to compare efficiencies of the approaches and to be consistent 
with existing literature, length of post-operative stay (Cameron, 2001; Roysam et al., 2001) and 
operation duration (Faure et al., 1993; Cameron, 2001; Weinhardt et al., 2004) were recorded. 
Rather than use the latter as a surrogate measure for difficulty with the procedure, a rating of 
surgeon perceived level of difficulty with the operative approach was collected as a direct measure 
of difficulty. Tourniquet time was also recorded in the event that local thrombo-embolic 
complications needed to be investigated. Eighteen months follow up was ideal for this study 
because it afforded time for pain to subside, function to improve and outcomes to potentially 
converge (Faure et al., 1993; Keating et al., 1999; Berth et al., 2007; Juosponis et al., 2009).  
The robust methodological design of this randomised controlled trial included randomisation of 
allocation, concealment of allocation with blinded assessors and participants, and sample size 
calculation. Linear mixed modelling conducted for the analysis of continuous variables revealed no 
difference on any outcome at any time-point between the groups except for earlier SLR (mean 
difference – on average 0.9 days earlier, p=0.044) in the SVa group, which is similar to previous 
research (Cameron, 2001; Weinhardt et al., 2004). Consistent with this finding was a significantly 
better AKSS objective (AKSSObj) score in the SVa group on day one post-operatively (mean 
difference nine points, p=0.029). While it was expected that results in both groups would converge 
at latter time-points, this was not the case and the MPa scored better on AKSSFun at 12 and 18 
months.  
7.2.1 Straight leg raise earlier in the SVa group 
Earlier quadriceps function in the SVa group, as demonstrated by time to SLR (mean difference on 
average 0.9 days earlier, p=0.044), was apparent during inpatient hospital stay. This finding concurs 
with previous research (Cameron, 2001; Roysam et al., 2001; Weinhardt et al., 2004) and anecdotal 
clinical observations on patients having simultaneous bilateral TKA; one SVa and one MPa. 
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Despite this result, length of hospital stay, which might be expected to be less in a patient whose 
quadriceps are functioning earlier, was no different between the groups. Sixty percent of patients 
who mobilised on the first post-operative day, regardless of approach, could perform a SLR which 
indicates that it is not a requirement in order to mobilise. All participants, however, had control of 
SLR prior to discharge, per the trial protocol. This highlights the limited impact of this isolated 
observation in terms of clinical or financial advantage.  
7.2.2 AKSSObj – Favours SVa group day one post-operatively 
Significantly better results on the AKSSObj score favouring the SVa group (mean difference nine 
points, p=0.029) were observed on the first day post-operatively. Exploration of the raw data 
suggested that the reason AKSSObj was better on day one was because more participants in the 
SVa group were able to perform a SLR (63.8%; 23/36) compared to the MPa group (37.5%; 15/40). 
While it may be tempting to accept the trial hypothesis H1(i): That participants receiving the SVa 
would experience better early outcomes than those receiving the MPa based on these results, the 
group difference did not persist beyond the first day post-operatively, which is very early in terms 
of arthroplasty time frames. Therefore, it was not deemed that the SLR and AKSSObj isolated 
findings constituted support for H1(i). Other trials have reported on earlier quadriceps function with 
the SVa up to three days post-operatively (Cameron, 2001; Weinhardt et al., 2004), but these 
findings were not confirmed in the current trial.  
7.2.3 AKSSFun – Favours MPa group 12 months and 18 months post-operatively 
AKSSFun scores were found to be higher in the MPa group from 12 months onwards (12 months: 
mean difference 11 points, p=0.032; and 18 months: mean difference 11.1, p=0.028). Interestingly, 
this finding is incongruous with two trials reported in the systematic review which suggested that 
the SVa is superior at 12 months (Cameron, 2001; Cila et al., 2002). In the absence of literature 
defining a minimal clinical important difference (MCID) for the AKSS, a difference of 5% was 
asserted to be clinically relevant for the current randomised controlled trial and the trial was 
powered as such. The difference in favour of the MPa group on the AKSSFun outcome was 
approximately 10% indicating a statistically better and seemingly clinically relevant result for the 
MPa group on this outcome. Close inspection of the data revealed that this result was not 
attributable to a number of individual cases as it was broadly represented across participants. A 
known MCID and future research would improve confidence in this finding. This finding led to 
rejection of H1(ii): that outcomes would converge by 18 months after surgery on the basis that a 
difference on the primary outcome was observed at both 12 and 18 month time points. Further 
exploration of the MCID of this outcome measure in future research may vary conclusions should it 
be shown to differ considerably from the current assertion. 
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7.2.4 Surgeons perceive the SVa to be more difficult 
Surgeons reported that the SVa was more difficult than the MPa (mean difference 2.1/10 on the 
numerical assessment scale, p=0.001). In an attempt to standardise the surgical approach and 
familiarise surgeons not routinely performing the SVa, a senior surgeon supervised each 
participating surgeon performing at least five SVa approaches prior to them participating in the 
trial. Despite this training, it was apparent that the more experienced surgeons rated the SVa easier 
than did the less experienced surgeons. The literature which infers that the SVa is more difficult 
than the MPa argues that eversion of the patella is the main issue (Hofmann et al., 1991; Matsueda 
et al., 2000). The patella was not everted as part of the standardised surgical protocol in this trial 
and this infers that the higher difficulty ratings may relate to surgeon experience. This observation 
is consistent with the senior surgeon’s impression on the approach who anecdotally noted that 
orthopaedic training registrars tend to avoid this approach when given the choice. This implies that 
even if the SVa did afford better outcomes, it is unclear if surgeons would be convinced to use this 
approach. 
Implications 
Every effort was made to ensure this randomised controlled trial was well designed with a rigorous 
methodology. Attention was given to adhering to the CONSORT statement (Moher et al., 2001) and 
self-calculation of the quality of methodology component score indicated this study rated 11/12 
(Bourke et al., 2011). This gives every confidence that the results are trustworthy in the light of 
other studies with different findings. The results of the randomised controlled trial in this thesis 
suggest that, as well as being a more difficult surgical approach, the SVa offers no substantial 
benefit over the MPa, and may in fact result in inferior functional outcomes from 12 months post-
operatively. In light of these findings, it would appear to be appropriate for only experienced 
surgeons with a particular desire to perform the SVa to attempt this procedure. 
Limitations 
While every effort was made to ensure the methodology of this randomised controlled trial was 
rigorous, there were a number of limitations which should be addressed in future clinical trials. 
• A longer follow-up period beyond 18 months would have allowed it to be determined if the 
MPa group sustained their functional advantage on the AKSSFun over the SVa group. The 
intention of this randomised controlled trial, however, was to investigate the early outcomes of 
SVa and MPa to TKA and although follow-up was short in terms of arthroplasty follow-up, 18 
months was determined sufficient for analysing the outcomes pertinent to this trial. 
• No consideration was made for the effect of prosthesis type on outcome in the randomised 
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controlled trial. However there is no convincing evidence that the type of prostheses the 
surgeons used for the trial (Smith and Nephew Genesis II or LCS® Depuy Mobile-Bearing) 
influenced outcomes (Jacobs et al., 2001; Jacobs et al., 2005). The randomisation of participants 
was stratified by surgeon to mitigate any impact of prosthesis on the outcomes. Future trials 
may choose to utilise a single prosthesis to determine if the prosthesis has any effect on 
outcomes for the different approaches. 
• Data on post-operative analgesia consumption was not collected in this randomised controlled 
trial which would have permitted more objective measurement of the variable of pain. 
• No measure of intra-operative blood loss was undertaken in the randomised controlled trial. One 
study has found the SVa to have less intra-operative blood loss (Roysam et al., 2001), but others 
have not (Faure et al., 1993; Cameron, 2001; Weinhardt et al., 2004). Data on intra-operative 
blood loss would have enabled comparison to existing literature to help resolve this issue. 
• Only participants with knee OA and those undergoing single knee procedures were included in 
this study. The inclusion of bilateral procedures and patients with rheumatoid arthritis would 
have increased participant numbers and enabled an analysis with these factors as covariates. 
This would have increased the generalisability of these results to these populations. 
• There were a few contraventions to the surgical protocol (n=5; section 4.4) in this randomised 
controlled trial. A reminder to the surgeon on the trial protocol immediately prior to surgery 
may have eliminated avoidable breaches in protocol. A further nine participants did not progress 
to surgery due to medical co-morbidities. This issue may have been alleviated if randomisation 
occurred nearer to the time of surgery. 
• Collecting data at a time frame when the patient was “ready for discharge” as determined by the 
physiotherapist meant that this time-point was variable (4.6±1.2 days). This was prospectively 
considered a strength of the design because it indicated when participants had met their 
discharge goals rather than the actual discharge date, which was sometimes related to 
organisational factors such as transport arrangements. However, for consistency within the 
study and for comparison with other literature (Faure et al., 1993), data at one week may be 
more useful in future trials. 
• The results of the current trial are generalisable only to those patients eligible for a TKA on 
whom a SVa could be performed. The study excluded patients with co-morbidities contravening 
this approach, as was any patient undergoing revision TKA, or with an extension lack greater 
than 20 degrees or flexion of less than 70 degrees (Section 4.3.1). Thus wider extrapolation of 
results is not possible. 
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Collectively, while numerous, these limitations do not significantly impact on the quality of the 
current trial and are feasibly addressable in future trials. 
Future directions 
Evidence based practice considers the best available evidence, clinical expertise and the individual 
patient (Sackett et al., 1997). Future trials are required to compare the outcomes of all commonly 
used surgical approaches (MPa, SVa, midvastus, lateral and medial trivector). There is a growing 
body of evidence comparing different approaches which indicates that surgeon experience and 
preference, rather than clinical evidence, may ultimately determine the choice of surgical approach. 
It would seem that outcomes, regardless of TKA surgical approach, tend to eventually converge 
(Dalury et al., 1999; Keating et al., 1999; Gelfer et al., 2003; Komatsu et al., 2003; Bathis et al., 
2005; Berth et al., 2007; Seyler et al., 2007; Karachalios et al., 2008; Juosponis et al., 2009; Bonutti 
et al., 2010; Nestor et al., 2010; Lee et al., 2011; Varnell et al., 2011). However, it would be of 
interest to design an innovative trial which uses the surgical approach most suited to the patient, 
which is performed by a surgeon with a preference for the required surgical approach. 
As discussed, future trials should follow up patients in the long term, to an extent consistent with 
current practice in orthopaedic surgery (e.g. >10 years) and a standard time point of one week post-
operatively, rather than “ready for discharge” would be better suited for early follow-up. Other 
functional outcomes could be of value including the Western Ontario and McMaster Universities 
index of osteoarthritis (WOMAC), and measures of blood loss and analgesic requirement would be 
of value. To ensure generalisability of results to the TKA population, future trials need to consider 
the impact of lateral releases, bilateral procedures, and patients with rheumatoid arthritis. Deeper 
investigation of why surgeons apparently perceive the SVa to be more difficult is interesting and 
warrants further investigation. 
7.3 A comparison of patellar vascularity between the MPa and SVa in TKA 
One of the proposed benefits of the SVa is that it preserves patellar vascularity (Hofmann et al., 
1991). The consequences of failing to do so can be serious. Anterior knee pain and the resultant 
reduction in function, prosthetic loosening and the subsequent need for re-operation (Brick et al., 
1989) are factors that are purported to be avoidable with the SVa (Hofmann et al., 1991). 
Angiography, which is arguably the gold standard in determining blood flow in the human body, 
would have been best for determining patellar vascularity. This procedure, however, carries a 
number of unwanted risks and costs that precluded its use in this study. These risks include femoral 
artery cannulation, higher radiation dose, and possible reactions to the contrast medium. 
Considering this, two surrogate measures of vascularity were used, which carry with them inherent 
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limitations. Patellar vascularity was measured from three phase bone scans where Tc99m 
hydroxymethane diphosphonate (HDP) was administered intravenously and accumulated in bone in 
proportion to blood flow. The first outcome measured was the ratio of uptake of Tc99m HDP in the 
patella (as photon counts per pixel) to uptake in a region of interest on the distal femur (pat:fem). 
Referencing the patella to a region of interest on the femur minimised the effect of confounding 
factors such as metabolic activity of the patient (influenced by patient size, activity level), time of 
day, and peripheral circulation which are known to affect absolute photon counts per pixel. A new 
subjective clinical rating scale, termed the Bone Vascularity Scale (BVS) was also developed for 
this study. It is five-point scale and is used to rate patellar vascularity where: 0 = Absent, 1 = 
Decreased (photopenic), 2 = Normal, 3 = Mildly increased and 4 = Moderately increased. It proved 
to have good intra-rater (κ>0.81) and inter-rater Kappa (0.61–0.81) reliability. This quantitative 
method was preferred over subjective commentary which is the traditional radiological approach 
and can vary between radiologists. Anterior knee pain was chosen as a patient reported outcome as 
it is closely related to patellar avascularity (Soucacos et al., 2004).  
The two methods for assessing patellar vascularity revealed concordant findings of no difference in 
patellar vascularity between the MPa and SVa groups at 18 months post-operatively. Furthermore, 
there was no difference in the experience of anterior knee pain between the MPa and SVa groups in 
this study. Vascularity measures on the first 10 participants in each treatment arm were used to 
perform an interim sample size calculation. Preliminary analysis based on pat:fem data revealed a 
sample size exceeding 18,000 participants would be required to adequately power a study to detect 
any difference.  
Implications 
The high number of participants required to adequately power this study was outside of the scope of 
the course of research in this thesis and as such the conclusions of this study should be viewed with 
caution, as a type two statistical error is possible. The historical notion that the SVa preserves blood 
supply and results in less pain was not supported by this study. Based on the results of this study, 
and the unlikelihood of future research being adequately powered to address this research question, 
it would appear that the SVa does not afford better patellar vascularity or less pain than the MPa. 
Therefore, the hypothesis (H2): That the SVa would have better outcomes for vascularity and 
anterior knee pain than the MPa due to the extensive dissection of the patellar arterial blood supply 
in the latter approach was rejected. 
Knees that required lateral releases were excluded from the randomised controlled trial because it is 
not a procedure usually required for patients who are suitable for a SVa, due to the ability of larger 
quadriceps to assist patella alignment. This may have impacted on vascularity outcomes in this 
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study because the retention of blood supply via the supero-lateral geniculate (SLG) artery may be 
sufficient to retain patellar vascularity (Kayler et al., 1988). Unfortunately the exclusion of lateral 
releases means that the findings on vascularity of this study cannot be extrapolated to TKAs with a 
lateral release. 
The high frequency of occasional and mild degrees of patellar avascularity observed on the outcome 
of pat:fem in the study sample meant that the ratios were clustered within a potentially normal 
range. The normal range has not as yet been established and therefore determining what is abnormal 
is difficult. Additionally, validation trials have not been conducted for either the pat:fem or the 
BVS. 
The results of this research differ from claims that the SVa carries less risk of patellar avascularity 
(Hofmann et al., 1991). Given that the power analysis indicated that unrealistic participant numbers 
are required to adequately power a study to detect a difference (over 18,000 required), it is unclear 
whether future studies will achieve statistically significant results. Although pat:fem and BVS have 
face validity, and have demonstrated good intra and inter-rater reliability, future studies should 
establish the concurrent validity of the pat:fem and BVS against the gold standard, angiography. 
While content validity was established to an extent with both measures (i.e. comparing photon 
counts to a region of interest [ROI] on the femur rather than absolute photon counts, and using two 
radiologists who prospectively agreed on the meanings of each increment on the BVS), this process 
could be refined by comparing the photon counts of multiple technicians for the pat:fem, and 
undertaking “think aloud” interviews with nuclear medicine radiologists while they apply the BVS 
to the images. Future trials should also investigate the specificity and sensitivity of the tests, and the 
positive and negative predictive values of the outcomes measured and their likelihood ratio.  
Once validated, pat:fem and BVS may prove to be the most feasible measures to determine the 
effect of surgical approach on patellar vascularity. Future studies will also require large numbers of 
participants and multiple surgical approaches. 
7.4 Towards a model that determines when a patient with knee OA should be referred 
for specialist attention: a case control study 
Opinions on when to refer a patient for TKA vary amongst orthopaedic surgeons, rheumatologists 
and primary health care providers (Dieppe et al., 1999; Cross et al., 2006). Potential indicators are 
numerous and include pain (Mancuso et al., 1996; Naylor et al., 1996; Hadorn et al., 1997), joint 
damage (Mancuso et al., 1996; Hadorn et al., 1997), functional impairment (Naylor et al., 1996; 
Hadorn et al., 1997), and radiographic severity of OA (Kellgren et al., 1957; Ahlback, 1968). With 
such a multitude of factors at play, and the inherently subjective nature of pain reporting, there is 
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potential for inappropriately early or delayed referral to an orthopaedic surgeon for consideration of 
TKA. 
It was reasoned that modelling variables such as physical measures, patient-assessed scoring 
instruments and clinical rating systems was a plausible method to develop an indicator for when it is 
appropriate to refer patients to an orthopaedic surgeon. Logistic regression modelling was 
performed on the data from participants in the randomised controlled trial and age matched normal, 
pain free participants to investigate if a model could be developed which accurately predicted group 
association. A number of different models were trialled and a model comprising the AKSS 
Functional (AKSSFun) score and knee flexion range of motion out-performed the others. The 
AKSSFunction/Flexion model was chosen ahead of another statistical model 
(AKSSFunction/Extension), as the former was most sensitive to change while maintaining 
predictive ability and plausible odds ratios. The AKSSFunction/Flexion model accurately predicted 
the group allocations (TKA or control) in over 95% of participants in the sample. Therefore 
hypothesis H3: That a model based on physical and functional measures can be used to quantify 
when it is appropriate to refer a patient to an orthopaedic surgeon was conditionally accepted 
based on promising results, but with the understanding that considerable future testing is required. 
The AKSSFunction/Flexion model synthesises common outcomes that may assist primary health 
care providers (e.g. general practitioners, physiotherapists) in deciding when to refer a patient to an 
orthopaedic surgeon for surgical management of their knee OA. It is not an attempt to simplify a 
referral decision to a mathematical formula. Rather the AKSSFunction/Flexion model can be used 
as an adjunct to aid decision-making. Whether clinicians will use the model may be dependent upon 
the rigour and credibility of its future development. 
The construction of this initial model was limited by several important factors. First, regarding the 
model construct itself, the exclusion of any control participants who had knee pain but did not 
require a TKA as evaluated by a surgeon, meant that the predictability of the model may have been 
overestimated. Also, only normally distributed data of the TKA group were retained with outliers 
removed for the analysis. Hence the ability of the model to accommodate extreme values is 
unknown. Second, the sample used to test the predictive ability of the model was the same as that 
used to build the model and therefore the accuracy of the model may be overstated. A more rigorous 
testing process, conducted by blinded assessors on a new group of participants, is required. Third, 
the potential for selection bias in the TKA group was considered, although was partially mitigated 
by having six different surgeons contribute cases. Additionally, there is potential for volunteer bias 
since a random volunteer sample from the population for the control group was used. 
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The incorporation of a group of patients with knee pain but not awaiting TKA into future modelling 
processes is crucial to determining whether or not any modelling of referral decisions can be 
successful. Future studies should also strive to include patients with varying degrees of OA. 
Prospective studies with a larger sample with a broad spectrum of knee pathologies are required for 
the model to be generalisable. The accuracy of the model may be improved with these changes and 
the inclusion of new variables (e.g. WOMAC, 36-Item Short Form Health Survey [SF-36], 
European quality of life questionnaire [EuroQol]). Should a suitable model be developed, its uptake 
by health practitioners into clinical practice would need to be carefully evaluated. 
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8 Conclusion 
This research compared physical and functional outcomes and patellar vascularity between the 
subvastus approach (SVa) and medial parapatellar approach (MPa) to TKA. The research also 
investigated a model to predict when a patient with knee OA should be referred for specialist care. 
It contributes original work that refutes current evidence suggesting that the SVa is superior to the 
MPa in TKA, and introduces the concept of use of physical and functional outcomes to develop a 
model to assist clinicians in referral decisions. 
The systematic review conducted for this thesis found that there was insufficient evidence to 
proclaim superiority of either the MPa or SVa to TKA and recommended a methodologically 
rigorous trial with follow-up beyond 6 months. A randomised controlled trial of such rigour was 
designed, conducted and reported according to the principles of the Consolidated Standards of 
Reporting Trials (CONSORT) statement. This randomised controlled trial found no evidence on its 
primary outcome (American Knee Society Score [AKSS]) or any other outcomes in favour of the 
SVa except for an earlier straight leg raise (SLR; 0.9 days). It did find evidence that surgeons found 
the SVa more difficult and that AKSSFun component scores favoured the MPa by 12 months post-
operatively. Furthermore, at 18 months, there was no difference between the approaches in anterior 
knee pain or vascularity of the patella. The latter was measured using the newly developed pat:fem 
and Bone Vascularity Scale (BVS). A preliminary model was developed which may assist primary 
health care providers in deciding when to refer a patient with an OA knee to an orthopaedic 
surgeon. 
Further investigation comparing approaches other than the SVa and the standard MPa is required to 
establish if any affords superior outcomes. If such comparisons are to be made, consolidation of the 
accumulated evidence by way of a systematic review and meta-analysis should be undertaken first 
to guide the research. This review should examine patient and health care system impacts and 
present a method for comparing the approaches. Future research should investigate the physical, 
functional and quality of life outcomes for the individual patient, as well as outcomes that have an 
organisational impact, such as length of hospital stay. This should be undertaken in a trial with 
methodological rigour and long term follow up. Further, the approaches should be compared on the 
outcome of patellar vascularity, after validation trials of the pat:fem and BVS. Finally, the model to 
quantify when a primary health care practitioner should refer a patient with knee OA to an 
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orthopaedic surgeon requires further development such as the inclusion of matched participants 
with knee pain. 
This research found no relevant evidence for supporting superiority of the SVa over the MPa. This 
thesis contributes original work that refutes supposition and claims in literature of this superiority. 
The thesis introduces novel alternate measures, without side effects, to investigate patellar 
vascularity and a preliminary model for use by primary health care practitioners to quantify their 
decision on when to refer a patient with knee OA to an orthopaedic surgeon. Directions have been 
provided for further research in these fields to optimise the outcomes for the growing numbers of 
individuals who will receive a TKA in the future. 
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Appendices 
Appendix 1  Quality of methodology component score 
Further information is to be obtained from the primary author if the published article provides 
inadequate information to the review. Score I or 0 
 Article identification number 
Was there clear concealment of allocation?  
Were the inclusion and exclusion criteria 
clearly defined? 
 
Were the treatment and control groups 
adequately described at entry and if so 
were the groups well matched or 
appropriate covariance adjustment made? 
 
Were the surgeons experienced in the 
various approaches prior to the trial? 
 
Were the care programs other than trial 
options identical? 
 
Were the outcome measures clearly defined 
in the text with a definition of ambiguous 
terms encountered e.g. range of motion. 
 
Were the outcome assessors blind to 
assignment status? 
 
Was a long-term follow-up performed? 
Minimum of six months 
 
Was the timing of outcome assessment in 
both groups comparable and appropriate? 
 
Was loss to follow-up reported and if so 
were less than five per cent of patients lost 
to follow up? 
 
Was a sample size calculation performed?  
Did the trial include an intention-to-treat 
analysis? 
 
Level of evidence  
Total x/12  
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Appendix 2  NHMRC levels of evidence used to rank articles in the review  
(National Health and Medical Research Council, 2007) 
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Appendix 3 Data extraction tool 
These may be split into Primary and Secondary upon reviewer advice. 
 Article Identifier: A____ 
Number of participants  
Allocation was concealed (yes/no)  
Intervention allocation method  
Inclusion criteria were clearly defined (yes/no)  
Groups were matched at baseline or appropriate 
covariance adjustment was made (yes/no)  
Surgeons were experienced in both approaches 
(yes/no)  
Care programs other than trial options were identical 
(yes/no)  
Outcome measures were clearly defined (yes/no)  
Outcome assessors were blind to assignment status  
Length of follow up (months)  
Timing of outcome assessment in both groups was 
comparable and appropriate (yes/no)  
Timing of outcome assessment  
Percent lost to follow up  
Sample size calculation details  
Intention to treat details  
Type of approaches investigated  
Date of trial  
Location of trial  
Ethnicity of participants  
Sponsor of trial  
Publication status  
Level of evidence  
  
Complications (Numbers - not percent of total)  
Deep vein thrombosis  
Pulmonary embolism  
Haemarthrosis  
Haematoma  
Infection deep  
Infection superficial  
Intra-operative damage to structures  
Fractures  
Soft tissue injury  
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Lateral release  
Related to the prosthesis  
Respiratory  
Mortality  
Re-operation  
Manipulation under anaesthetic  
Component loosening  
Polythene wear  
Patella mal-tracking  
Subluxation  
Other  
  
Post-operative outcomes  
Pain  
Knee scoring system  
American Knee Society Score  
Hospital for special surgery score  
Oxford knee score  
Other  
Health related quality of life measures  
Length of stay Days and (Cost ($))  
Days to mobilisation  
Discharge destination  
Walking aids at discharge  
Quadriceps function (ability to straight leg raise, lag 
on straight leg raise)  
Flexion  
Extension Lack  
Blood loss  
Patellar vascularity  
Length of surgery  
Perceived operation difficulty reported by surgeon  
Imaging results  
Other  
  
Other adverse outcomes  
Other economic data  
Other fields not listed above (discuss with co-
reviewers and add as you go along?)  
 
Appendix 4 Literature review raw data sample of included articles 
Study 
(Author, 
Journal year, 
country) 
Aim Method & length of study Sample characteristics 
Interventions & outcome 
measures used 
Results Comments 
Cameron,  
 
Journal of 
Applied 
Research 
 
2001 
 
Eau Claire, 
Wisconsin, USA 
Compare SVa 
and MPa on 
listed 
outcomes 
Prospective analysis. 
 
Randomised by hospital 
registration number 
 
Bilateral had same 
procedure on both knees 
 
PCL sparing 
tricompartmental 
cemented replacements on 
all 
 
Assessed at 3/52, 3/12, 
6/12, 12/12 
41 TKAs (16 MPa; 25 SVa) 
 
34 participants. 24 unilateral, 7 
bilateral 
 
Age 41-88yrs.  
Mean  SVa 66.7; MPa 69.6 
 
Necessity for lateral release 
 
Estimated blood loss 
 
Tourniquet times 
 
Complications 
 
Pain 
 
SLR ability 
 
RoM 
No LR’s 
 
No diff (SVa 519, MPa 684) 
 
Tourn SVa 102, MPa91 p=0.02
 
 
 
Pain Day 1 SVa 2.68, MPa 4.31 
p=0.0004 
SLR SVa 1.12, MPa 4.31 
p<0.0001 
 
6/12 SVa 110.68, MPa 103.25 
p=0.04 
Not clear if only 
OA ???RA.  
 
Does not state how 
RoM collected 
 
No baseline 
comparison of 
groups. 
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Cila 
 
Archives of 
Orthopaedic 
Trauma Surgery 
 
2002 
 
Ankara, Turkey 
To compare 
subvastus  
versus 
standard 
medial 
parapatellar 
approach to 
TKR using 
post-op knee 
scores and 
quadriceps 
strength 
Prospective ?randomised 
study 
(Not controlled) 
 
2 patient groups similar 
characteristics 
 
Statistically similar 
characteristics 
 
Freeman-Samuelson TKR 
System used in all patients 
inserted by the senior 
surgeon 
 
All had regional 
anaesthesia and inflatable 
tourniquet 
 
Low MW heparin. 
Prophylactic IV AB’s for 
72 hrs 
 
Preop: Alignment, Knee 
score & Cybex testing 
Group 1: 
12 knees of 9 patients MPa 
 
Group 2: 
10 knees of 10 patients SubV 
 
22 knees 19 patients. 18 
female, 1 male.  
 
Primary degenerative joint 
disease 
 
The surgical approach was 
decided randomly by the 
surgeon 
 
All patients stood at bedside 
and walked Day 1 
F/E exercise Day 2. No CPM or 
knee immobilisers were used 
Knee scores and quads 
strength preop, post-op at 
week 6, 3 months, 6 months 
 
Outcome measures: 
Hospital for Special Surgery 
score 
Isometric & Isokinetic 
quads strength tests 
 
 
Knee scores improved similarly 
but the change more 
pronounced in the SubV group 
 
Quads strength greater at week 
6 subV. No signif diff at 3 and 
6 months 
 
No DVT 
1 Infection was revised 
SubV offers greater 
quads strength in 
early post-
operative period it 
has no significant 
advantage in this 
respect over the 
MPa 
 
Statistics very poor 
– no group 
comparisons made 
early. Pre/post-op 
change in each 
group 
 
Problems – poor 
sample size. Stats 
prevent re-
comparison of 
actual muscle 
inhibition and 
knee score 
improvements 
between groups 
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Roysam and 
Oakley 
 
Journal of 
Arthroplasty 
 
2001 
 
UK 
To test the 
hypothesis 
that there are 
no significant 
benefits of the 
subvastus 
approach over 
the standard 
parapatellar 
approach. 
 
Prospective, randomised, 
patient and observer-
blinded. 
 
Randomised into two 
groups using sealed 
envelopes.   
 
No significant differences 
between the 2 groups. 
Group 1 (MPP): 43 pts (22 
male, 21 female). 
 
Group 2 (SVa): 46 pts (25 male, 
21 female). 
 
Mean age: 
MPP 69.8 yrs 
SVa 70.2 yrs 
 
Mean preop FFD: 
MPP 14.4 o 
SVa 16.3 o 
 
Mean preop flexion: 
MPP 71.8 o 
SVa 68.6 o 
 
All surgery performed by 
senior author using Insall-
Burstein II prosthesis under 
tourniquet control, no lateral 
releases or patella buttons, 
PCA for all patients, identical 
skin incisions.     
 
Assessment performed by PT: 
first day of unassisted SLR, 
flexion ROM at 1wk, 4 wks 
and 3mths. 
 
N/staff noted: total blood loss 
after surgery, total consumed 
dose of opiates, duration of 
hospital stay. 
Time to unassisted SLR  
SVa 3.2 days   MPa 5.8 days 
(P<0.001) 
 
Total blood loss  
SVa 527mL    MPa 748mL 
(P<0.001) 
 
1st week opiate consumption 
SVa 78mg    MPa 102mg 
(P<0.001) 
 
Knee flexion at 1 week 
SVa 78o    MPa 55o 
(P<0.001) 
 
No significant difference in 
LOS, flexion at 4wks, flexion 
at 3mths. 
No functional 
outcome measures. 
 
Very high LOS  
SVa 17.3   MPa 
20.3 
?rehab intensity 
Weinhardt 
 
Archives of 
Orthopaedic 
Trauma Surgery 
 
2004 
To evaluate 
the clinical 
and 
radiographic 
results 
immediately 
after TKA 
Randomised prospective 
study  
52 patients Genesis II Smith & Nephew 
prosthesis with patella inlay 
in all cases 
Significant difference in 
passive ROM. 
 
2 randomly allocated 
consecutive groups 
 
 
33 female 19 male 
26 SVa 26 PP 
 
Diagnosis OA only 
 
Mean age  
 
Tourniquet 400mmHg 
 
Daily gait  rehab FWB 
 
Subvastus had full knee 
extension and 90 flexion 
significantly earlier than 
parapatellar. 
Regardless of 
approach, the AP 
tibial femoral angle 
improved 
significantly. 
 
No major 
99 
 Germany 
 
comparing the 
parapatellar 
and subvastus 
approach 
MPa 74.4+/-7.0 yrs 
SVa 69.6+/-8.5 yrs 
 
Mean Operation time 
MPa 80+/-22mins 
SVa 75+/-6mins 
 
Mean blood loss 
MPa 264+/-120mls SVa 243+/-
120mls 
 
Mean Periop blood 
substitution 
MPa 471+/-199mls 
SVa 312+/-215mls 
 
 
 
Radiography – AP of 
complete leg to measure the 
leg axis correction pre & 
post-op. A lateral film to 
determine inclination of the 
tibial component. 
 
Xrays performed preop, 
immediately post-op and 
before discharge (mean 20.5 
days) 
 
Clinical Ix included ROM, 
joint stability, ability of 
active extension from 30 
flexion, ability to FWB each 
day, pain documented by 
VAS 
 
SVa 
90oF D7+/-2.4 
0oExt D2.2+/-2.6 
SLR D8.3+/-2.8 
 
PP 
90oF D11+/-4.2 
Poorer Ext results 
SLR D12+/-3.1 
 
On discharge both groups 
were comparable 
 
Analogous results in both 
groups on radiological 
assessment 
 
48 required valgus/varus 
correction 
 
No complications 
 
No significant difference in 
patient overall satisfaction 
 
differences could 
be seen concerning 
pain, operation 
time, blood loss, 
blood substitution 
and complications 
 
Advise wider use 
in primary TKR 
100 
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Significant improvement in 
pain since preop both groups 
– SVa slightly lower 
Faure et al 
 
Journal of 
Arthroplasty 
 
1993 
 
USA 
Assess the 
relative 
benefits of the 
SVa and MPa 
surgical 
exposures on 
the patient’s 
post-op 
recovery. 
Prospective, randomised 
clinical trial. 
 
Follow-up to 3 months 
post-op. 
 
Performed on 20 patients 
undergoing one stage 
bilateral TKA. 
 
Random selection decided 
by the senior surgeon at 
the time of surgery. 
20 patients: 11 men, 9 women. 
 
Mean age: 70 yrs 
 
14 bilateral TKA, 6 bilateral 
UKA 
 
Mean Preop ROM 
6 – 112 o. 
Strength testing and ROM at 
Preop, 1 week, 1 month, 3 
months using LIDO device.  
Performed by a single 
blinded assessor. 
 
Identical surgical procedure 
(excluding approach). 
 
Bedside PT on 1st postop day, 
with knee ROM and 
ambulation commencing Day 
2.  CPM if flexion <60o or lag 
>20o.   
Strength: 
At 1 week – SVa 35% greater 
strength on 60o/sec testing, 
38% greater on 120o/sec test. 
At 1 month – SVa 16% and 
12% greater respectively. 
No significant difference at 3 
months. 
 
Tourniquet time: 
PP 71 mins    SVa 74 mins 
(not significant) 
Drainage: 
PP 411mL     SVa 375mL 
No significant difference 
between surgical approaches. 
 
No difference in post-op 
ROM between PP and SVa. 
 
5 lateral releases in PP, 2 in 
SVa 
No functional 
outcome measures. 
 
Allocation decided 
by surgeon. 
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Appendix 5  Ethics approval correspondence - randomised controlled trial 
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Appendix 6 Participant information and consent forms - randomised controlled trial 
 
 
PARTICIPANT INFORMATION SHEET – QEII JUBILEE HOSPITAL 
 
 
PROJECT TITLE  An evaluation of the clinical outcomes of the subvastus versus the 
medial parapatellar approach to total knee replacement. 
LAY TITLE The effectiveness of a medial approach to knee replacement compared 
to a subvastus approach. 
INVESTIGATORS All members of the research team are contactable on 07 3275 6331 where they may 
be paged by reception staff.  The after hours contact is 3275 6111.  Michael Bourke’s 
direct contact number is 3275 6173. 
Michael Bourke         Senior Physiotherapist – Orthopaedics, QEII Jubilee Hospital 
Peter Buttrum            Director of Physiotherapy, QEII Jubilee Hospital 
Dr Philip Dalton        Director of Orthopaedic Surgery, QEII Jubilee Hospital 
Dr Mark Dekkers       Asst. Director of Orthopaedics, Princess Alexandra Hospital 
Dr John Dodsworth   Orthopaedic Surgeon, QEII Jubilee Hospital 
Dr Peter Johnstone    Orthopaedic Surgeon, QEII Jubilee Hospital 
Dr Prue Fitzpatrick     Orthopaedic Surgeon, QEII Jubilee Hospital 
Dr Ross Kennedy        Orthopaedic Surgeon, QEII Jubilee Hospital 
Dr Gary Nielsen         Orthopaedic Surgeon, QEII Jubilee Hospital 
 Dr Trevor Russell   , Department of Physiotherapy, University of Queensland. 
 
You have elected to have a Total Knee Replacement. This process involves preparation for surgery 
and rehabilitation after surgery. The rehabilitation phase of your recovery is split into two parts, 
inpatient rehabilitation, while you are still on the ward, and outpatient rehabilitation. We would like 
your help in investigating the difference between two types of surgical approach to knee 
replacement surgery which are both commonly used at QEII Jubilee Hospital. There are no risks 
involved in this study outside of the risks associated with routine knee replacement surgery 
 
If you agree to participate in the study, you will be randomly assigned to one of two groups; like the 
toss of a coin.  Group one will consist of participants having a medial parapatellar approach to knee 
replacement.  Group two will have a subvastus approach.  The medial parapatellar approach is the 
more common of these routine procedures.  During this approach the quadriceps (thigh) muscle is 
cut so the surgeon has enough room to replace your knee.  In the subvastus approach the surgeon 
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goes under the quadriceps to replace your knee.  You will not be told which approach you are 
having.  This is important to ensure the study is impartial.  Regardless of which group you are 
assigned to, you will undergo standard preparation and rehabilitation for your operation.  You will 
be required to attend follow-up Doctor and Physiotherapy appointments at two weeks, six weeks, 
six months and 12 months after your operation. At these follow-up appointments the Doctors and 
Physiotherapists will measure your knee motion, girth, strength and function. As part of this study, 
at 18 months you will be required to have a bone scan of your knee to check its blood supply.  All 
protocols and rehabilitation for your operation will be identical across both groups.  For this study 
you will need to consent for photography of your knee. 
 
You will be required to undergo a number of assessments at six weeks, six months and 12 months.  
At these assessments, the following will occur: 
1. Questions about your ability to function will be asked 
2. You will be required to undergo physical assessments of your knee similar to those normally 
expected in a knee examination. Such things as knee range of motion, muscle strength and 
swelling. 
3. A Bone Scan of your knee will be requested 18 months after you have been discharged from 
hospital to assess the blood supply to your knee cap. This is not a routine procedure after knee 
replacement surgery. It is only being done for the purpose of this study. Please review the 
attached information sheet from Queensland X-Ray which explains in detail the risks of a bone 
scan.  
 
You can elect to participate in the study but not have a bone scan.  Simply tick the box indicating 
your preference on the Participant Consent Form 
 
None of the assessments performed during the study will cause any pain beyond that normally 
encountered with physical knee assessment and rehabilitation after knee replacement.  
 
Participation in this study is on a voluntary basis and you reserve the right to withdraw at any time 
from the study for any reason, without any penalty and without affecting any further treatment or 
relations with the QEII Jubilee Hospital.  Should you elect not to participate in the study you will 
continue to follow the standard process for knee replacement surgery.  In discussion with your 
surgeon you can decide which type of surgery will be performed rather than being randomly 
allocated a type of surgery.  In order for the researchers to accurately assess the effectiveness of 
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your knee replacement, we request that you continue with the prescribed exercises and 
physiotherapy treatment as instructed by your physiotherapist. 
 
Your confidentiality will be maintained at all times throughout the study and you will in no way be 
identified in any publication or report. Furthermore, you will be assigned a number that will be 
used, rather than your name, on all stored information. All assessment measures will be stored in a 
lockable cabinet in the Physiotherapy Department at the QEII Jubilee Hospital. Data collected with 
computer technology will be stored in a password protected secure database in coded format and 
will be available only to those researchers directly involved in this research. De-identified data will 
be stored for a maximum of fifteen years upon completion of the study. 
 
A copy of the outcomes of this study will be available from the Physiotherapy Department at the 
QEII Jubilee Hospital for your interest at the completion of the study in January 2010. Additionally, 
you are invited to attend QEII Physiotherapy Department on completion of the study where the 
results of the study will be available. The information gathered from this study will assist 
Orthopaedic Surgeons determine the most appropriate surgical approach to knee replacement. 
 
Both the QEII Jubilee Hospital and the University of Queensland ethics committees have given 
ethical clearance for this study. You are free to discuss your participation in this study with the 
project staff on 3275 6173, however, if you would like to speak to an officer not involved in the 
study, you may contact the Ethics Officer at the University of Queensland on 3365 3924. The 
Princess Alexandra Hospital Research Ethics Committee (acting for the QEII Jubilee Hospital) may 
be contacted on 3240 5856. 
 
By consenting to participate in this study you give members of the research team permission to 
access your medical record for the purpose of the study. This study is being conducted as part of a 
requirement for a Physiotherapy higher research degree at the University of Queensland, Brisbane, 
Australia. 
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Photographic Consent Form Information 
Important note: 
 
Important information explaining this consent is located on the next page of this consent 
form. You may request a copy of this information at any time. 
 
IMPORTANT PRIVACY INFORMATION: 
The Department is collecting the information contained in this form to verify your consent for 
use of your image or recording for the purposes contained in the consent form. Your consent to 
the use of your personal information is required in accordance with the Queensland 
Government’s Information Privacy Standard 42. The information privacy principles contained 
within this Standard govern the collection, use, storage, security, and disclosure of personal 
information. Only authorised Departmental officers have access to this information. From time 
to time the Department may provide some or all of this material to other government 
departments and agencies, or to recognised media outlets for their use to promote Departmental 
programs, services and initiatives as outlined above. Your personal information contained in this 
form will not be disclosed to any other third party without your consent, unless authorised or 
required by law. If you have any queries about any privacy issues that relate to this consent form 
then please contact the Department’s privacy contact officer. 
 
EXPLANATORY NOTES FOR THE PARTICIPANT 
What is this consent for? 
This consent form authorises the Department to use the specified image or recording of the 
participant, together with information about their participation in Departmental initiatives, in 
publications, productions and presentations in connection with the Department’s work. The 
consent extends to use of the image or recording in whole or part and digital adaptations used 
alone or in conjunction with words, drawings and other images. 
 
What sort of publications could this material appear in? 
This material can appear in television advertising, videos, brochures, forms, public relations 
displays, annual reports, press advertising, internal documents such as manuals, web sites, 
certificates, strategic plan, posters and promotional material and other materials produced by the 
Department. The images and recordings may also be used by other government departments and 
agencies for similar purposes (if authorised). 
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What is an image or recording? 
An image or recording referred to in this consent form includes photographs, videos, films, or 
sound recordings of the Participant. 
 
Who is a child? 
A child is defined as any person who has not yet turned 18 years of age. 
 
Who is a person with a decision-making disability? 
For the purposes of this consent form, a person with a decision making disability is a person 
who cannot give consent because they lack capacity or have an intellectual or other impairment 
that affects their capacity to consent. If a person is an adult and unable to give consent, an 
authorised decision-maker must give consent on the person’s behalf (see for example Powers of 
Attorney Act 1998 and/or the Guardianship and Administration Act 2000). 
 
What happens to the consent form once it is filled out? 
The consent form is retained by the Department and will be placed on file. A copy will be 
provided to the Participant. 
 
Modification or Withdrawal of consent 
Consent can be modified or withdrawn in writing at any time however, any changes will only 
apply from the date of receipt by the Department. Any existing material in which the image or 
recording is used will not be withdrawn from use. 
 
Produced by Media and Communication Unit, Queensland Health 
© State of Queensland, Queensland Health, 2004 
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CONSENT FORM FOR PARTICIPATION IN STUDY 
QEII JUBILEE HOSPITAL 
 
PROJECT TITLE An evaluation of the clinical outcomes of the subvastus versus the medial 
parapatellar approach to total knee replacement 
LAY TITLE The effectiveness of a medial approach to knee replacement compared to a 
subvastus approach 
INVESTIGATORS Michael Bourke         Senior Physiotherapist – Orthopaedics, QEII Jubilee Hospital 
Peter Buttrum            Director of Physiotherapy, QEII Jubilee Hospital 
Dr James Curtis         Orthopaedic Surgeon, QEII Jubilee Hospital 
Dr Philip Dalton        Director of Orthopaedic Surgery, QEII Jubilee Hospital 
Dr Mark Dekkers       Asst. Director of Orthopaedics, Princess Alexandra Hospital 
Dr John Dodsworth   Orthopaedic Surgeon, QEII Jubilee Hospital 
Dr Peter Johnstone    Orthopaedic Surgeon, QEII Jubilee Hospital 
Dr Prue Fitzpatrick     Orthopaedic Surgeon, QEII Jubilee Hospital 
Dr Ross Kennedy        Orthopaedic Surgeon, QEII Jubilee Hospital 
Dr Trevor Russell          Lecturer, Department of Physiotherapy, 
I ____________________________(print participant’s name) consent to take part in the above study. 
I have read the attached Participant Information Sheet.  I understand the nature and purpose of this 
randomised study and any side-effects or risks involved.  
 
All my questions have been answered to my satisfaction. I acknowledge that my involvement in the 
study may not be of benefit to me. The opportunity has been given to me to have a friend or relative 
present when the study was explained. I understand that taking part in the study is voluntary and I 
am free to withdraw at any time I wish and this will not affect my clinical management. 
 
I understand that all the information gained in the study will be treated confidentially.  
 
I give permission for the research team to access my medical record. 
 
Please tick one of the following options: 
? I elect to have a bone scan as part of this study 
? I do not wish to have a bone scan as part this study 
 
Participant: ________________ Print name:______________________ Date:___/___/___ 
 
Witness:___________________ Print name:______________________ Date:___/___/___ 
 
I have explained the nature and purpose of this study to the above participant and have answered 
their questions. 
 
Investigating Consultant Surgeon:_______________________ Date:______________ 
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Appendix 7 Excerpt from the Queensland Health total knee replacement clinical pathway 
(© Reprinted with permission of Queensland Health) 
 
 
 
 113  
 
 
 
 
 
 114  
 
 
 
 115  
 
 
 
 116  
 
 
 
 117  
 
 
 
 118  
 
 
 
 
 119  
 
 
 
 120  
 
 
 
 121  
 
 
 
 
 122  
Appendix 8 Surgical procedure standardisation. 
 
Subvastus and Medial Parapatellar Surgical Procedure 
 
Perform five Subvastus with Dr Dodsworth and sign declaration before commencing recruitment of 
participants 
(Investigating surgeon to be present for all participants) 
 
Subvastus Surgical Protocol  
1. Tourniquet on but not inflated 
2. Knee flexed for skin incision and incision of inferior aspect of capsule. Subvastus 
then dissected with knee flexed or extended 
3. Patella not to be everted, but subluxed laterally 
4. Patella not denervated 
5. Tourniquet up for duration of cementing only 
6. Redivac™ exits laterally avoiding vastus lateralis if possible.  Removed Day 1 
7. Incision closure in flexion at approximately 90 degrees 
i. Strategic interrupted sutures (superior/ inferior pole patella) 
ii. Then continuous capsular 
 
Medial Parapatellar Surgical Protocol 
1. Tourniquet on but not inflated 
2. Knee flexed 
3. Medial parapatellar incision extending 6-7cm above proximal pole of the patella 
4. Extend incision inferiorly to medial aspect tibial tubercle 
5. Evert patella, if required, for the duration of the surgery 
6. Tourniquet up for duration of cementing only 
7. Redivac™ drain exits laterally avoiding vastus lateralis if possible. Removed Day 1 
8. Incision closure in flexion at approximately 90 degrees 
i. Strategic interrupted sutures (superior/ inferior pole patella) 
ii. Then continuous capsular 
 
Theatre Research Protocols 
Recruitment 
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1. Collect your pink recruitment kit before each clinic 
2. Check patient meets inclusion/exclusion criteria 
3. Issue Patient Information Sheet 
4. Obtain signatures on: 
i. Study Consent Form 
ii. Photograph Consent Form 
5. Place patient sticker on referral form 
6. For Participant who would like to go away and think:  
Record their name and phone number on Study Consent Form in kit – make follow-
up phone call the following week 
7. Send Participant to Allied Health Reception (with all pink forms signed appropriately) for 
registration into the study. 
 
Recruitment from waiting list 
1. Obtain list of patients on waiting list from Nurse Case manager 
2. Surgeon to Telephone patients 
3. Explain study over the phone 
4. Determine patients desire to participate in the study  
5. Book appointment with patient to establish eligibility 
6. Follow usual recruitment procedure above 
 
Operating Theatre 
Establish the randomised surgical approach before entering theatre: 
□ Collect PDA from the Large dangerous drugs cupboard in Recovery Room before the 
operation. 
□ Turn On PDA (top right corner) 
□ Remove stylus (top right corner) 
□ Tap Start (top left of screen) 
□ SMPPS (i.e. Subvastus Medial Para Patella Study) 
□ …. Wait… it can take a moment too open 
□ Enter Password – “cat” – tap login 
□ Tap “Intra-Operative Data’ 
□ Enter UR and identify the Surgical Approach 
o Group allocation will be revealed when the patient’s data is opened and it will be 
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to either SVa or MPa 
Collect all data and photographs as trained – Tap Accept 
PDA Data Entry 
Including photographs Flexion (hanging with hip ~90º) 
Extension (hanging with heel supported) 
(Greater Trochanter, LFC and Lat Mal visible) 
Comfeel Dressing applied in flexion Left intact 48 hrs then change if excessive ooze 
Blinding of Physiotherapists Place original Operation Report in Study Envelope- 
place envelope in chart. Place copy in chart (Black Out 
the Surgical Approach on the copy so it cannot be 
identified by the Physiotherapist on the ward)  
Return PDA to Large DD cupboard in Recovery 
_____________________________________________________________________ 
Pain Relief Discuss preop with the anaesthetist that there are to be 
no epidurals or femoral nerve blocks on the ward (due 
to impact on early quads function and mobility) 
PCA removed Day two post-operatively 
 Drain Removed Day one (after Active Flexion) 
IDC Removed Day 2 
Antibiotic prophylaxis 1. Cephazolin IV 1g & gentamicin 3mg/kg on 
induction 
 2. Cephazolin IV 1g TDS for 24hrs & single dose 
Gentamicin at 24hrs 
TEDS Bilateral below knee (nil else) for six weeks 
Oedema management Tubigrip after Day one flexion 
 Cold therapy. Elevation as able 
Inpatient anticoagulation Surgeon Specific 
Discharge Criteria Safe and Comfortable 
 ~90° Flexion 
 aim <5º Extension Lack 
 aim <5º Extension Lag on SLR 
 Independently mobile on appropriate aid 
Clip removal 10-14 Days at GP or at QEII 
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Appendix 9 Physiotherapy post-operative guidelines 
Total Knee Replacement 
Guidelines for Physiotherapy Management 
Day one Post-operatively: 
• Respiratory and circulatory assessment and exercises 
• SLR to be commenced as able, bed mobility 
• May mobilise FWB with a walking aid a short distance if appropriate (i.e. consider BP, Hb, 
nausea etc)  
• Richard’s splints – may be used: a) overnight to maintain extension 
           b) to mobilise if insufficient quads control 
           c) on unstable knee as determined by treating consultant 
• Day one knee flexion – can be performed in a chair or on the edge of the bed (lowered).  This 
should be performed whilst the drain is in-situ (if drain used). The patient’s foot should be 
supported on a skateboard or a powder board.  The knee dressings can be de-bulked and the 
patient ‘actively’ flexes the knee to 80-90° (without being over-zealous). The leg at no time 
should ‘dangle’ as quadriceps inhibition will increase pain and hinder the flexion.  Once 
completed the patient is assisted back into bed, the knee slightly elevated and a Lumark Cold 
Compression Device applied. Nursing staff are then notified for removal of the drain 1-2 hours 
later, usually around midday. Sitting time on day one is limited to treatment time only unless the 
patient has respiratory compromise. 
Note: assisted knee flexion may be performed with the patient supine if they are unable to sit up 
due to dizziness (e.g. low Hb/BP etc) 
• All patients require a double layer of tubigrip on their operated limb for two weeks 
• Bed exercises may include inner range quadriceps, gentle knee flexion with powder board and 
straight leg raise (SLR). 
Day 2: 
• Continue exercises as above, focusing on SLR and IRQ. 
• Mobilise the patient with a rollator or progress to hopper/wheeled walker as appropriate  
• Active knee flexion can be continued in a chair. It may be appropriate to limit the flexion to 
approximately 70-75° due to the potential for over doing the exercises and increasing the post-
operative swelling. Treatment should be followed by elevation and cold compression therapy 
repeated as required. Sitting time limited to manage swelling. 
Day three → discharge: 
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• Progress exercise as above. 
• Progress knee flex to 90° and beyond as able & commence standing exercises (e.g. mini-squats, 
standing flexion, heel raises, stair lunges and knee extension hangs). 
• Progress quads exercises to independent SLR and mini squats (if FWB), and balance exercises. 
• Mobility may be progressed to hopper frame, four wheeled walker or 2x sticks. 
• Length of Stay usually 4-5 days. 
Post discharge follow-up: 
• All local patients are encouraged (if indicated) to attend the post-operative knee class. Some may 
only need to attend 2-3 times. 
• Patients who require follow up and have transport difficulties may be offered post-acute funded 
physiotherapy home visits, but only in liaison with discharge facilitator (#6112). 
Unicompartmental Knee Replacement (UKR): 
• Similar guidelines as above - should progress much quicker and aim D/C day 2-4. 
General Aims of Treatment: 
• All inpatient treatment should be aimed at assisting patients to become independent in their 
exercise programme. They should refer to their exercise handout regularly. 
• CPM may be considered if daily flexion goals are not being achieved. 
• Discharge occurs when the patient is safe and comfortable. 
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Appendix 10 Linear mixed modelling  
Normal Q-Q plots of residuals, scatterplots of residuals and predicted values, and line graphs 
of means 
American Knee Society Score - Objective 
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 No data collected 
 
Legend: 
Time 1   Pre-operative 
Time 3   Day 1  
Time 4   Day 2 
Time 5   Day 3 
Time 6   Discharge 
Time 7   Week 6 
Time 8   Month 6 
Time 9   Month 12 
Time 10  Month 18 
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American Knee Society Score - Functional 
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 No data collected 
Legend: 
Time 1   Pre-operative 
Time 5   Day 3 
Time 6   Discharge 
Time 7   Week 6 
Time 8   Month 6 
Time 9   Month 12 
Time 10  Month 18 
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Oxford Knee Score 
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 No data collected 
Legend: 
Time 1   Pre-operative 
Time 3   Day 1  
Time 4   Day 2 
Time 5   Day 3 
Time 6   Discharge 
Time 7   Week 6 
Time 8   Month 6 
Time 9   Month 12 
Time 10  Month 18 
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Timed Up and Go test (Transformed data) 
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Flexion 
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Legend: 
Time 1   Pre-operative 
Time 2   Intra-operative 
Time 3   Day 1  
Time 4   Day 2 
Time 5   Day 3 
Time 6   Discharge 
Time 7   Week 6 
Time 8   Month 6 
Time 9   Month 12 
Time 10  Month 18 
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Extension 
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Legend: 
Time 1   Pre-operative 
Time 2   Intra-operative 
Time 3   Day 1  
Time 4   Day 2 
Time 5   Day 3 
Time 6   Discharge 
Time 7   Week 6 
Time 8   Month 6 
Time 9   Month 12 
Time 10  Month 18 
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Quadriceps lag on straight leg raise 
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 No data collected 
Legend: 
Time 1   Pre-operative 
Time 3   Day 1  
Time 4   Day 2 
Time 5   Day 3 
Time 6   Discharge 
Time 7   Week 6 
Time 8   Month 6 
Time 9   Month 12 
Time 10  Month 18 
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Knee pain 
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 No data collected 
Legend: 
Time 1   Pre-operative 
Time 3   Day 1  
Time 4   Day 2 
Time 5   Day 3 
Time 6   Discharge 
Time 7   Week 6 
Time 8   Month 6 
Time 9   Month 12 
Time 10  Month 18 
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Knee girth 
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 No data collected 
Legend: 
Time 1   Pre-operative 
Time 3   Day 1  
Time 4   Day 2 
Time 5   Day 3 
Time 6   Discharge 
Time 7   Week 6 
Time 8   Month 6 
Time 9   Month 12 
Time 10  Month 18 
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Appendix 11 Line graph: AKSS Objective Day one Score  
Demonstrating significantly better scores for the subvastus approach on Day 1.  
 
 
No data collected 
 
Legend: 
Time 1   Pre-operative 
Time 3   Day 1  
Time 4   Day 2 
Time 5   Day 3 
Time 6   Discharge 
Time 7   Week 6 
Time 8   Month 6 
Time 9   Month 12 
Time 10  Month 18 
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Appendix 12 Line graph: AKSS Functional Score 12 and 18 months  
Demonstrating significantly better scores for the subvastus approach.  
 
 
No data collected 
Time 1   Pre-operative 
Time 5   Day 3 
Time 6   Discharge 
Time 7   Week 6 
Time 8   Month 6 
Time 9   Month 12 
Time 10  Month 18 
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Appendix 13 Surgeon perceived level of difficulty 
Demonstrating that surgeons perceived the subvastus approach to be a more difficult operation. 
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Appendix 14 Ethics approval correspondence – Patellar vascularity 
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 149  
Appendix 15 Ethics approval - Probability 
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Appendix 16 Participant information and consent forms - Probability 
 
 
PARTICIPANT INFORMATION SHEET – QEII JUBILEE HOSPITAL 
 
PROJECT TITLE  A comparison of healthy knees to knees requiring total knee 
arthroplasty. Probability of knee replacement. 
LAY TITLE Healthy knees compared to knees requiring replacement. Chance of 
needing a knee replacement. 
INVESTIGATORS All members of the research team are contactable on 07 3275 6331 
where they may be paged by reception staff.  The after hours contact is  
3275 6111.  Michael Bourke’s direct contact number is 3275 6173. 
Michael Bourke         Senior Physiotherapist – Orthopaedics, QEII Jubilee Hospital 
Peter Buttrum            Director of Physiotherapy, QEII Jubilee Hospital 
Linh Ho                      Senior Physiotherapist – Orthopaedics, QEII Jubilee Hospital 
Dr Trevor Russell     Lecturer, Department of Physiotherapy, University of Queensland. 
 
 
 
 
 
 
 
 
 
 
We would like your help in establishing normal values for healthy knees.  The measures from your 
knee will be compared with people undergoing knee replacement. There are no risks involved in 
this study. 
To be included in this study you must meet the following criteria: 
• Age of 18 years or over 
• Healthy and no knee pain on a general daily basis 
• Ability to accurately follow commands 
• Ability to attend a supervised outpatient physiotherapy assessment session 
• Ability to participate voluntarily and provide signed informed consent. 
 
You cannot participate in the study if you: 
• have medical conditions such as malignant tumours or severe chronic obstructive 
pulmonary disease that would prevent participation in the required assessment process 
• have a previous history of knee surgery 
• are unable to follow commands 
• cannot walk normally with or without a walking aid. 
• are unable to provide signed informed consent 
• cannot bend your knee to a right angle 
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• cannot straighten your knee. 
 
If you agree to participate in the study, you will be required to attend a one hour session at the 
Physiotherapy Department at the QEII Jubilee Hospital. At this session, the following will occur: 
Questions about your ability to function will be asked 
You will be required to undergo physical assessments of your knee similar to those normally 
expected in a knee examination. Such things as knee range of motion, muscle strength and 
swelling. 
None of the assessments performed during the study will cause any pain beyond that normally 
encountered with physical knee assessment. 
For this study you will need to consent for photography of your knee. 
 
Participation in this study is on a voluntary basis and you reserve the right to withdraw at any time 
from the study for any reason, without any penalty and without affecting any further relations with 
the QEII Jubilee Hospital.  
 
Your confidentiality will be maintained at all times throughout the study and you will in no way be 
identified in any publication or report. Furthermore, you will be assigned a number that will be 
used, rather than your name, on all stored information.  All assessment measures will be stored in a 
lockable cabinet in the Physiotherapy Department at the QEII Jubilee Hospital. Data collected with 
computer technology will be stored in a password protected secure database in coded format and 
will be available only to those researchers directly involved in this research. De-identified data will 
be stored for a maximum of fifteen years upon completion of the study. 
 
A copy of the outcomes of this study will be available from the Physiotherapy Department at the 
QEII Jubilee Hospital for your interest at the completion of the study in January 2010. Additionally, 
you are invited to attend QEII Physiotherapy Department on completion of the study where the 
results of the study will be available.  
 
Both the QEII Jubilee Hospital and the University of Queensland ethics committees have given 
ethical clearance for this study. You are free to discuss your participation in this study with the 
project staff on 3275 6173, however, if you would like to speak to an officer not involved in the 
study, you may contact the Ethics Officer at the University of Queensland on 3365 3924. The 
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Princess Alexandra Hospital Research Ethics Committee (acting for the QEII Jubilee Hospital) may 
be contacted on 3240 5856. 
 
By consenting to participate in this study you give members of the research team permission to 
access your medical record for the purpose of the study if required. 
 
This study is being conducted as part of a requirement for a Masters of Physiotherapy higher 
research degree at the University of Queensland, Brisbane, Australia. 
 
Photographic Consent Form Information 
Important note: Important information explaining this consent is located on the next page of 
this consent form. You may request a copy of this information at any time. 
 
IMPORTANT PRIVACY INFORMATION: 
The Department is collecting the information contained in this form to verify your consent for use 
of your image or recording for the purposes contained in the consent form. Your consent to the use 
of your personal information is required in accordance with the Queensland Government’s 
Information Privacy Standard 42. The information privacy principles contained within this Standard 
govern the collection, use, storage, security, and disclosure of personal information. Only 
authorised Departmental officers have access to this information. From time to time the Department 
may provide some or all of this material to other government departments and agencies, or to 
recognised media outlets for their use to promote Departmental programs, services and initiatives as 
outlined above. Your personal information contained in this form will not be disclosed to any other 
third party without your consent, unless authorised or required by law. If you have any queries 
about any privacy issues that relate to this consent form then please contact the Department’s 
privacy contact officer. 
Photographic Consent Form Information 
 
EXPLANATORY NOTES FOR THE PARTICIPANT 
 
What is this consent for? 
This consent form authorises the Department to use the specified image or recording of the 
participant, together with information about their participation in Departmental initiatives, in 
publications, productions and presentations in connection with the Department’s work. The consent 
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extends to use of the image or recording in whole or part and digital adaptations used alone or in 
conjunction with words, drawings and other images. 
 
What sort of publications could this material appear in? 
This material can appear in television advertising, videos, brochures, forms, public relations 
displays, annual reports, press advertising, internal documents such as manuals, web sites, 
certificates, strategic plan, posters and promotional material and other materials produced by the 
Department. The images and recordings may also be used by other government departments and 
agencies for similar purposes (if authorised). 
 
What is an image or recording? 
An image or recording referred to in this consent form includes photographs, videos, films, or sound 
recordings of the Participant. 
 
Who is a child? 
A child is defined as any person who has not yet turned 18 years of age. 
 
Who is a person with a decision-making disability? 
For the purposes of this consent form, a person with a decision making disability is a person who 
cannot give consent because they lack capacity or have an intellectual or other impairment that 
affects their capacity to consent. If a person is an adult and unable to give consent, an authorised 
decision-maker must give consent on the person’s behalf (see for example Powers of Attorney Act 
1998 and/or the Guardianship and Administration Act 2000). 
 
What happens to the consent form once it is filled out? 
The consent form is retained by the Department and will be placed on file. A copy will be provided 
to the Participant. 
 
Modification or Withdrawal of consent 
Consent can be modified or withdrawn in writing at any time however, any changes will only apply 
from the date of receipt by the Department. Any existing material in which the image or recording 
is used will not be withdrawn from use. 
 
Produced by Media and Communication Unit, Queensland Health 
© State of Queensland, Queensland Health, 2004 
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CONSENT FORM FOR PARTICIPATION IN STUDY 
QEII JUBILEE HOSPITAL 
PROJECT TITLE A comparison of healthy knees to knees requiring total knee arthroplasty. 
LAY TITLE Healthy knees compared to knees requiring replacement. 
INVESTIGATORS Michael Bourke         Senior Physiotherapist – Orthopaedics, QEII Jubilee Hospital 
Peter Buttrum            Director of Physiotherapy, QEII Jubilee Hospital 
Linh Ho                      Senior Physiotherapist – Orthopaedics, QEII Jubilee Hospital 
Dr Trevor Russell      Lecturer, Department of Physiotherapy, University of Queensland 
 
 
I _____________________________(print name) consent to take part in the above study. 
 
 
I have read the attached Participant Information Sheet.  I understand the nature and purpose of this 
study.  I understand that there are no side-effects or risks involved. All my questions have been 
answered to my satisfaction. 
 
I acknowledge that my involvement in the study may not be of benefit to me. 
 
The opportunity has been given to me to have a friend or relative present when the study was 
explained. 
 
I understand that taking part in the study is voluntary and I am free to withdraw at any time  
 
I give permission for the research team to access my medical record. 
I understand that all the information gained in the study will be treated confidentially. 
 
 
 
Participant: ________________ Print name:______________________ Date:___/___/___ 
 
 
 
Witness:___________________ Print name:______________________ Date:___/___/___ 
 
 
I have explained the nature and purpose of this study to the above participant and have answered 
their questions. 
 
 
Investigator:    ________________________ Date:______________ 
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Appendix 17 Logistic regression models – Stata 10.0 output 
 
Models highlighted in yellow 
 
. * GENERATE A VARIABLE FOR CASES AND CONTROL * 
.  
. gen case_control=1 if group==2 
(42 missing values generated) 
 
. replace case_control=0 if group==1 
(42 real changes made) 
 
.  
. * LOOK AT THE CORRELATION MATRIX INCLUDING ALL VARIABLES * 
.  
. corr   gkp  maxflx ke truelag tug oxford akssobj akssfun 
(obs=84) 
 
             |      gkp   maxflx       ke  truelag      tug   oxford  akssobj  akssfun 
-------------+------------------------------------------------------------------------ 
         gkp |   1.0000 
      maxflx |  -0.6642   1.0000 
          ke |   0.5900  -0.5321   1.0000 
     truelag |   0.0245  -0.0963  -0.0311   1.0000 
         tug |   0.7213  -0.6175   0.4874   0.1227   1.0000 
      oxford |   0.8512  -0.7417   0.6585   0.1321   0.7817   1.0000 
     akssobj |  -0.9310   0.7247  -0.6951  -0.1044  -0.6926  -0.8660   1.0000 
     akssfun |  -0.7552   0.6533  -0.6094  -0.1930  -0.7630  -0.8723   0.7947   1.0000 
 
 
.  
. * FIT UNIVARIATE LOGISTIC REGRESSION MODELS ONE BY ONE 
.  
. logistic  case_control gkp 
 
note: gkp != 1 predicts success perfectly 
      gkp dropped and 40 obs not used 
 
 
Logistic regression                               Number of obs   =         44 
                                                  LR chi2(0)      =      -0.00 
                                                  Prob > chi2     =          . 
Log likelihood = -8.1359256                       Pseudo R2       =    -0.0000 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
------------------------------------------------------------------------------ 
 
. logistic  case_control maxflx 
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(1)      =      65.85 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -25.298399                       Pseudo R2       =     0.5655 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
      maxflx |   .7940135   .0405615    -4.52   0.000     .7183646    .8776287 
------------------------------------------------------------------------------ 
 
. logistic  case_control ke 
 
Logistic regression                               Number of obs   =         84 
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                                                  LR chi2(1)      =      61.84 
                                                  Prob > chi2     =     0.0000 
Log likelihood =  -27.30565                       Pseudo R2       =     0.5310 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
          ke |   1.957467   .2782028     4.73   0.000     1.481557     2.58625 
------------------------------------------------------------------------------ 
 
. logistic  case_control  truelag  
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(1)      =       0.83 
                                                  Prob > chi2     =     0.3623 
Log likelihood = -57.809372                       Pseudo R2       =     0.0071 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     truelag |   1.078102   .0897547     0.90   0.366     .9157887    1.269184 
------------------------------------------------------------------------------ 
 
. logistic  case_control  tug 
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(1)      =      79.17 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -18.640182                       Pseudo R2       =     0.6799 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         tug |   3.460932   1.054232     4.08   0.000     1.905062    6.287485 
------------------------------------------------------------------------------ 
 
. logistic  case_control oxford 
outcome = oxford > 17 predicts data perfectly 
r(2000); 
 
end of do-file 
 
r(2000); 
 
. logistic  case_control akssobj  
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(1)      =     103.78 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -6.3362591                       Pseudo R2       =     0.8912 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     akssobj |   .5404446   .1358372    -2.45   0.014      .330223    .8844943 
------------------------------------------------------------------------------ 
Note: 0 failures and 11 successes completely determined. 
 
. logistic  case_control akssfun 
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(1)      =      85.42 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -15.515001                       Pseudo R2       =     0.7335 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     akssfun |   .8381752   .0350472    -4.22   0.000     .7722234    .9097596 
------------------------------------------------------------------------------ 
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.  
. *gen lngkp=ln(gkp) 
. *logistic  case_control lngkp 
.  
. * LOOK AT THE MODEL WITH AKS OBJECTIVE AS THE PREDICTOR 
.  
. logistic  case_control akssobj  
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(1)      =     103.78 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -6.3362591                       Pseudo R2       =     0.8912 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     akssobj |   .5404446   .1358372    -2.45   0.014      .330223    .8844943 
------------------------------------------------------------------------------ 
Note: 0 failures and 11 successes completely determined. 
 
.  
. * TRY OBJECTIVE AND FUNCTIONAL IN THE SAME MODEL 
. * THIS BREAKS DOWN BECAUSE THE TWO VARIABLES ARE STRONGLY CORRELATED 
.  
. logistic  case_control akssobj akssfun 
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(2)      =     116.45 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -6.773e-08                       Pseudo R2       =     1.0000 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     akssobj |   .0008897    1.42557    -0.00   0.997            0           . 
     akssfun |   .2440843   134.5514    -0.00   0.998            0           . 
------------------------------------------------------------------------------ 
Note: 41 failures and 40 successes completely determined. 
 
.  
.  
. * START AGAIN USING AKS FUNCTIONAL AS THE FIRST INDEPENDANT VARIABLE 
.  
. logistic  case_control akssfun  
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(1)      =      85.42 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -15.515001                       Pseudo R2       =     0.7335 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     akssfun |   .8381752   .0350472    -4.22   0.000     .7722234    .9097596 
------------------------------------------------------------------------------ 
 
.  
.  
. * NOW ADD KNEE EXTENSION TO THE MODEL 
. * THIS IS MODEL 1 
.  
. logistic  case_control akssfun ke  
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(2)      =     105.38 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -5.5334376                       Pseudo R2       =     0.9050 
 
------------------------------------------------------------------------------ 
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case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     akssfun |   .7662152   .0958762    -2.13   0.033     .5995705    .9791771 
          ke |   2.160413   .7123772     2.34   0.019     1.132037    4.122997 
------------------------------------------------------------------------------ 
Note: 0 failures and 7 successes completely determined. 
 
. predict  prob1 
(option pr assumed; Pr(case_control)) 
 
.  
. * NOW ADD MAXFLEX INSTEAD OF KNEE EXTENSION 
. * THIS IS MODEL 4 
.  
. logistic  case_control akssfun maxflx 
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(2)      =      98.58 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -8.9323456                       Pseudo R2       =     0.8466 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     akssfun |   .8665039   .0385575    -3.22   0.001     .7941343    .9454685 
      maxflx |   .7830936   .0930401    -2.06   0.040     .6204141    .9884295 
------------------------------------------------------------------------------ 
 
. predict  prob4 
(option pr assumed; Pr(case_control)) 
 
.  
. * NOW HAVE AKS FUNCTIONAL, KNEE EXTENSION and MAXFLUX IN THE MODEL 
. * THIS MODEL HAS VERY LARGE ODDS RATIOS 
.  
. logistic  case_control akssfun ke maxflx  
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(3)      =     116.45 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -1.600e-08                       Pseudo R2       =     1.0000 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     akssfun |   .0014209          .        .       .            .           . 
          ke |   3.17e+07          .        .       .            .           . 
      maxflx |   .0344765   1.939003    -0.06   0.952     4.62e-50    2.57e+46 
------------------------------------------------------------------------------ 
Note: 41 failures and 42 successes completely determined. 
 
.  
. * NOW CONSIDER THE MODEL WITH AKS FUNCTIONAL KE and TUG 
. * IN THIS MODEL TUG IS NOT SIGNIFICANT 
.  
. logistic  case_control akssfun ke tug 
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(3)      =     110.92 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -2.7667095                       Pseudo R2       =     0.9525 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     akssfun |   .8360005   .1142184    -1.31   0.190     .6396042    1.092702 
          ke |   3.122065   2.429613     1.46   0.143     .6792521    14.35003 
         tug |   8.372278    16.6397     1.07   0.285     .1702555    411.7049 
------------------------------------------------------------------------------ 
Note: 4 failures and 21 successes completely determined. 
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. predict probnew 
(option pr assumed; Pr(case_control)) 
 
.  
. * NOW CONSIDER THE MODEL WITH AKS FUNCTIONAL KE and TRUELAG 
. * IN THIS MODEL TRUELAG IS NOT SIGNIFICANT 
.  
. logistic  case_control akssfun ke truelag 
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(3)      =     105.39 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -5.5289614                       Pseudo R2       =     0.9050 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     akssfun |   .7611958   .1126729    -1.84   0.065     .5695093    1.017401 
          ke |   2.164031   .7248356     2.30   0.021     1.122422    4.172255 
     truelag |   .9632084   .3844963    -0.09   0.925     .4404891    2.106228 
------------------------------------------------------------------------------ 
Note: 0 failures and 7 successes completely determined. 
 
. predict probnew1 
(option pr assumed; Pr(case_control)) 
 
.   
. * NOW CONSIDER THE MODEL WITH AKS FUNCTIONAL KE TRUELAG and TUG 
. * THIS MODEL HAS VERY LARGE ODDS RATIOS 
.  
. logistic  case_control akssfun ke tug truelag  
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(4)      =     116.45 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -3.420e-08                       Pseudo R2       =     1.0000 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
     akssfun |   .0309871   2.209038    -0.05   0.961     6.46e-63    1.49e+59 
          ke |   2.20e+07          .        .       .            .           . 
         tug |   1.74e+15          .        .       .            .           . 
     truelag |   3.30e-07   .0012359    -0.00   0.997            0           . 
------------------------------------------------------------------------------ 
Note: 41 failures and 41 successes completely determined. 
 
.  
.  
. corr akssobj akssfun 
(obs=84) 
 
             |  akssobj  akssfun 
-------------+------------------ 
     akssobj |   1.0000 
     akssfun |   0.7947   1.0000 
 
 
.  
. * NOW BUILD MODEL AGAIN STARTING FROM maximum flex * 
.  
. logistic  case_control maxflx  
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(1)      =      65.85 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -25.298399                       Pseudo R2       =     0.5655 
 
------------------------------------------------------------------------------ 
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case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
      maxflx |   .7940135   .0405615    -4.52   0.000     .7183646    .8776287 
------------------------------------------------------------------------------ 
 
.  
. * NOW MODEL WITH KE AND MAXFLX THIS IS MODEL 2  
. logistic  case_control ke maxflx  
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(2)      =      88.68 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -13.886774                       Pseudo R2       =     0.7615 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
          ke |   1.780432    .319818     3.21   0.001     1.252059    2.531782 
      maxflx |   .8296008   .0450093    -3.44   0.001     .7459127    .9226785 
------------------------------------------------------------------------------ 
 
. predict prob2 
(option pr assumed; Pr(case_control)) 
 
.  
. * THE MODEL WITH KE MAXFLX AND AKS FUNCTIONAL HAS LARGE ORS 
. logistic  case_control ke maxflx akssfun 
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(3)      =     116.45 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -1.600e-08                       Pseudo R2       =     1.0000 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
          ke |   3.17e+07          .        .       .            .           . 
      maxflx |   .0344765   1.939003    -0.06   0.952     4.62e-50    2.57e+46 
     akssfun |   .0014209          .        .       .            .           . 
------------------------------------------------------------------------------ 
Note: 41 failures and 42 successes completely determined. 
 
.   
. * THE MODEL WITH KE MAXFLX AND TRUE LAG THIS IS MODEL 3 
. logistic  case_control ke maxflx truelag 
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(3)      =      91.53 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -12.461451                       Pseudo R2       =     0.7860 
 
------------------------------------------------------------------------------ 
case_control | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
          ke |   2.144537   .5647034     2.90   0.004     1.279952    3.593135 
      maxflx |   .8084275   .0546322    -3.15   0.002     .7081386    .9229197 
     truelag |   1.526829   .3997034     1.62   0.106     .9140234     2.55049 
------------------------------------------------------------------------------ 
 
. predict prob3 
(option pr assumed; Pr(case_control)) 
 
.  
. sort prob1 
 
.  
. browse givenname surname case_control prob1 prob2 prob3 prob4 probnew probnew1 
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Appendix 18 Website for calculating probability of TKA 
 
A web page that calculates the probability of TKA using KSS(Fun)/flexion is provisionally located 
http://www.uq.edu.au/tru/tkrprob/ 
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